Other Sites:
Robert J. Robbins is a biologist, an educator, a science administrator, a publisher, an information technologist, and an IT leader and manager who specializes in advancing biomedical knowledge and supporting education through the application of information technology. More About: RJR | OUR TEAM | OUR SERVICES | THIS WEBSITE
RJR: Recommended Bibliography 21 Nov 2026 at 01:41 Created:
Biofilm
Wikipedia: Biofilm A biofilm is any group of microorganisms in which cells stick to each other and often also to a surface. These adherent cells become embedded within a slimy extracellular matrix that is composed of extracellular polymeric substances (EPS). The EPS components are produced by the cells within the biofilm and are typically a polymeric conglomeration of extracellular DNA, proteins, and polysaccharides. Because they have three-dimensional structure and represent a community lifestyle for microorganisms, biofilms are frequently described metaphorically as cities for microbes. Biofilms may form on living or non-living surfaces and can be prevalent in natural, industrial and hospital settings. The microbial cells growing in a biofilm are physiologically distinct from planktonic cells of the same organism, which, by contrast, are single-cells that may float or swim in a liquid medium. Biofilms can be present on the teeth of most animals as dental plaque, where they may cause tooth decay and gum disease. Microbes form a biofilm in response to many factors, which may include cellular recognition of specific or non-specific attachment sites on a surface, nutritional cues, or in some cases, by exposure of planktonic cells to sub-inhibitory concentrations of antibiotics. When a cell switches to the biofilm mode of growth, it undergoes a phenotypic shift in behavior in which large suites of genes are differentially regulated.
Created with PubMed® Query: ( biofilm[title] NOT 28392838[PMID] NOT 31293528[PMID] NOT 29372251[PMID] ) NOT pmcbook NOT ispreviousversion
Citations The Papers (from PubMed®)
RevDate: 2026-11-19
Frankincense-Myrrh Essential Oil Modulates Biofilm Formation and the Expression of Quorum Sensing Associated Genes in Multidrug-Resistant Pseudomonas aeruginosa and MRSA: Integrated Metabolomic, Network Pharmacology, and Wound-Healing Evidence.
Microbial pathogenesis pii:S0882-4010(26)00651-0 [Epub ahead of print].
Biofilm-associated wound infections involving multidrug-resistant pathogens represent a substantial clinical and public health burden, driven by persistent microbial colonization, impaired tissue regeneration, and reduced responsiveness to conventional antimicrobial therapy. This study elucidated the chemical composition and biological properties of a frankincense-myrrh essential-oil blend (FM-EO) through an integrated phytochemical, microbiological, and computational investigation. Its activity was characterized by using clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), with emphasis on pathogen susceptibility, biofilm-associated phenotypes, and wound-healing responses. FM-EO exhibited significant antibacterial activity, with inhibition zones of 25-30 mm and minimum inhibitory concentrations of 1.3 mg/mL against P. aeruginosa and 0.78 mg/mL against MRSA. At sub-inhibitory concentrations, FM-EO inhibited biofilm formation and reduced the expression of quorum-sensing-associated genes (lasR, lasI, rhlR, and rhlI) in P. aeruginosa, as well as the biofilm-associated genes icaA and icaD in MRSA. GC-MS analysis revealed complementary phytochemical profiles, with frankincense oil dominated by D-limonene-rich monoterpenes, whereas myrrh oil was enriched in triterpenoids, including 24-norursa derivatives and α-amyrin. In infected excision wound models, FM-EO accelerated wound closure, achieving healing rates of 92.18% and 95.95%, approaching or exceeding those observed with MEBO. FM-EO increased miR-21 expression and modulated Nrf2-associated antioxidant defense while suppressing miR-125b, TNF-α, NF-κB, nitric oxide, and lipid peroxidation, suggesting modulation of oxidative stress, inflammatory signaling, and tissue remodeling. Histopathological and immunohistochemical findings supported enhanced re-epithelialization, VEGF-associated angiogenesis, collagen deposition, and reduced inflammatory infiltration. Network pharmacology analysis identified 191 overlapping targets between the phytochemicals and wound infection, with TNF, NFKB1, NFE2L2, and VEGFA emerging as key network hubs implicated primarily in VEGF- and NF-κB-mediated signaling pathways. These findings demonstrate that FM-EO exhibits antibacterial, biofilm-formation inhibitory activity, downregulates the transcription of QS-associated genes and promotes wound healing in infected wounds, with complementary anti-inflammatory, antioxidant, and tissue-repair effects. These integrated findings support further investigation of FM-EO as a potential adjunctive candidate for managing antimicrobial-resistant wound infections.
Additional Links: PMID-43057544
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43057544,
year = {2026},
author = {Turkey, MS and Nazeam, JA and El-Shazly, M and Mohsen, M and Ali, MM and Essa, MA},
title = {Frankincense-Myrrh Essential Oil Modulates Biofilm Formation and the Expression of Quorum Sensing Associated Genes in Multidrug-Resistant Pseudomonas aeruginosa and MRSA: Integrated Metabolomic, Network Pharmacology, and Wound-Healing Evidence.},
journal = {Microbial pathogenesis},
volume = {},
number = {},
pages = {108925},
doi = {10.1016/j.micpath.2026.108925},
pmid = {43057544},
issn = {1096-1208},
abstract = {Biofilm-associated wound infections involving multidrug-resistant pathogens represent a substantial clinical and public health burden, driven by persistent microbial colonization, impaired tissue regeneration, and reduced responsiveness to conventional antimicrobial therapy. This study elucidated the chemical composition and biological properties of a frankincense-myrrh essential-oil blend (FM-EO) through an integrated phytochemical, microbiological, and computational investigation. Its activity was characterized by using clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), with emphasis on pathogen susceptibility, biofilm-associated phenotypes, and wound-healing responses. FM-EO exhibited significant antibacterial activity, with inhibition zones of 25-30 mm and minimum inhibitory concentrations of 1.3 mg/mL against P. aeruginosa and 0.78 mg/mL against MRSA. At sub-inhibitory concentrations, FM-EO inhibited biofilm formation and reduced the expression of quorum-sensing-associated genes (lasR, lasI, rhlR, and rhlI) in P. aeruginosa, as well as the biofilm-associated genes icaA and icaD in MRSA. GC-MS analysis revealed complementary phytochemical profiles, with frankincense oil dominated by D-limonene-rich monoterpenes, whereas myrrh oil was enriched in triterpenoids, including 24-norursa derivatives and α-amyrin. In infected excision wound models, FM-EO accelerated wound closure, achieving healing rates of 92.18% and 95.95%, approaching or exceeding those observed with MEBO. FM-EO increased miR-21 expression and modulated Nrf2-associated antioxidant defense while suppressing miR-125b, TNF-α, NF-κB, nitric oxide, and lipid peroxidation, suggesting modulation of oxidative stress, inflammatory signaling, and tissue remodeling. Histopathological and immunohistochemical findings supported enhanced re-epithelialization, VEGF-associated angiogenesis, collagen deposition, and reduced inflammatory infiltration. Network pharmacology analysis identified 191 overlapping targets between the phytochemicals and wound infection, with TNF, NFKB1, NFE2L2, and VEGFA emerging as key network hubs implicated primarily in VEGF- and NF-κB-mediated signaling pathways. These findings demonstrate that FM-EO exhibits antibacterial, biofilm-formation inhibitory activity, downregulates the transcription of QS-associated genes and promotes wound healing in infected wounds, with complementary anti-inflammatory, antioxidant, and tissue-repair effects. These integrated findings support further investigation of FM-EO as a potential adjunctive candidate for managing antimicrobial-resistant wound infections.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Molecular Mechanisms and Regulation of Biofilm Formation in Vibrio parahaemolyticus.
Journal of food science, 91(11):.
Vibrio parahaemolyticus is a major foodborne pathogen whose biofilm formation enhances environmental persistence and virulence. This review examines the structural basis and dynamic development of V. parahaemolyticus biofilms, including key surface-associated structures (flagella, pili, and capsular polysaccharide [CPS]) and extracellular matrix components (two distinct exopolysaccharides [EPS-I and EPS-II] and other matrix elements). It then discusses how c-di-GMP signaling, quorum sensing (QS), two-component systems, and global transcriptional regulators form an interconnected regulatory network controlling the motile-to-sessile transition and its reversal. By distinguishing EPS-I and EPS-II and clarifying the dual role of CPS in biofilm architecture and serotype classification, this review provides an integrated view of matrix biology and regulatory integration, and highlights unresolved questions regarding signal integration and phenotypic heterogeneity.
Additional Links: PMID-43058033
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058033,
year = {2026},
author = {Tang, H and Lu, R and Zhang, Y},
title = {Molecular Mechanisms and Regulation of Biofilm Formation in Vibrio parahaemolyticus.},
journal = {Journal of food science},
volume = {91},
number = {11},
pages = {},
doi = {10.1111/1750-3841.71654},
pmid = {43058033},
issn = {1750-3841},
support = {JCZ2025004//Natural Science Foundation of Nantong/ ; JC2023045//Natural Science Foundation of Nantong/ ; MS2025051//Research Projects of Nantong Health Commission/ ; },
mesh = {*Biofilms/growth & development ; *Vibrio parahaemolyticus/physiology/genetics ; Quorum Sensing ; Gene Expression Regulation, Bacterial ; Signal Transduction ; Bacterial Proteins/genetics/metabolism ; Cyclic GMP/analogs & derivatives/metabolism ; Polysaccharides, Bacterial/metabolism ; },
abstract = {Vibrio parahaemolyticus is a major foodborne pathogen whose biofilm formation enhances environmental persistence and virulence. This review examines the structural basis and dynamic development of V. parahaemolyticus biofilms, including key surface-associated structures (flagella, pili, and capsular polysaccharide [CPS]) and extracellular matrix components (two distinct exopolysaccharides [EPS-I and EPS-II] and other matrix elements). It then discusses how c-di-GMP signaling, quorum sensing (QS), two-component systems, and global transcriptional regulators form an interconnected regulatory network controlling the motile-to-sessile transition and its reversal. By distinguishing EPS-I and EPS-II and clarifying the dual role of CPS in biofilm architecture and serotype classification, this review provides an integrated view of matrix biology and regulatory integration, and highlights unresolved questions regarding signal integration and phenotypic heterogeneity.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Vibrio parahaemolyticus/physiology/genetics
Quorum Sensing
Gene Expression Regulation, Bacterial
Signal Transduction
Bacterial Proteins/genetics/metabolism
Cyclic GMP/analogs & derivatives/metabolism
Polysaccharides, Bacterial/metabolism
RevDate: 2026-11-19
CmpDate: 2026-11-19
Biofilm-State Probiotics for Seafood Safety: Multifactorial Mechanisms and Emerging Biocontrol Strategies.
Comprehensive reviews in food science and food safety, 25(6):.
Biofilms formed by foodborne pathogens on seafood and processing surfaces can withstand refrigeration, cleaning, and chemical sanitization, allowing them to persist as reservoirs for recurrent product contamination. The antimicrobial and antibiofilm activities of probiotic bacteria, particularly lactic acid bacteria (LAB), are well documented, but the physiological state in which a probiotic is applied has received far less attention. Biofilm-state probiotics (BSPs), defined here as probiotic microorganisms intentionally established as confirmed surface-associated biofilms, occupy the colonizable surface before pathogens arrive, whereas planktonic cells and probiotic-derived preparations such as cell-free supernatants and bacteriocins deliver activity that dilutes, degrades, and must be reapplied. Existing reviews discuss these categories together, making it difficult to determine whether reported activity is attributable to the biofilm state. This review applies an explicit framework separating direct BSP evidence, in which a confirmed probiotic biofilm is challenged with a pathogen, from supporting evidence obtained by other means. Applying it leaves a small body of work. Preformed probiotic biofilms have excluded Listeria monocytogenes, Salmonella Typhimurium, and Escherichia coli O157:H7 from abiotic surfaces; a pre-established Lactiplantibacillus plantarum biofilm suppressed adhesion, motility, and quorum sensing in Vibrio parahaemolyticus; and competitive-exclusion bacteria eliminated L. monocytogenes from five of six drains in a commercial processing plant for 13 weeks. However, no study has compared one strain as biofilm, planktonic cells, and cell-free preparation in a seafood matrix, and none has evaluated food-contact surfaces during production. BSPs therefore remain an emerging platform rather than a validated intervention, requiring standardized biofilm verification, sanitation compatibility, regulatory clarification, and pilot-scale validation.
Additional Links: PMID-43058043
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058043,
year = {2026},
author = {Ghimire, A and Rahman, MA and Akter, S and Ashrafudoulla, M and Ha, SD},
title = {Biofilm-State Probiotics for Seafood Safety: Multifactorial Mechanisms and Emerging Biocontrol Strategies.},
journal = {Comprehensive reviews in food science and food safety},
volume = {25},
number = {6},
pages = {},
doi = {10.1111/1541-4337.70700},
pmid = {43058043},
issn = {1541-4337},
support = {RS-2024-00339436//National Research Foundation of Korea/ ; RS-2026-25522906//Ministry of Food and Drug Safety/ ; },
mesh = {*Biofilms/growth & development ; *Probiotics ; *Seafood/microbiology ; *Food Safety ; Food Microbiology ; Animals ; Humans ; },
abstract = {Biofilms formed by foodborne pathogens on seafood and processing surfaces can withstand refrigeration, cleaning, and chemical sanitization, allowing them to persist as reservoirs for recurrent product contamination. The antimicrobial and antibiofilm activities of probiotic bacteria, particularly lactic acid bacteria (LAB), are well documented, but the physiological state in which a probiotic is applied has received far less attention. Biofilm-state probiotics (BSPs), defined here as probiotic microorganisms intentionally established as confirmed surface-associated biofilms, occupy the colonizable surface before pathogens arrive, whereas planktonic cells and probiotic-derived preparations such as cell-free supernatants and bacteriocins deliver activity that dilutes, degrades, and must be reapplied. Existing reviews discuss these categories together, making it difficult to determine whether reported activity is attributable to the biofilm state. This review applies an explicit framework separating direct BSP evidence, in which a confirmed probiotic biofilm is challenged with a pathogen, from supporting evidence obtained by other means. Applying it leaves a small body of work. Preformed probiotic biofilms have excluded Listeria monocytogenes, Salmonella Typhimurium, and Escherichia coli O157:H7 from abiotic surfaces; a pre-established Lactiplantibacillus plantarum biofilm suppressed adhesion, motility, and quorum sensing in Vibrio parahaemolyticus; and competitive-exclusion bacteria eliminated L. monocytogenes from five of six drains in a commercial processing plant for 13 weeks. However, no study has compared one strain as biofilm, planktonic cells, and cell-free preparation in a seafood matrix, and none has evaluated food-contact surfaces during production. BSPs therefore remain an emerging platform rather than a validated intervention, requiring standardized biofilm verification, sanitation compatibility, regulatory clarification, and pilot-scale validation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Probiotics
*Seafood/microbiology
*Food Safety
Food Microbiology
Animals
Humans
RevDate: 2026-11-19
CmpDate: 2026-11-19
Rationalizing local antibiotic therapies for biofilm-associated ventricular assist device driveline infections: an in vitro simulation.
The Journal of antimicrobial chemotherapy, 81(12):.
OBJECTIVES: Recurrent ventricular assist device (VAD) driveline infections due to microbial biofilm growths in the driveline tunnel may be managed by local antibiotic therapies. This study aims to use in vitro simulation to rationalize and optimize local antibiotic therapies for biofilm-associated deep driveline infections.
METHODS: Laboratory reference strains and clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis obtained from patients with driveline infections, together with seven conventional antibiotics, were selected for this study. Antibiotic susceptibility tests were performed for bacteria grown as microplate-based biofilms using endpoints relevant to clinical driveline infection management outcomes. Bacterial lethality and metabolic activity were investigated for each antibiotic across different concentrations to mechanistically understand their anti-biofilm efficacy. Localized antibiotics delivered via commercially available carriers were evaluated against staphylococcal biofilms established on driveline cutouts within simulated tissue tunnels, mimicking the conditions encountered in deep driveline infections.
RESULTS: Gentamicin and vancomycin combination at high concentrations outperformed single antibiotics or other combinations in eradicating microplate-based staphylococcal biofilms, achieving a complete killing in 3/5 strains. High concentrations of gentamicin demonstrated potent bacterial lethality that was less dependent on cell metabolic activity, whereas cell wall-targeting antibiotics killed only metabolically active cells. STIMULAN beads embedded with gentamicin and vancomycin showed ideal pharmacodynamics in the driveline tunnel and effectively kill driveline-based staphylococcal biofilms; vancomycin powder or TYRX incorporating rifampicin and minocycline only demonstrated limited anti-staphylococcal biofilm efficacy.
CONCLUSIONS: Local administration of high concentrations of gentamicin, ideally in combination with vancomycin, may serve as a potential curative strategy for staphylococcal driveline infections.
Additional Links: PMID-43058062
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058062,
year = {2026},
author = {Qu, Y and McGiffin, D and Kaye, DM and Sun, Y and Spencer, N and Peleg, AY},
title = {Rationalizing local antibiotic therapies for biofilm-associated ventricular assist device driveline infections: an in vitro simulation.},
journal = {The Journal of antimicrobial chemotherapy},
volume = {81},
number = {12},
pages = {},
doi = {10.1093/jac/dkag393},
pmid = {43058062},
issn = {1460-2091},
support = {//Consortium for Infection and Innovation (CII)/ ; //First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China/ ; //Alfred Hospital Foundation, Department of Infectious Diseases/ ; //Artificial Heart Frontier Program/ ; },
mesh = {*Biofilms/drug effects/growth & development ; *Anti-Bacterial Agents/pharmacology/therapeutic use ; Humans ; *Staphylococcus epidermidis/drug effects/isolation & purification/physiology ; *Heart-Assist Devices/microbiology/adverse effects ; Microbial Sensitivity Tests ; *Staphylococcus aureus/drug effects/isolation & purification/physiology ; *Prosthesis-Related Infections/drug therapy/microbiology ; *Staphylococcal Infections/drug therapy/microbiology ; Microbial Viability/drug effects ; Vancomycin/pharmacology ; },
abstract = {OBJECTIVES: Recurrent ventricular assist device (VAD) driveline infections due to microbial biofilm growths in the driveline tunnel may be managed by local antibiotic therapies. This study aims to use in vitro simulation to rationalize and optimize local antibiotic therapies for biofilm-associated deep driveline infections.
METHODS: Laboratory reference strains and clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis obtained from patients with driveline infections, together with seven conventional antibiotics, were selected for this study. Antibiotic susceptibility tests were performed for bacteria grown as microplate-based biofilms using endpoints relevant to clinical driveline infection management outcomes. Bacterial lethality and metabolic activity were investigated for each antibiotic across different concentrations to mechanistically understand their anti-biofilm efficacy. Localized antibiotics delivered via commercially available carriers were evaluated against staphylococcal biofilms established on driveline cutouts within simulated tissue tunnels, mimicking the conditions encountered in deep driveline infections.
RESULTS: Gentamicin and vancomycin combination at high concentrations outperformed single antibiotics or other combinations in eradicating microplate-based staphylococcal biofilms, achieving a complete killing in 3/5 strains. High concentrations of gentamicin demonstrated potent bacterial lethality that was less dependent on cell metabolic activity, whereas cell wall-targeting antibiotics killed only metabolically active cells. STIMULAN beads embedded with gentamicin and vancomycin showed ideal pharmacodynamics in the driveline tunnel and effectively kill driveline-based staphylococcal biofilms; vancomycin powder or TYRX incorporating rifampicin and minocycline only demonstrated limited anti-staphylococcal biofilm efficacy.
CONCLUSIONS: Local administration of high concentrations of gentamicin, ideally in combination with vancomycin, may serve as a potential curative strategy for staphylococcal driveline infections.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
*Anti-Bacterial Agents/pharmacology/therapeutic use
Humans
*Staphylococcus epidermidis/drug effects/isolation & purification/physiology
*Heart-Assist Devices/microbiology/adverse effects
Microbial Sensitivity Tests
*Staphylococcus aureus/drug effects/isolation & purification/physiology
*Prosthesis-Related Infections/drug therapy/microbiology
*Staphylococcal Infections/drug therapy/microbiology
Microbial Viability/drug effects
Vancomycin/pharmacology
RevDate: 2026-11-19
CmpDate: 2026-11-19
Sugar-binding protein MalE mediates cadmium immobilization and promotes biofilm formation in microbial communities.
NPJ biofilms and microbiomes, 12(1):.
Microbial communities survive in stressful environments like cadmium (Cd) contamination through adaptive responses. Cd pollution is frequently associated with elevated zinc (Zn); however, how microorganisms utilize Zn to shape community structure remains unclear. Here, we find that Zn enhances Cd(II) immobilization in Paenarthrobacter sp. CC6. Proteomic analysis and heterologous expression identified a sugar-binding protein (MalE) and an energy-related gene cluster (ansP-acoAB-aceF-menH) as key contributors to this process. We performed a one-month co-culture of the MalE-expressing strain with various Cd-resistant bacteria. This resulted in enrichment of Chitinophaga sp. CC14 within a synthetic community. Surface-displayed MalE enhanced biofilm formation by CC14, an effect that was abolished when the strains were separated by a membrane. Mass-spectrum analysis showed a concomitant increase in surface maltose on CC14, and point mutation verified that lysine-155 is associated with this interaction. Our findings unveil a MalE-mediated defense system that coordinately links Cd immobilization with biofilm-driven community assembly.
Additional Links: PMID-43058425
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058425,
year = {2026},
author = {Huo, X and Ye, L and Yi, J and Chen, D and Shi, K},
title = {Sugar-binding protein MalE mediates cadmium immobilization and promotes biofilm formation in microbial communities.},
journal = {NPJ biofilms and microbiomes},
volume = {12},
number = {1},
pages = {},
pmid = {43058425},
issn = {2055-5008},
support = {2024YFD1200202//the National Key Research and Development Program of China/ ; 2024040801020294//the Natural Science Foundation of Wuhan City/ ; },
mesh = {*Biofilms/growth & development ; *Cadmium/metabolism ; *Bacterial Proteins/metabolism/genetics ; Zinc/metabolism ; *Microbiota ; Proteomics ; Multigene Family ; },
abstract = {Microbial communities survive in stressful environments like cadmium (Cd) contamination through adaptive responses. Cd pollution is frequently associated with elevated zinc (Zn); however, how microorganisms utilize Zn to shape community structure remains unclear. Here, we find that Zn enhances Cd(II) immobilization in Paenarthrobacter sp. CC6. Proteomic analysis and heterologous expression identified a sugar-binding protein (MalE) and an energy-related gene cluster (ansP-acoAB-aceF-menH) as key contributors to this process. We performed a one-month co-culture of the MalE-expressing strain with various Cd-resistant bacteria. This resulted in enrichment of Chitinophaga sp. CC14 within a synthetic community. Surface-displayed MalE enhanced biofilm formation by CC14, an effect that was abolished when the strains were separated by a membrane. Mass-spectrum analysis showed a concomitant increase in surface maltose on CC14, and point mutation verified that lysine-155 is associated with this interaction. Our findings unveil a MalE-mediated defense system that coordinately links Cd immobilization with biofilm-driven community assembly.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Cadmium/metabolism
*Bacterial Proteins/metabolism/genetics
Zinc/metabolism
*Microbiota
Proteomics
Multigene Family
RevDate: 2026-11-20
Correction to "Molecular Regulation of Virulence and Dental Biofilm Formation in Streptococcus mutans: Unravelling the Crosstalk Between the VicRK and LiaSR Two-Component Systems''.
Additional Links: PMID-43059029
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059029,
year = {2026},
author = {},
title = {Correction to "Molecular Regulation of Virulence and Dental Biofilm Formation in Streptococcus mutans: Unravelling the Crosstalk Between the VicRK and LiaSR Two-Component Systems''.},
journal = {Molecular oral microbiology},
volume = {},
number = {},
pages = {},
doi = {10.1111/omi.70047},
pmid = {43059029},
issn = {2041-1014},
}
RevDate: 2026-11-20
Management of Non-Dental Biofilm-Induced Gingival Diseases and Conditions and Gingival Enlargement: The EFP S2k-Level Clinical Practice Guideline.
Journal of clinical periodontology [Epub ahead of print].
BACKGROUND: Following the 2018 Classification, the European Federation of Periodontology (EFP) developed Clinical Practice Guidelines (CPGs) for the management of periodontitis and peri-implant diseases. To date, no clinical practice guidelines have been developed for non-dental biofilm-induced gingival diseases (NBIGDs) and conditions or for gingival enlargement. While these conditions are less common/rare, they present in general and specialist practice settings and there is therefore a need to develop such a set of guidelines.
AIM: To develop an S2k-level CPG for the management of NBIGDs and conditions and gingival enlargement.
METHODS: This S2k-level CPG was developed by the EFP, following methodological guidance from the Association of Scientific Medical Societies in Germany and, where applicable, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) process. A rigorous and transparent process included the following: synthesis of relevant research in two specifically commissioned systematic reviews; evaluation of the quality and strength of evidence; formulation of specific recommendations; and a structured consensus process involving leading experts and broadly based stakeholders. Recommendations were based on the best available evidence, combined with structured expert consensus, particularly in areas where direct evidence remains scarce.
RESULTS: The S2k-level CPG for management of NBIGDs demonstrates that, because of their rarity, heterogeneity and complexity, and of the paucity of randomised controlled trials, NBIGDs should be managed within specialist centres, with urgent/immediate referral for suspected malignancies. Treating biofilm-induced inflammation is beneficial in most cases. Management of gingival enlargement is context-dependent and should be medical in nature, with surgery reserved for non-responsive cases.
CONCLUSION: The present S2k-level CPG informs clinical practice, health systems, policymakers and indirectly the public on the most effective interventions in the management of NBIGDs and gingival enlargement.
Additional Links: PMID-43059581
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059581,
year = {2026},
author = {Chapple, I and Herrera, D and Sanz, M and Sculean, A and Teughels, W and Kebschull, M and Papapanou, PN and Tonetti, MS and Aimetti, M and Alajbeg, I and Belibasakis, GN and Blanco, J and Bol-van den Hil, E and Bostanci, N and Bouchard, P and Božić, D and Buduneli, N and Bunæs, DF and Calciolari, E and Carra, MC and Ceballos, L and Chackartchi, T and Cosgarea, R and Danser, M and Derks, J and Discepoli, N and Dommisch, H and Donos, N and Dörfer, C and Eickholz, P and Eren Kuru, B and Faria Almeida, R and Farina, R and Figuero, E and Francisco, H and Fransson, H and Geisinger, ML and Goldstein, M and Gosset, M and Graziani, F and Gursoy, UK and Jepsen, S and Lang, NP and Loos, BG and López, R and Madianos, P and Matesanz, P and Meleti, M and Meyle, J and Mignogna, MD and Molina, A and Montero, E and Nibali, L and Pilloni, A and Polyzois, I and Preshaw, P and Rakic, M and Sánchez, N and Sanz-Sánchez, I and Shapira, L and Slot, DE and Stavropoulos, A and Suvan, J and Toma, S and Tomasi, C and Trombelli, L and van der Weijden, F and Vassilopoulos, S and West, N and Wilensky, A and Windisch, P and Yesiltan, E and Zampa, EP and , },
title = {Management of Non-Dental Biofilm-Induced Gingival Diseases and Conditions and Gingival Enlargement: The EFP S2k-Level Clinical Practice Guideline.},
journal = {Journal of clinical periodontology},
volume = {},
number = {},
pages = {},
doi = {10.1111/jcpe.70210},
pmid = {43059581},
issn = {1600-051X},
support = {//European Federation of Periodontology/ ; },
abstract = {BACKGROUND: Following the 2018 Classification, the European Federation of Periodontology (EFP) developed Clinical Practice Guidelines (CPGs) for the management of periodontitis and peri-implant diseases. To date, no clinical practice guidelines have been developed for non-dental biofilm-induced gingival diseases (NBIGDs) and conditions or for gingival enlargement. While these conditions are less common/rare, they present in general and specialist practice settings and there is therefore a need to develop such a set of guidelines.
AIM: To develop an S2k-level CPG for the management of NBIGDs and conditions and gingival enlargement.
METHODS: This S2k-level CPG was developed by the EFP, following methodological guidance from the Association of Scientific Medical Societies in Germany and, where applicable, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) process. A rigorous and transparent process included the following: synthesis of relevant research in two specifically commissioned systematic reviews; evaluation of the quality and strength of evidence; formulation of specific recommendations; and a structured consensus process involving leading experts and broadly based stakeholders. Recommendations were based on the best available evidence, combined with structured expert consensus, particularly in areas where direct evidence remains scarce.
RESULTS: The S2k-level CPG for management of NBIGDs demonstrates that, because of their rarity, heterogeneity and complexity, and of the paucity of randomised controlled trials, NBIGDs should be managed within specialist centres, with urgent/immediate referral for suspected malignancies. Treating biofilm-induced inflammation is beneficial in most cases. Management of gingival enlargement is context-dependent and should be medical in nature, with surgery reserved for non-responsive cases.
CONCLUSION: The present S2k-level CPG informs clinical practice, health systems, policymakers and indirectly the public on the most effective interventions in the management of NBIGDs and gingival enlargement.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Anti-Biofilm Effects of Alcohol-Free Mouthwash against Streptococcus mutans.
Journal of dental hygiene science, 26(1):10-19.
BACKGROUND: Various commercial mouthwashes are used in Korea. However, comparative data on how alcohol-containing and alcohol-free formulations differ in their ability to inhibit Streptococcus mutans biofilm formation remain limited. Few studies have assessed both planktonic antimicrobial activity and antibiofilm efficacy under conditions that simulate clinical use. This study aimed to evaluate these effects by comparing alcohol-containing and alcohol-free mouthwashes in a single species, S. mutans.
METHODS: Four commercially available mouthwashes were tested: two cetylpyridinium chloride-based formulations (Garglin Original[Ⓡ], Garglin Zero[Ⓡ]), two essential oil (EO)-based formulations, one alcohol-containing (Listerine Cool Mint[Ⓡ]), and one alcohol-free (Listerine Cool Mint Mild[Ⓡ] [LM]). Sterile distilled water and 0.1% chlorhexidine (CHX) served as the negative and positive controls, respectively. The planktonic antimicrobial activity was evaluated after a 1-minute exposure. For the biofilm experiment, S. mutans biofilms were formed on hydroxyapatite discs for 16 hours and subsequently treated with each mouthwash three times per day for 1 minute, totaling six treatments during a 64-hour maturation period that simulated clinical rinsing. Biofilm viability (log CFU/ml), thickness, and live/dead cell ratios were assessed using culture-based methods and confocal laser scanning microscopy with COMSTAT software.
RESULTS: All commercial mouthwashes demonstrated complete bactericidal activity below the detection limit against planktonic S. mutans. In contrast, only LM and CHX showed significant antibiofilm activity. LM reduced biofilm colony-forming unit (CFU) by approximately 0.7 log and decreased biofilm thickness and live/dead ratios by 39.0% and 30.8%, respectively, compared with the control (p<0.01). CHX exhibited the greatest reduction across all parameters.
CONCLUSION: LM exhibited the strongest antibiofilm potential among all tested mouthwashes. These findings indicate that alcohol-free EO rinses may be a clinically useful alternative for patients who cannot tolerate alcohol-containing products or long-term CHX use. Incorporating such formulations into daily oral hygiene routines may help prevent dental caries.
Additional Links: PMID-43059615
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059615,
year = {2026},
author = {Go, HB and Choi, JH},
title = {Anti-Biofilm Effects of Alcohol-Free Mouthwash against Streptococcus mutans.},
journal = {Journal of dental hygiene science},
volume = {26},
number = {1},
pages = {10-19},
pmid = {43059615},
issn = {2233-7679},
abstract = {BACKGROUND: Various commercial mouthwashes are used in Korea. However, comparative data on how alcohol-containing and alcohol-free formulations differ in their ability to inhibit Streptococcus mutans biofilm formation remain limited. Few studies have assessed both planktonic antimicrobial activity and antibiofilm efficacy under conditions that simulate clinical use. This study aimed to evaluate these effects by comparing alcohol-containing and alcohol-free mouthwashes in a single species, S. mutans.
METHODS: Four commercially available mouthwashes were tested: two cetylpyridinium chloride-based formulations (Garglin Original[Ⓡ], Garglin Zero[Ⓡ]), two essential oil (EO)-based formulations, one alcohol-containing (Listerine Cool Mint[Ⓡ]), and one alcohol-free (Listerine Cool Mint Mild[Ⓡ] [LM]). Sterile distilled water and 0.1% chlorhexidine (CHX) served as the negative and positive controls, respectively. The planktonic antimicrobial activity was evaluated after a 1-minute exposure. For the biofilm experiment, S. mutans biofilms were formed on hydroxyapatite discs for 16 hours and subsequently treated with each mouthwash three times per day for 1 minute, totaling six treatments during a 64-hour maturation period that simulated clinical rinsing. Biofilm viability (log CFU/ml), thickness, and live/dead cell ratios were assessed using culture-based methods and confocal laser scanning microscopy with COMSTAT software.
RESULTS: All commercial mouthwashes demonstrated complete bactericidal activity below the detection limit against planktonic S. mutans. In contrast, only LM and CHX showed significant antibiofilm activity. LM reduced biofilm colony-forming unit (CFU) by approximately 0.7 log and decreased biofilm thickness and live/dead ratios by 39.0% and 30.8%, respectively, compared with the control (p<0.01). CHX exhibited the greatest reduction across all parameters.
CONCLUSION: LM exhibited the strongest antibiofilm potential among all tested mouthwashes. These findings indicate that alcohol-free EO rinses may be a clinically useful alternative for patients who cannot tolerate alcohol-containing products or long-term CHX use. Incorporating such formulations into daily oral hygiene routines may help prevent dental caries.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Identification of Early Colonizing Bacteria Involved in Formation of Dental Unit Waterlines Biofilm Using TA Cloning.
Journal of dental hygiene science, 24(4):383-390.
BACKGROUND: Bacterial adhesion is the first and the most important step in biofilm formation in dental unit waterlines (DUWLs). Information on the initial adhesion and colonizing bacteria is needed to prevent biofilm formation in DUWLs. To identify the bacterial strains involved in the early adhesion step of DUWL biofilm formation, the thymine adenine (TA) cloning method was used to identify the constituent bacterial species in biofilms formed at different time points in DUWL biofilm models.
METHODS: DUWL biofilms were formed in the United States Centers for Disease Control and Prevention (CDC) biofilm reactor model, and the bacterial species in the DUWL biofilms obtained at different formation periods were identified using TA cloning.
RESULTS: Thirteen genera and 19 species were identified from 267 clones. For Rhizobium pusense and Pseudomonas parafulva, the detection was low in batch culture but high in the biofilm formed.
CONCLUSION: R. pusense and P. parafulva may be involved in the early stages of DUWLs biofilm formation. The findings of this study may be helpful in developing methods for preventing DUWL biofilm formation in the future.
Additional Links: PMID-43059666
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059666,
year = {2024},
author = {Lee, SY and Yoon, HY},
title = {Identification of Early Colonizing Bacteria Involved in Formation of Dental Unit Waterlines Biofilm Using TA Cloning.},
journal = {Journal of dental hygiene science},
volume = {24},
number = {4},
pages = {383-390},
pmid = {43059666},
issn = {2233-7679},
abstract = {BACKGROUND: Bacterial adhesion is the first and the most important step in biofilm formation in dental unit waterlines (DUWLs). Information on the initial adhesion and colonizing bacteria is needed to prevent biofilm formation in DUWLs. To identify the bacterial strains involved in the early adhesion step of DUWL biofilm formation, the thymine adenine (TA) cloning method was used to identify the constituent bacterial species in biofilms formed at different time points in DUWL biofilm models.
METHODS: DUWL biofilms were formed in the United States Centers for Disease Control and Prevention (CDC) biofilm reactor model, and the bacterial species in the DUWL biofilms obtained at different formation periods were identified using TA cloning.
RESULTS: Thirteen genera and 19 species were identified from 267 clones. For Rhizobium pusense and Pseudomonas parafulva, the detection was low in batch culture but high in the biofilm formed.
CONCLUSION: R. pusense and P. parafulva may be involved in the early stages of DUWLs biofilm formation. The findings of this study may be helpful in developing methods for preventing DUWL biofilm formation in the future.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Inhibitory Effect of Korean Mugwort (Artemisia princeps Pamp.) Extract on Growth and Biofilm Formation of Streptococcus mutans.
Journal of dental hygiene science, 24(4):400-405.
BACKGROUND: Dental plaque biofilms play a key role in the development of oral diseases such as dental caries. Streptococcus mutans is the primary contributor to oral biofilm formation and leads to the formation of other microbial communities. Artemisia princeps (AP) is a traditional herbal medicine with various pharmacological activities, including analgesic, antibacterial, and anti-inflammatory. This study investigated the inhibitory effects of AP extract on the growth and biofilm formation of S. mutans.
METHODS: AP extract was obtained via methanol extraction. The antimicrobial activity of the AP extract against S. mutans was measured using the minimum bactericidal concentration (MBC) test. Antibiofilm activity of the AP extract was investigated using a human saliva-coated biofilm formation assay, and the biofilms were confirmed using crystal violet.
RESULTS: AP extract reduced the growth of S. mutans in a dose-dependent manner, with an MBC of 1,250 ppm. Additionally, at 1,000 ppm of AP extract, biofilm formation was inhibited by approximately 70% compared to the negative control group, which is a higher anti-biofilm activity than chlorhexidine solution as positive control.
CONCLUSION: AP extract, which showed high antibacterial and antibiofilm activities against S. mutans, has potential as a preventive and therapeutic agent against oral diseases.
Additional Links: PMID-43059683
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059683,
year = {2024},
author = {Min, JH and Kim, KR},
title = {Inhibitory Effect of Korean Mugwort (Artemisia princeps Pamp.) Extract on Growth and Biofilm Formation of Streptococcus mutans.},
journal = {Journal of dental hygiene science},
volume = {24},
number = {4},
pages = {400-405},
pmid = {43059683},
issn = {2233-7679},
abstract = {BACKGROUND: Dental plaque biofilms play a key role in the development of oral diseases such as dental caries. Streptococcus mutans is the primary contributor to oral biofilm formation and leads to the formation of other microbial communities. Artemisia princeps (AP) is a traditional herbal medicine with various pharmacological activities, including analgesic, antibacterial, and anti-inflammatory. This study investigated the inhibitory effects of AP extract on the growth and biofilm formation of S. mutans.
METHODS: AP extract was obtained via methanol extraction. The antimicrobial activity of the AP extract against S. mutans was measured using the minimum bactericidal concentration (MBC) test. Antibiofilm activity of the AP extract was investigated using a human saliva-coated biofilm formation assay, and the biofilms were confirmed using crystal violet.
RESULTS: AP extract reduced the growth of S. mutans in a dose-dependent manner, with an MBC of 1,250 ppm. Additionally, at 1,000 ppm of AP extract, biofilm formation was inhibited by approximately 70% compared to the negative control group, which is a higher anti-biofilm activity than chlorhexidine solution as positive control.
CONCLUSION: AP extract, which showed high antibacterial and antibiofilm activities against S. mutans, has potential as a preventive and therapeutic agent against oral diseases.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Inhibitory Effect of Ethanol Extract of Angelica gigas Nakai on Biofilm Formation and Metabolic Activity of Streptococcus mutans according to Xylitol and Sucrose.
Journal of dental hygiene science, 24(4):374-382.
BACKGROUND: Angelica gigas Nakai Root (AGN) is a medicinal plant with various therapeutic effects. The purpose of this study was to determine the effect of a 70% ethanol extract of AGN (EAGN) on biofilm formation and metabolic activities of Streptococcus mutans according to exposure to xylitol and sucrose, and to confirm the possibility of using EAGN as an effective medicinal plant-derived anti-cariogenic substance.
METHODS: Bacterial growth and disk diffusion test were performed to confirm the antibacterial effects of EAGN against S. mutans in a brain-heart infusion (BHI) medium containing 1% xylitol and 1% sucrose, measurement of. Biofilm formation was confirmed using a biofilm formation assay and glycosyltransferase (GTF) activity. Metabolic activity was evaluated using a calcium assay, acid production assay and buffering capacity measurements.
RESULTS: EAGN showed antibacterial activity against S. mutans in a BHI medium containing 1% xylitol and sucrose. At 3.75 and 5.0 mg/ml EAGN in S. mutans-inoculated medium containing 1% sucrose, the antibacterial effect was greater than those of BHI only and 1% xylitol BHI media. In S. mutans-inoculated medium containing 1% sucrose, cariogenic biofilm formation, GTF activity, released Ca[2+] levels, and acidogenicity were significantly increased, but the buffering capacity was significantly decreased. According to EAGN treatment, cariogenic biofilm formation, GTF activity, measured released Ca[2+] levels, and acidogenicity were significantly decreased and buffering capacity was significantly increased. An EAGN over 3.75 mg/ml significantly reduced biofilm formation and Ca[2+]. Regardless of the concentration of EAGN, acidogenicity was reduced, and the buffering capacity was increased.
CONCLUSION: EAGN is a safe natural anti-cariogenic substance that inhibits biofilm formation by directly inhibiting GTF activity and adjusts the microenvironment for tooth remineralization by reducing Ca[2+] and acidogenicity and increasing the buffering capacity according to exposure to sucrose in S. mutans.
Additional Links: PMID-43059703
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059703,
year = {2024},
author = {Jeong, MJ and Kim, SO and Lim, DS and Heo, K and Jeong, SJ},
title = {Inhibitory Effect of Ethanol Extract of Angelica gigas Nakai on Biofilm Formation and Metabolic Activity of Streptococcus mutans according to Xylitol and Sucrose.},
journal = {Journal of dental hygiene science},
volume = {24},
number = {4},
pages = {374-382},
pmid = {43059703},
issn = {2233-7679},
abstract = {BACKGROUND: Angelica gigas Nakai Root (AGN) is a medicinal plant with various therapeutic effects. The purpose of this study was to determine the effect of a 70% ethanol extract of AGN (EAGN) on biofilm formation and metabolic activities of Streptococcus mutans according to exposure to xylitol and sucrose, and to confirm the possibility of using EAGN as an effective medicinal plant-derived anti-cariogenic substance.
METHODS: Bacterial growth and disk diffusion test were performed to confirm the antibacterial effects of EAGN against S. mutans in a brain-heart infusion (BHI) medium containing 1% xylitol and 1% sucrose, measurement of. Biofilm formation was confirmed using a biofilm formation assay and glycosyltransferase (GTF) activity. Metabolic activity was evaluated using a calcium assay, acid production assay and buffering capacity measurements.
RESULTS: EAGN showed antibacterial activity against S. mutans in a BHI medium containing 1% xylitol and sucrose. At 3.75 and 5.0 mg/ml EAGN in S. mutans-inoculated medium containing 1% sucrose, the antibacterial effect was greater than those of BHI only and 1% xylitol BHI media. In S. mutans-inoculated medium containing 1% sucrose, cariogenic biofilm formation, GTF activity, released Ca[2+] levels, and acidogenicity were significantly increased, but the buffering capacity was significantly decreased. According to EAGN treatment, cariogenic biofilm formation, GTF activity, measured released Ca[2+] levels, and acidogenicity were significantly decreased and buffering capacity was significantly increased. An EAGN over 3.75 mg/ml significantly reduced biofilm formation and Ca[2+]. Regardless of the concentration of EAGN, acidogenicity was reduced, and the buffering capacity was increased.
CONCLUSION: EAGN is a safe natural anti-cariogenic substance that inhibits biofilm formation by directly inhibiting GTF activity and adjusts the microenvironment for tooth remineralization by reducing Ca[2+] and acidogenicity and increasing the buffering capacity according to exposure to sucrose in S. mutans.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Dual-synergistic engineered MXene sonosensitizer with stabilized semiquinone radicals enables biofilm eradication and immunomodulatory bone regeneration in osteomyelitis.
Bioactive materials, 70:345-359.
Deep colonization of drug-resistant biofilms and impaired bone regeneration within the infectious microenvironment represent two major bottlenecks in the clinical management of osteomyelitis. Herein, we design a dually synergistically modified Ti3C2 MXene sonosensitizer. Lattice strain is introduced via Zn[2+] substitution doping, while interfacial passivation is achieved by coordination-stabilized dopamine semiquinone radicals. Such engineering extends the carrier lifetime by 86-fold, enabling efficient generation of hydroxyl radicals under ultrasound irradiation. This engineered material exhibits triple biofunctional activities: it eliminates over 99.9% of MRSA biofilms in vitro and downregulates bacterial drug-resistance pathways; sustained Zn[2+] release polarizes macrophages toward the pro-repair M2 phenotype to remodel the inflammatory microenvironment of infected tissues; in a rat osteomyelitis model, a single local administration combined with ultrasound eradicates deep-seated infection, facilitates collagen deposition and bone regeneration, with favorable biosafety both in vitro and in vivo. This work offers a strategy based on novel multifunctional bioactive materials for treating infectious bone defects, holding promising potential for clinical translation.
Additional Links: PMID-43060978
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060978,
year = {2027},
author = {Wang, Y and Li, C and Deng, R and Liu, Q and Huang, J and Mao, C and Li, Y and Chen, C and Liu, X and Juma, T and Wang, C and Wang, Y and Wu, S and Cao, Y},
title = {Dual-synergistic engineered MXene sonosensitizer with stabilized semiquinone radicals enables biofilm eradication and immunomodulatory bone regeneration in osteomyelitis.},
journal = {Bioactive materials},
volume = {70},
number = {},
pages = {345-359},
pmid = {43060978},
issn = {2452-199X},
abstract = {Deep colonization of drug-resistant biofilms and impaired bone regeneration within the infectious microenvironment represent two major bottlenecks in the clinical management of osteomyelitis. Herein, we design a dually synergistically modified Ti3C2 MXene sonosensitizer. Lattice strain is introduced via Zn[2+] substitution doping, while interfacial passivation is achieved by coordination-stabilized dopamine semiquinone radicals. Such engineering extends the carrier lifetime by 86-fold, enabling efficient generation of hydroxyl radicals under ultrasound irradiation. This engineered material exhibits triple biofunctional activities: it eliminates over 99.9% of MRSA biofilms in vitro and downregulates bacterial drug-resistance pathways; sustained Zn[2+] release polarizes macrophages toward the pro-repair M2 phenotype to remodel the inflammatory microenvironment of infected tissues; in a rat osteomyelitis model, a single local administration combined with ultrasound eradicates deep-seated infection, facilitates collagen deposition and bone regeneration, with favorable biosafety both in vitro and in vivo. This work offers a strategy based on novel multifunctional bioactive materials for treating infectious bone defects, holding promising potential for clinical translation.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Process and microbial signatures of nitrification constraints in a full-scale drinking water moving-bed biofilm reactor.
Biofilm, 12:100409.
Seasonal ammonia loading can impair nitrification in drinking-water biofilm reactors even when bulk dissolved oxygen remains high. We investigated a 450 MLD full-scale moving-bed biofilm reactor treating Shitalakshya River water in Dhaka, Bangladesh, across two six-month monitoring campaigns. December 2024-May 2025 as the primary dataset, supported by a second independent campaign (December 2025-May 2026) used to assess seasonal recurrence, together with demand-accounted oxygen analysis, composite shotgun metagenomics, and literature-informed mass-transfer screening. The reactor achieved 84.2% NH3-N and 83.3% sulfide removal, with volumetric and protected-area nitrification rates of 0.16 kg N m[-3] d[-1] and 0.49 g N m[-2] d[-1], respectively. The protected-area rate represents the mass of ammonia nitrogen removed per unit of carrier surface area per unit time, providing a measure of intrinsic biofilm nitrification capacity. The central empirical observation was that during peak dry-season loading, influent NH3-N reached a monthly mean of 11.36 mg L[-1] and residual ammonia and nitrite accumulated despite outlet dissolved oxygen remaining above 6 mg L[-1]. This high-DO/nitrification failure signature indicates that bulk-liquid oxygen depletion alone was insufficient to explain the observed impairment. Quantified liquid-phase terms accounted for 3.1-4.6% of oxygen introduced with air; because off-gas oxygen was not measured, this value is reported as an accounted oxygen fraction that represents a screening-level accounting proxy, not oxygen-transfer efficiency. Reactor-associated metagenomic profiles showed stronger descriptive enrichment of selected Nitrosomonas-affiliated taxa (2.9-10.2-fold) than of the detected Nitrobacter-affiliated taxon (1.9-fold) within a heterotroph-rich community. Together, the process and microbial signals were consistent with hypothesized carrier-scale mass-transfer and nitrifier-guild constraints during high ammonia loading. Empirical screening identified an apparent operational shift near 10.5-11 mg NH3-N L[-1], which prioritized hybrid coarse and fine-bubble aeration for pilot testing. The study provides a biofilm-centered diagnostic framework linking bulk reactor conditions to carrier-scale transport and microbial community structure in full-scale drinking-water pretreatment.
Additional Links: PMID-43061011
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061011,
year = {2026},
author = {Haque, ME and Sultana, M and Begum, A},
title = {Process and microbial signatures of nitrification constraints in a full-scale drinking water moving-bed biofilm reactor.},
journal = {Biofilm},
volume = {12},
number = {},
pages = {100409},
pmid = {43061011},
issn = {2590-2075},
abstract = {Seasonal ammonia loading can impair nitrification in drinking-water biofilm reactors even when bulk dissolved oxygen remains high. We investigated a 450 MLD full-scale moving-bed biofilm reactor treating Shitalakshya River water in Dhaka, Bangladesh, across two six-month monitoring campaigns. December 2024-May 2025 as the primary dataset, supported by a second independent campaign (December 2025-May 2026) used to assess seasonal recurrence, together with demand-accounted oxygen analysis, composite shotgun metagenomics, and literature-informed mass-transfer screening. The reactor achieved 84.2% NH3-N and 83.3% sulfide removal, with volumetric and protected-area nitrification rates of 0.16 kg N m[-3] d[-1] and 0.49 g N m[-2] d[-1], respectively. The protected-area rate represents the mass of ammonia nitrogen removed per unit of carrier surface area per unit time, providing a measure of intrinsic biofilm nitrification capacity. The central empirical observation was that during peak dry-season loading, influent NH3-N reached a monthly mean of 11.36 mg L[-1] and residual ammonia and nitrite accumulated despite outlet dissolved oxygen remaining above 6 mg L[-1]. This high-DO/nitrification failure signature indicates that bulk-liquid oxygen depletion alone was insufficient to explain the observed impairment. Quantified liquid-phase terms accounted for 3.1-4.6% of oxygen introduced with air; because off-gas oxygen was not measured, this value is reported as an accounted oxygen fraction that represents a screening-level accounting proxy, not oxygen-transfer efficiency. Reactor-associated metagenomic profiles showed stronger descriptive enrichment of selected Nitrosomonas-affiliated taxa (2.9-10.2-fold) than of the detected Nitrobacter-affiliated taxon (1.9-fold) within a heterotroph-rich community. Together, the process and microbial signals were consistent with hypothesized carrier-scale mass-transfer and nitrifier-guild constraints during high ammonia loading. Empirical screening identified an apparent operational shift near 10.5-11 mg NH3-N L[-1], which prioritized hybrid coarse and fine-bubble aeration for pilot testing. The study provides a biofilm-centered diagnostic framework linking bulk reactor conditions to carrier-scale transport and microbial community structure in full-scale drinking-water pretreatment.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
An i-Motif-gated DNA-based nanoassembly enables pH-responsive biofilm control and enamel remineralization for initial caries therapy.
Bioactive materials, 70:293-311.
Dental caries is a biofilm-mediated disease characterized by acidogenic microbial dysbiosis and enamel demineralization. Current antibacterial and remineralization strategies are often limited by poor penetration into cariogenic biofilms, nonselective antimicrobial activity, and the acid instability of mineral precursors. Here, we developed an i-Motif-gated DNA-based nanoassembly that integrates biofilm penetration, pH-responsive biofilm control, and biomimetic enamel regeneration for initial caries therapy. The nanoassembly was constructed by co-assembling i-Motif-forming DNA strands, DNA-templated silver nanoclusters and amorphous calcium phosphate precursors. In a validated three-species streptococcal biofilm model, the nanoassembly exhibited efficient penetration throughout the biofilm matrix. Under acidic cariogenic conditions, folding of the i-Motif structure promoted the release of silver-containing species, resulting in enhanced antibacterial activity against cariogenic-state biofilms while exerting minimal effects under relatively non-cariogenic conditions. Simultaneously, protonation of the DNA scaffold stabilized the amorphous calcium phosphate against acid dissolution down to pH 4.0, facilitating the regeneration of densely packed enamel-like crystals. In a rat caries model, topical treatment effectively suppressed cariogenic bacterial colonization and minimized lesion development without disrupting oral microbial diversity. These findings demonstrate that programmable DNA nanoassemblies can couple pH-responsive antibacterial activation with biomimetic mineralization, providing a promising strategy for precise management of initial caries.
Additional Links: PMID-43061391
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061391,
year = {2027},
author = {Lei, C and Zhu, YN and Jin, SY and Wang, M and Sun, H and Ma, YX and Luo, HW and Zhang, SH and Habelitz, S and Wei, JH and Niu, LN and Mu, Z},
title = {An i-Motif-gated DNA-based nanoassembly enables pH-responsive biofilm control and enamel remineralization for initial caries therapy.},
journal = {Bioactive materials},
volume = {70},
number = {},
pages = {293-311},
pmid = {43061391},
issn = {2452-199X},
abstract = {Dental caries is a biofilm-mediated disease characterized by acidogenic microbial dysbiosis and enamel demineralization. Current antibacterial and remineralization strategies are often limited by poor penetration into cariogenic biofilms, nonselective antimicrobial activity, and the acid instability of mineral precursors. Here, we developed an i-Motif-gated DNA-based nanoassembly that integrates biofilm penetration, pH-responsive biofilm control, and biomimetic enamel regeneration for initial caries therapy. The nanoassembly was constructed by co-assembling i-Motif-forming DNA strands, DNA-templated silver nanoclusters and amorphous calcium phosphate precursors. In a validated three-species streptococcal biofilm model, the nanoassembly exhibited efficient penetration throughout the biofilm matrix. Under acidic cariogenic conditions, folding of the i-Motif structure promoted the release of silver-containing species, resulting in enhanced antibacterial activity against cariogenic-state biofilms while exerting minimal effects under relatively non-cariogenic conditions. Simultaneously, protonation of the DNA scaffold stabilized the amorphous calcium phosphate against acid dissolution down to pH 4.0, facilitating the regeneration of densely packed enamel-like crystals. In a rat caries model, topical treatment effectively suppressed cariogenic bacterial colonization and minimized lesion development without disrupting oral microbial diversity. These findings demonstrate that programmable DNA nanoassemblies can couple pH-responsive antibacterial activation with biomimetic mineralization, providing a promising strategy for precise management of initial caries.},
}
RevDate: 2026-11-18
CmpDate: 2026-11-18
Biofilm mediated immune modulation in cancer progression.
Progress in molecular biology and translational science, 225:147-183.
The role of bacteria in causing cancer has been emerging as an increasingly important yet complex factor in tumor formation and proliferation, predominantly through indirect mechanisms, including chronic inflammation, immune modulation, and metabolic genotoxicity. Although only a handful of bacteria have been reported to contribute to specific types of cancers, for example, Chlamydia pneumoniae in lung carcinoma and Streptococcus bovis in colon cancer, their association with tumors is not specific and relies predominantly on chronic inflammatory processes. Nevertheless, the mouth offers a distinct and fragile niche because of its rich and complex microflora, biofilms, and exposure to environmental carcinogens. Specifically, patients with Oral squamous cell carcinoma (OSCC) present with a high colonization rate for bacterial pathogens like Streptococcus anginosus, Prevotella melaninogenica, and Capnocytophaga gingivalis. The main mechanisms driving tumor growth include cytokine network promotion, inhibition of apoptosis and cell cycle control, and production of carcinogenic metabolites like acetaldehyde, which is formed by alcohol metabolism. Moreover, microbial nitrosation produces N-nitroso compounds that can induce DNA alterations and mutations. The complex relationship involving microbial dysbiosis, biofilm formation, and immune system activity is further complicated by poor oral health practices and periodontitis. Overall, while roles of bacteria in cancers like melanoma or lung carcinoma are variable and indirect, the mouth is a highly relevant example of carcinogenic processes involving the microbiome, making it an important target for future cancer research and treatment. These findings underscore the need for continued investigation into oral biofilm-immune interactions as a foundation for novel cancer prevention and treatment strategies.
Additional Links: PMID-43051715
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051715,
year = {2026},
author = {Chakraborty, A and Chakravarti, M and Bhattacharya, R},
title = {Biofilm mediated immune modulation in cancer progression.},
journal = {Progress in molecular biology and translational science},
volume = {225},
number = {},
pages = {147-183},
doi = {10.1016/bs.pmbts.2026.07.013},
pmid = {43051715},
issn = {1878-0814},
mesh = {Humans ; *Biofilms/growth & development ; Animals ; *Disease Progression ; *Neoplasms/immunology/pathology/microbiology ; *Immunomodulation ; },
abstract = {The role of bacteria in causing cancer has been emerging as an increasingly important yet complex factor in tumor formation and proliferation, predominantly through indirect mechanisms, including chronic inflammation, immune modulation, and metabolic genotoxicity. Although only a handful of bacteria have been reported to contribute to specific types of cancers, for example, Chlamydia pneumoniae in lung carcinoma and Streptococcus bovis in colon cancer, their association with tumors is not specific and relies predominantly on chronic inflammatory processes. Nevertheless, the mouth offers a distinct and fragile niche because of its rich and complex microflora, biofilms, and exposure to environmental carcinogens. Specifically, patients with Oral squamous cell carcinoma (OSCC) present with a high colonization rate for bacterial pathogens like Streptococcus anginosus, Prevotella melaninogenica, and Capnocytophaga gingivalis. The main mechanisms driving tumor growth include cytokine network promotion, inhibition of apoptosis and cell cycle control, and production of carcinogenic metabolites like acetaldehyde, which is formed by alcohol metabolism. Moreover, microbial nitrosation produces N-nitroso compounds that can induce DNA alterations and mutations. The complex relationship involving microbial dysbiosis, biofilm formation, and immune system activity is further complicated by poor oral health practices and periodontitis. Overall, while roles of bacteria in cancers like melanoma or lung carcinoma are variable and indirect, the mouth is a highly relevant example of carcinogenic processes involving the microbiome, making it an important target for future cancer research and treatment. These findings underscore the need for continued investigation into oral biofilm-immune interactions as a foundation for novel cancer prevention and treatment strategies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Biofilms/growth & development
Animals
*Disease Progression
*Neoplasms/immunology/pathology/microbiology
*Immunomodulation
RevDate: 2026-11-18
CmpDate: 2026-11-18
Genetic profiling of biofilm-associated cancers: Towards personalized medicine.
Progress in molecular biology and translational science, 225:27-63.
Biofilms are structured aggregation of microorganisms, mainly with bacterial species that are embedded in a self-produced matrix. Biofilms are the key players in various chronic infections, which recently includes the pathogenesis of several cancers. These structured microbial communities can be made up of single or multiple species. It has the ability to resist the antimicrobial agents and evade the host immune defense mechanism, which results in persistent chronic inflammation and the establishment of a tumor-promoting microenvironment, ultimately proceed to cancer development. In the conventional way to detect biofilms associated with cancers, there are plenty of steps like culturing, staining, microscopic analysis, assay development, molecular gene expression profiling by PCR, protein-based analysis, non-invasive ultrasound imaging etc. All of these steps have the main drawback in the inability to detect uncultured microorganisms. To get rid of this limitation of conventional methods, the genetic profiling of biofilm producing microorganisms which are associated with cancers, is an alternative and imperative. Genetic profiling, mainly using the next-generation sequencing, an ideal as well as high-throughput method to characterize the microbial composition of tumors by identifying specific genes that contribute to biofilm formation, resulting in the alteration of the host immune response. The genetic profiling also has the translational approach in discovering novel biomarkers from microbial biofilms that can help to detect cancers in early stage or can also develop personalized treatment strategies. This chapter deciphering the genetic make-up of microbial biofilms that are associated with various cancer, by the alternative method of detection that can develop novel interventions to disrupt biofilm formation and develop effective anti-cancer personalized treatment strategies.
Additional Links: PMID-43051720
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051720,
year = {2026},
author = {Roy, S and Ghosh, S and Hansda, S and Karmakar, S and Ghosh, G and Ghosh, S},
title = {Genetic profiling of biofilm-associated cancers: Towards personalized medicine.},
journal = {Progress in molecular biology and translational science},
volume = {225},
number = {},
pages = {27-63},
doi = {10.1016/bs.pmbts.2026.07.002},
pmid = {43051720},
issn = {1878-0814},
mesh = {*Biofilms/growth & development ; Humans ; *Neoplasms/genetics/microbiology/therapy ; *Precision Medicine ; *Gene Expression Profiling ; Animals ; },
abstract = {Biofilms are structured aggregation of microorganisms, mainly with bacterial species that are embedded in a self-produced matrix. Biofilms are the key players in various chronic infections, which recently includes the pathogenesis of several cancers. These structured microbial communities can be made up of single or multiple species. It has the ability to resist the antimicrobial agents and evade the host immune defense mechanism, which results in persistent chronic inflammation and the establishment of a tumor-promoting microenvironment, ultimately proceed to cancer development. In the conventional way to detect biofilms associated with cancers, there are plenty of steps like culturing, staining, microscopic analysis, assay development, molecular gene expression profiling by PCR, protein-based analysis, non-invasive ultrasound imaging etc. All of these steps have the main drawback in the inability to detect uncultured microorganisms. To get rid of this limitation of conventional methods, the genetic profiling of biofilm producing microorganisms which are associated with cancers, is an alternative and imperative. Genetic profiling, mainly using the next-generation sequencing, an ideal as well as high-throughput method to characterize the microbial composition of tumors by identifying specific genes that contribute to biofilm formation, resulting in the alteration of the host immune response. The genetic profiling also has the translational approach in discovering novel biomarkers from microbial biofilms that can help to detect cancers in early stage or can also develop personalized treatment strategies. This chapter deciphering the genetic make-up of microbial biofilms that are associated with various cancer, by the alternative method of detection that can develop novel interventions to disrupt biofilm formation and develop effective anti-cancer personalized treatment strategies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
Humans
*Neoplasms/genetics/microbiology/therapy
*Precision Medicine
*Gene Expression Profiling
Animals
RevDate: 2026-11-18
Effect of different finishing protocols on biofilm formation in speed-sintered zirconia: An in vitro study.
The Journal of prosthetic dentistry pii:S0022-3913(26)00716-X [Epub ahead of print].
STATEMENT OF PROBLEM: Speed-sintered multilayer zirconia materials enable in-office fabrication of fixed dental restorations; however, the influence of surface finishing protocols on surface roughness and early bacterial biofilm formation is unclear.
PURPOSE: The purpose of this in vitro study was to evaluate the effect of different surface finishing techniques on surface roughness and Streptococcus mutans (S mutans) biofilm formation on enamel and dentin layers of 2 multilayer zirconia materials intended for in-office use.
MATERIAL AND METHODS: Rectangular specimens were prepared from the enamel and dentin layers of a 4 mol% yttria-partially stabilized zirconia (4Y-PSZ) and a 3 mol% yttria-stabilized tetragonal zirconia polycrystals (3Y-TZP)/5 mol% yttria-partially stabilized (5Y-PSZ) multilayered zirconia. Specimens were either polished before speed-sintering (PS), polished after speed-sintering (SP), or polished and glazed after speed-sintering (SPG). Surface roughness parameters (Sa, Sz) were measured using 3-dimensional (3D) laser-scanning microscopy. Biofilm formation of S mutans was assessed after 24 hours in a dynamic flow-chamber model using crystal violet staining and optical density measurement. Scanning electron microscopy was performed for qualitative analysis. Data were analyzed using Kruskal-Wallis and Dunn post hoc tests (α=.05).
RESULTS: Surface finishing significantly affected surface roughness for both zirconia materials (P<.001), with the highest Sa for PS (0.81 µm ±0.17 µm) and lowest for SP (0.06 µm ±0.03 µm). Layer composition from 3 mol% to 5 mol% yttria doped zirconia did not statistically affect surface roughness (P=.793). Biofilm accumulation was minimal for all groups, and no significant differences were found among materials, layers, or surface finishing methods.
CONCLUSIONS: Postsintering polishing produced the smoothest speed-sintered zirconia surfaces, while glazing increased roughness without increasing early S mutans adhesion. Early bacterial adhesion was not significantly associated with surface finish, material, or zirconia layer under the tested conditions.
Additional Links: PMID-43052161
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43052161,
year = {2026},
author = {Meyr, T and Astasov-Frauenhoffer, M and Karlin, S and Filipuzzi, E and Rohr, N},
title = {Effect of different finishing protocols on biofilm formation in speed-sintered zirconia: An in vitro study.},
journal = {The Journal of prosthetic dentistry},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.prosdent.2026.11.001},
pmid = {43052161},
issn = {1097-6841},
abstract = {STATEMENT OF PROBLEM: Speed-sintered multilayer zirconia materials enable in-office fabrication of fixed dental restorations; however, the influence of surface finishing protocols on surface roughness and early bacterial biofilm formation is unclear.
PURPOSE: The purpose of this in vitro study was to evaluate the effect of different surface finishing techniques on surface roughness and Streptococcus mutans (S mutans) biofilm formation on enamel and dentin layers of 2 multilayer zirconia materials intended for in-office use.
MATERIAL AND METHODS: Rectangular specimens were prepared from the enamel and dentin layers of a 4 mol% yttria-partially stabilized zirconia (4Y-PSZ) and a 3 mol% yttria-stabilized tetragonal zirconia polycrystals (3Y-TZP)/5 mol% yttria-partially stabilized (5Y-PSZ) multilayered zirconia. Specimens were either polished before speed-sintering (PS), polished after speed-sintering (SP), or polished and glazed after speed-sintering (SPG). Surface roughness parameters (Sa, Sz) were measured using 3-dimensional (3D) laser-scanning microscopy. Biofilm formation of S mutans was assessed after 24 hours in a dynamic flow-chamber model using crystal violet staining and optical density measurement. Scanning electron microscopy was performed for qualitative analysis. Data were analyzed using Kruskal-Wallis and Dunn post hoc tests (α=.05).
RESULTS: Surface finishing significantly affected surface roughness for both zirconia materials (P<.001), with the highest Sa for PS (0.81 µm ±0.17 µm) and lowest for SP (0.06 µm ±0.03 µm). Layer composition from 3 mol% to 5 mol% yttria doped zirconia did not statistically affect surface roughness (P=.793). Biofilm accumulation was minimal for all groups, and no significant differences were found among materials, layers, or surface finishing methods.
CONCLUSIONS: Postsintering polishing produced the smoothest speed-sintered zirconia surfaces, while glazing increased roughness without increasing early S mutans adhesion. Early bacterial adhesion was not significantly associated with surface finish, material, or zirconia layer under the tested conditions.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Oak-fruit-extract-mediated synthesis of silver and copper quantum dots reduces biofilm gene expression in clinical isolates of Staphylococcus aureus and Acinetobacter baumannii.
GMS hygiene and infection control, 21:Doc74.
BACKGROUND: The emergence of multidrug-resistant (MDR) bacteria, particularly Staphylococcus (S.) aureus and Acinetobacter (A.) baumannii, poses a critical global health challenge due to their strong ability to form biofilms. Alternative strategies targeting biofilm formation are urgently needed.
METHODS: Silver (Ag) and copper (Cu) quantum dots (QDs) were synthesized via a green hydrothermal method using oak fruit extract. Their antimicrobial and antibiofilm activities were tested against strong biofilm-producing clinical isolates of S. aureus (n=5) and A. baumannii (n=5) using broth microdilution and biofilm inhibition assays. The effect of sub-MIC concentrations of QDs on biofilm-associated genes (icaA, icaD, icaR in S. aureus; bap, ompA in A. baumannii) was evaluated by RT-qPCR.
RESULTS: The MIC values of Ag-QDs and Cu-QDs were 300 µg/mL and 400 µg/mL, respectively. Both QDs significantly inhibited biofilm formation at sub-MIC levels. RT-qPCR analysis showed marked downregulation of all tested genes following QD treatment, with Ag-QDs exhibiting a stronger inhibitory effect than Cu-QDs.
CONCLUSION: Green-synthesized Ag-QDs and Cu-QDs demonstrate significant antibiofilm activity by suppressing key biofilm-related genes in S. aureus and A. baumannii. These findings highlight their potential as eco-friendly nano-antibiofilm agents for infection control.
Additional Links: PMID-43054257
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054257,
year = {2026},
author = {Nabipour, YS and Hesampour, A and Asbchin, SA and Tajabadi, M and Rostamzad, A},
title = {Oak-fruit-extract-mediated synthesis of silver and copper quantum dots reduces biofilm gene expression in clinical isolates of Staphylococcus aureus and Acinetobacter baumannii.},
journal = {GMS hygiene and infection control},
volume = {21},
number = {},
pages = {Doc74},
pmid = {43054257},
issn = {2196-5226},
abstract = {BACKGROUND: The emergence of multidrug-resistant (MDR) bacteria, particularly Staphylococcus (S.) aureus and Acinetobacter (A.) baumannii, poses a critical global health challenge due to their strong ability to form biofilms. Alternative strategies targeting biofilm formation are urgently needed.
METHODS: Silver (Ag) and copper (Cu) quantum dots (QDs) were synthesized via a green hydrothermal method using oak fruit extract. Their antimicrobial and antibiofilm activities were tested against strong biofilm-producing clinical isolates of S. aureus (n=5) and A. baumannii (n=5) using broth microdilution and biofilm inhibition assays. The effect of sub-MIC concentrations of QDs on biofilm-associated genes (icaA, icaD, icaR in S. aureus; bap, ompA in A. baumannii) was evaluated by RT-qPCR.
RESULTS: The MIC values of Ag-QDs and Cu-QDs were 300 µg/mL and 400 µg/mL, respectively. Both QDs significantly inhibited biofilm formation at sub-MIC levels. RT-qPCR analysis showed marked downregulation of all tested genes following QD treatment, with Ag-QDs exhibiting a stronger inhibitory effect than Cu-QDs.
CONCLUSION: Green-synthesized Ag-QDs and Cu-QDs demonstrate significant antibiofilm activity by suppressing key biofilm-related genes in S. aureus and A. baumannii. These findings highlight their potential as eco-friendly nano-antibiofilm agents for infection control.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Green synthesis of carbon quantum dots (CQDs) from oak fruit: antimicrobial and anti-biofilm efficacy against ESKAPE pathogens in wound infections.
GMS hygiene and infection control, 21:Doc76.
AIM: The present study aims to synthesize Carbon Quantum Dots (CQDs) using natural oak fruit as a green carbon precursor and to evaluate their antimicrobial and anti-biofilm activities against WHO priority antibiotic-resistant ESKAPE pathogens isolated from clinical wound infections.
METHODS: CQDs were synthesized via a one-step hydrothermal method (190°C for 5 hours). The study design consisted of four main phases: nanoparticle synthesis and characterization (TEM, FTIR, UV-Vis, fluorescence spectroscopy), in vitro microbiological evaluations (disk diffusion, minimal inhibition concentration/ minimal bactericidal concentration (MIC/MBC), and microtiter plate assays), molecular investigations (Real-Time PCR targeting biofilm-associated genes), and in vivo animal model studies using murine infected wound model. A total of 122 clinical isolates from diabetic, burn, and surgical wounds were collected over 6 months, alongside standard bacterial strains.
RESULTS: Successful synthesis of CQDs was confirmed by blue/green luminescence under 365 nm UV irradiation and the presence of surface functional groups (OH, COOH, C=O) via FTIR. TEM revealed uniform spherical morphology with an average particle size <10 nm. Molecular analysis showed that sub-MIC concentrations of CQDs significantly down-regulated key biofilm-associated genes (icaA/icaD in Staphylococcus aureus, lecA/pelA in Pseudomonas aeruginosa, mrkA/mrkD in Klebsiella pneumoniae, and bap/ompA in Acinetobacter baumannii) compared to the 16S rRNA reference gene (P<0.05). In vivo evaluation demonstrated that topical application of CQDs significantly accelerated epithelialization, improved wound contraction, and reduced wound area over 14 days compared to untreated and antibiotic-treated controls (P<0.05).
CONCLUSION: Hydrothermally synthesized oak-derived CQDs effectively disrupt biofilm formation at the transcriptional level, reduce wound bacterial burden, and accelerate tissue regeneration. These findings highlight the potential of green-synthesized CQDs as alternative therapeutic agents for managing multidrug-resistant wound infections.
Additional Links: PMID-43054264
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054264,
year = {2026},
author = {Nabipour, YS and Hesampour, A and Asbchin, SA and Tajabadi, M and Rostamza, A},
title = {Green synthesis of carbon quantum dots (CQDs) from oak fruit: antimicrobial and anti-biofilm efficacy against ESKAPE pathogens in wound infections.},
journal = {GMS hygiene and infection control},
volume = {21},
number = {},
pages = {Doc76},
pmid = {43054264},
issn = {2196-5226},
abstract = {AIM: The present study aims to synthesize Carbon Quantum Dots (CQDs) using natural oak fruit as a green carbon precursor and to evaluate their antimicrobial and anti-biofilm activities against WHO priority antibiotic-resistant ESKAPE pathogens isolated from clinical wound infections.
METHODS: CQDs were synthesized via a one-step hydrothermal method (190°C for 5 hours). The study design consisted of four main phases: nanoparticle synthesis and characterization (TEM, FTIR, UV-Vis, fluorescence spectroscopy), in vitro microbiological evaluations (disk diffusion, minimal inhibition concentration/ minimal bactericidal concentration (MIC/MBC), and microtiter plate assays), molecular investigations (Real-Time PCR targeting biofilm-associated genes), and in vivo animal model studies using murine infected wound model. A total of 122 clinical isolates from diabetic, burn, and surgical wounds were collected over 6 months, alongside standard bacterial strains.
RESULTS: Successful synthesis of CQDs was confirmed by blue/green luminescence under 365 nm UV irradiation and the presence of surface functional groups (OH, COOH, C=O) via FTIR. TEM revealed uniform spherical morphology with an average particle size <10 nm. Molecular analysis showed that sub-MIC concentrations of CQDs significantly down-regulated key biofilm-associated genes (icaA/icaD in Staphylococcus aureus, lecA/pelA in Pseudomonas aeruginosa, mrkA/mrkD in Klebsiella pneumoniae, and bap/ompA in Acinetobacter baumannii) compared to the 16S rRNA reference gene (P<0.05). In vivo evaluation demonstrated that topical application of CQDs significantly accelerated epithelialization, improved wound contraction, and reduced wound area over 14 days compared to untreated and antibiotic-treated controls (P<0.05).
CONCLUSION: Hydrothermally synthesized oak-derived CQDs effectively disrupt biofilm formation at the transcriptional level, reduce wound bacterial burden, and accelerate tissue regeneration. These findings highlight the potential of green-synthesized CQDs as alternative therapeutic agents for managing multidrug-resistant wound infections.},
}
RevDate: 2026-11-19
Conformational dynamics of exopolysaccharides underlie biofilm matrix mechanics in Vibrio cholerae.
Newton ((New York, N.Y.) [Epub ahead of print].
Polysaccharides remain the least understood biomacromolecules, particularly in terms of the relationship between their chemical structure and physical properties. On the other hand, polysaccharides often serve as the main structural components in biofilms: surface-attached aggregates of bacterial cells encased within a mechanically resilient extracellular matrix. The large chemical space explored by bacteria within biofilms provides excellent opportunities to establish the structure-function relationship for polysaccharides. In this paper, we systematically characterize various polymer properties of Vibrio polysaccharide (VPS), the major exopolysaccharide in biofilms formed by Vibrio cholerae, the causative agent of pandemic cholera. Using a combination of shear rheology, dynamic and static light scattering, and small-angle X-ray scattering, we measure the viscosity, molecular weight, persistence length, radius of gyration, and hydrodynamic radius of this chemically unique biopolymer. Combining all-atom and coarse-grained simulations, we show how the conformational flexibility of a single glycosidic linkage within each VPS monomer can lead to dramatic compaction of the entire polymer chain and nonclassical entanglement behavior. Our comprehensive quantification represents a rare endeavor for bacterial biofilms, whose matrix composition and physical properties remain largely nebulous; it also represents a significant step towards a detailed understanding of the molecular origins of biofilm mechanics.
Additional Links: PMID-43055016
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055016,
year = {2026},
author = {Nam, KM and Fowler, N and Kandel, R and Zhu, Y and Liu, Y and Lai, YJ and Hassan, MF and Gerace, E and Hinbest, AJ and Asp, M and Olson, R and Li, Y and Nieh, MP and Zhong, M and Woods, RJ and Moreau, A and Yan, J},
title = {Conformational dynamics of exopolysaccharides underlie biofilm matrix mechanics in Vibrio cholerae.},
journal = {Newton ((New York, N.Y.)},
volume = {},
number = {},
pages = {},
pmid = {43055016},
issn = {2950-6360},
abstract = {Polysaccharides remain the least understood biomacromolecules, particularly in terms of the relationship between their chemical structure and physical properties. On the other hand, polysaccharides often serve as the main structural components in biofilms: surface-attached aggregates of bacterial cells encased within a mechanically resilient extracellular matrix. The large chemical space explored by bacteria within biofilms provides excellent opportunities to establish the structure-function relationship for polysaccharides. In this paper, we systematically characterize various polymer properties of Vibrio polysaccharide (VPS), the major exopolysaccharide in biofilms formed by Vibrio cholerae, the causative agent of pandemic cholera. Using a combination of shear rheology, dynamic and static light scattering, and small-angle X-ray scattering, we measure the viscosity, molecular weight, persistence length, radius of gyration, and hydrodynamic radius of this chemically unique biopolymer. Combining all-atom and coarse-grained simulations, we show how the conformational flexibility of a single glycosidic linkage within each VPS monomer can lead to dramatic compaction of the entire polymer chain and nonclassical entanglement behavior. Our comprehensive quantification represents a rare endeavor for bacterial biofilms, whose matrix composition and physical properties remain largely nebulous; it also represents a significant step towards a detailed understanding of the molecular origins of biofilm mechanics.},
}
RevDate: 2026-11-19
Disruption of Staphylococcus aureus biofilm architecture by Myrica esculenta bark extract: in vitro and in silico perspectives.
Biofouling [Epub ahead of print].
Staphylococcus aureus is a notorious pathogen distinguished by its robust capacity to form biofilms, a key factor for host immune evasion and antibiotic resistance. In the quest for novel antibiofilm agents, revisiting traditional medicinal knowledge - particularly plant-based therapies - offers a promising strategy. Myrica esculenta, an ethnomedicinal Himalayan plant, is widely used in folk medicine for treating respiratory, gastrointestinal disorders, wound care, and toothache. Although preliminary studies on the antibacterial activity of its bark extract against S. aureus have been reported, its antibiofilm potential remains unexplored. In this study, six solvents were systematically evaluated for extraction efficiency from M. esculenta bark, with methanol yielding the highest metabolite recovery (33.79%) and exhibiting strong antibacterial activity with MIC of 1 mg/mL. The extract significantly inhibited biofilm initiation and disrupted mature biofilms of S. aureus (Newman) in a dose-dependent manner (MIC to 4 × MIC), accompanied by reduced exopolysaccharide production and decreased surface colonization. GC-MS analysis identified eight bioactive compounds, while molecular docking with the aggregation-prone region of the biofilm-associated protein (Bap) revealed strong binding affinities for key constituents. Additionally, membrane damage and bactericidal effects were confirmed. Toxicity assessment revealed no toxicity to HEK-293 mammalian cells, highlighting its safe therapeutic potential.
Additional Links: PMID-43056073
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056073,
year = {2026},
author = {Ezung, E and Kabir, ME and Mondal, R and Banerjee, R},
title = {Disruption of Staphylococcus aureus biofilm architecture by Myrica esculenta bark extract: in vitro and in silico perspectives.},
journal = {Biofouling},
volume = {},
number = {},
pages = {1-17},
doi = {10.1080/08927014.2026.2763370},
pmid = {43056073},
issn = {1029-2454},
abstract = {Staphylococcus aureus is a notorious pathogen distinguished by its robust capacity to form biofilms, a key factor for host immune evasion and antibiotic resistance. In the quest for novel antibiofilm agents, revisiting traditional medicinal knowledge - particularly plant-based therapies - offers a promising strategy. Myrica esculenta, an ethnomedicinal Himalayan plant, is widely used in folk medicine for treating respiratory, gastrointestinal disorders, wound care, and toothache. Although preliminary studies on the antibacterial activity of its bark extract against S. aureus have been reported, its antibiofilm potential remains unexplored. In this study, six solvents were systematically evaluated for extraction efficiency from M. esculenta bark, with methanol yielding the highest metabolite recovery (33.79%) and exhibiting strong antibacterial activity with MIC of 1 mg/mL. The extract significantly inhibited biofilm initiation and disrupted mature biofilms of S. aureus (Newman) in a dose-dependent manner (MIC to 4 × MIC), accompanied by reduced exopolysaccharide production and decreased surface colonization. GC-MS analysis identified eight bioactive compounds, while molecular docking with the aggregation-prone region of the biofilm-associated protein (Bap) revealed strong binding affinities for key constituents. Additionally, membrane damage and bactericidal effects were confirmed. Toxicity assessment revealed no toxicity to HEK-293 mammalian cells, highlighting its safe therapeutic potential.},
}
RevDate: 2026-11-19
Evaluating the antibiofilm effect of EPS-ZnO nanoparticles against Staphylococcus aureus biofilm and analysing its cytotoxic potential.
Preparative biochemistry & biotechnology [Epub ahead of print].
Antimicrobial resistance (AMR) in foodborne pathogens like methylene-resistant Staphylococcus aureus (MRSA) requires sustainable alternatives. This study evaluates the multifunctional efficacy of green-synthesized, exopolysaccharide-mediated zinc oxide nanoparticles. EPS-ZnONP exhibited potent antibiofilm activity against S. aureus (MIC at 6 µg/ml; 20 mm inhibition zone at 10 µg/ml). SEM and fluorescence analysis elucidated strong antibiofilm potential revealing dense staphylococcal cell clusters in untreated samples while the treated samples showed biofilm eradication and cell shrinkage. Quorum sensing-associated virulence was markedly attenuated, showing a 24.9 ± 3.99% reduction in cell surface hydrophobicity at 100 μg/mL and strong inhibition of staphyloxanthin production. In Vigna radiata sprouts, EPS-ZnONPs boosted secondary metabolites and antioxidant capacity, peaking at 60 ppm with elevated total phenolics (2.27 ± 0.005 mg GAE/g), total flavonoids (7.46 ± 0.02 mg QE/g), saponins (0.486 mg/g), and DPPH radical scavenging (32.59 ± 0.04%). Primary metabolic reserves peaked distinctively, with carbohydrates reaching 128.6 ± 0.05 mg/g at 40 ppm and proteins hitting 0.79 ± 0.002 mg/g at 60 ppm. Biosafety assessments in zebrafish (Danio rerio) demonstrated enhanced growth kinetics and survival rates, alongside intact genomic DNA and RNA profiles confirming zero genotoxicity. Cytocompatibility was verified via MTT assay, retaining 92.7% viability in V79 fibroblasts (100 μg/mL) and 76.2% in A375 melanoma cells (50 μg/mL). These statistically significant (p < 0.05) outcomes validate EPS-ZnONPs as secure, multifunctional agents for biomedical and agricultural applications.
Additional Links: PMID-43056722
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056722,
year = {2026},
author = {Nath, R and Lahiri, D and Nag, M and Dutta, K and Biswas, B and Janani, G and Udayakumar, S and Girigoswami, K},
title = {Evaluating the antibiofilm effect of EPS-ZnO nanoparticles against Staphylococcus aureus biofilm and analysing its cytotoxic potential.},
journal = {Preparative biochemistry & biotechnology},
volume = {},
number = {},
pages = {1-17},
doi = {10.1080/10826068.2026.2760286},
pmid = {43056722},
issn = {1532-2297},
abstract = {Antimicrobial resistance (AMR) in foodborne pathogens like methylene-resistant Staphylococcus aureus (MRSA) requires sustainable alternatives. This study evaluates the multifunctional efficacy of green-synthesized, exopolysaccharide-mediated zinc oxide nanoparticles. EPS-ZnONP exhibited potent antibiofilm activity against S. aureus (MIC at 6 µg/ml; 20 mm inhibition zone at 10 µg/ml). SEM and fluorescence analysis elucidated strong antibiofilm potential revealing dense staphylococcal cell clusters in untreated samples while the treated samples showed biofilm eradication and cell shrinkage. Quorum sensing-associated virulence was markedly attenuated, showing a 24.9 ± 3.99% reduction in cell surface hydrophobicity at 100 μg/mL and strong inhibition of staphyloxanthin production. In Vigna radiata sprouts, EPS-ZnONPs boosted secondary metabolites and antioxidant capacity, peaking at 60 ppm with elevated total phenolics (2.27 ± 0.005 mg GAE/g), total flavonoids (7.46 ± 0.02 mg QE/g), saponins (0.486 mg/g), and DPPH radical scavenging (32.59 ± 0.04%). Primary metabolic reserves peaked distinctively, with carbohydrates reaching 128.6 ± 0.05 mg/g at 40 ppm and proteins hitting 0.79 ± 0.002 mg/g at 60 ppm. Biosafety assessments in zebrafish (Danio rerio) demonstrated enhanced growth kinetics and survival rates, alongside intact genomic DNA and RNA profiles confirming zero genotoxicity. Cytocompatibility was verified via MTT assay, retaining 92.7% viability in V79 fibroblasts (100 μg/mL) and 76.2% in A375 melanoma cells (50 μg/mL). These statistically significant (p < 0.05) outcomes validate EPS-ZnONPs as secure, multifunctional agents for biomedical and agricultural applications.},
}
RevDate: 2026-11-19
Membrane-aerated biofilm reactors (MABRs) are enriched with filamentous fungi at high carbon concentrations.
Water research, 309(Pt C):127310 pii:S0043-1354(26)01981-0 [Epub ahead of print].
Membrane-aerated biofilm reactors (MABRs) are an energy-efficient wastewater treatment technology based on biofilms grown on gas-permeable membranes. As with most wastewater treatment technologies, MABR biofilms are typically dominated by bacteria. However, here we show that MABRs supplied with high organic carbon loadings can be dominated by filamentous fungi, leading to stiff biofilms. When fed with food processing wastewater at approximately 550 mg COD L[-1], filamentous fungi accounted for 85% of the biofilm, compared to 30% for co-diffusional controls. The MABR biofilms showed EPS matrices enriched in protein and extracellular DNA, and were stiffer than co-diffusional biofilms. When supplied with 550 mg COD L[-1] acetate in minimal medium, filamentous fungi accounted for 67% of the biofilm and were dominated by Geotrichum and Galactomyces. In contrast, MABRs supplied with 150 mg COD L[-1] acetate had only 4% filamentous fungi. These findings identify filamentous fungi as important and overlooked members of MABR biofilms, especially for high carbon loadings. A potential benefit is that fungi can degrade recalcitrant compounds not degraded by bacteria. However, the biofilm's greater mechanical strength may lead to excessive biofilm accumulation and may require special measures to promote detachment.
Additional Links: PMID-43057036
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43057036,
year = {2026},
author = {Martín-Linares, A and Li, M and Aybar, M and Ontiveros-Valencia, A and Espinosa-Ortiz, EJ and Nerenberg, R},
title = {Membrane-aerated biofilm reactors (MABRs) are enriched with filamentous fungi at high carbon concentrations.},
journal = {Water research},
volume = {309},
number = {Pt C},
pages = {127310},
doi = {10.1016/j.watres.2026.127310},
pmid = {43057036},
issn = {1879-2448},
abstract = {Membrane-aerated biofilm reactors (MABRs) are an energy-efficient wastewater treatment technology based on biofilms grown on gas-permeable membranes. As with most wastewater treatment technologies, MABR biofilms are typically dominated by bacteria. However, here we show that MABRs supplied with high organic carbon loadings can be dominated by filamentous fungi, leading to stiff biofilms. When fed with food processing wastewater at approximately 550 mg COD L[-1], filamentous fungi accounted for 85% of the biofilm, compared to 30% for co-diffusional controls. The MABR biofilms showed EPS matrices enriched in protein and extracellular DNA, and were stiffer than co-diffusional biofilms. When supplied with 550 mg COD L[-1] acetate in minimal medium, filamentous fungi accounted for 67% of the biofilm and were dominated by Geotrichum and Galactomyces. In contrast, MABRs supplied with 150 mg COD L[-1] acetate had only 4% filamentous fungi. These findings identify filamentous fungi as important and overlooked members of MABR biofilms, especially for high carbon loadings. A potential benefit is that fungi can degrade recalcitrant compounds not degraded by bacteria. However, the biofilm's greater mechanical strength may lead to excessive biofilm accumulation and may require special measures to promote detachment.},
}
RevDate: 2026-11-17
CmpDate: 2026-11-17
Correction: Campylobacter jejuni biofilm formation under aerobic conditions and inhibition by ZnO nanoparticles.
Frontiers in microbiology, 17:2024304.
[This corrects the article DOI: 10.3389/fmicb.2020.00207.].
Additional Links: PMID-43041802
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43041802,
year = {2026},
author = {Zhong, X and Wu, Q and Zhang, J and Ma, Z and Wang, J and Nie, X and Ding, Y and Xue, L and Chen, M and Wu, S and Wei, X and Zhang, Y},
title = {Correction: Campylobacter jejuni biofilm formation under aerobic conditions and inhibition by ZnO nanoparticles.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {2024304},
doi = {10.3389/fmicb.2026.2024304},
pmid = {43041802},
issn = {1664-302X},
abstract = {[This corrects the article DOI: 10.3389/fmicb.2020.00207.].},
}
RevDate: 2026-11-17
CmpDate: 2026-11-17
Antibacterial, anti-biofilm, and depth-penetrant activity of a Cissus quadrangularis mediated biogenic Ag-HAp-MSN nanocomposite against cariogenic pathogens.
Discover nano, 21(1):.
Cariogenic biofilms primarily associated with Streptococcus mutans and Lactobacillus acidophilus contribute to one of the most prevalent chronic oral diseases worldwide. Although current Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) systems are effective in remineralization, they lack direct biofilm-disrupting capabilities, highlighting the need for multifunctional materials. A biogenic Ag-HAp-MSN nanocomposite, previously synthesized using Cissus quadrangularis extract and confirmed to possess favourable physicochemical properties and cytocompatibility, was evaluated for its antibacterial and anti-biofilm efficacy. Antibacterial activity was assessed using agar well diffusion, Minimum Inhibitory Concentration (MIC), and Minimum Bactericidal Concentration (MBC) assays, while anti-biofilm activity was analysed via crystal violet inhibition, acridine orange/ethidium bromide (AO/EB) live-dead fluorescence, and Confocal Laser Scanning Microscopy (CLSM). GC Tooth Mousse served as a contextual clinical reference. At 1000 µg/mL, the nanocomposite produced ZOI values of 25 mm (S. mutans) and 29 mm (L. acidophilus), outperforming all individual components. The MIC values were 250 µg/mL (S. mutans) and 125 µg/mL (L. acidophilus), representing a 2-4-fold improvement, with MBC/MIC ratios of 2, confirming bactericidal action. Crystal violet biofilm inhibition reached 82.53% and 87.53%, while AO/EB dead-cell fractions were 83.63% and 89.33%, respectively (p < 0.001 vs. all controls). Under agar diffusion conditions, the nanocomposite showed inhibition zones comparable to GC Tooth Mousse against L. acidophilus at 800 µg/mL. These findings support further investigation of biogenic Ag-HAp-MSN nanocomposite for anti-cariogenic applications.
Additional Links: PMID-43043381
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43043381,
year = {2026},
author = {Krishnakumar, S and Venugopal, VN and Suresh, M and Ali, S and Kondas, VV},
title = {Antibacterial, anti-biofilm, and depth-penetrant activity of a Cissus quadrangularis mediated biogenic Ag-HAp-MSN nanocomposite against cariogenic pathogens.},
journal = {Discover nano},
volume = {21},
number = {1},
pages = {},
pmid = {43043381},
issn = {2731-9229},
abstract = {Cariogenic biofilms primarily associated with Streptococcus mutans and Lactobacillus acidophilus contribute to one of the most prevalent chronic oral diseases worldwide. Although current Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) systems are effective in remineralization, they lack direct biofilm-disrupting capabilities, highlighting the need for multifunctional materials. A biogenic Ag-HAp-MSN nanocomposite, previously synthesized using Cissus quadrangularis extract and confirmed to possess favourable physicochemical properties and cytocompatibility, was evaluated for its antibacterial and anti-biofilm efficacy. Antibacterial activity was assessed using agar well diffusion, Minimum Inhibitory Concentration (MIC), and Minimum Bactericidal Concentration (MBC) assays, while anti-biofilm activity was analysed via crystal violet inhibition, acridine orange/ethidium bromide (AO/EB) live-dead fluorescence, and Confocal Laser Scanning Microscopy (CLSM). GC Tooth Mousse served as a contextual clinical reference. At 1000 µg/mL, the nanocomposite produced ZOI values of 25 mm (S. mutans) and 29 mm (L. acidophilus), outperforming all individual components. The MIC values were 250 µg/mL (S. mutans) and 125 µg/mL (L. acidophilus), representing a 2-4-fold improvement, with MBC/MIC ratios of 2, confirming bactericidal action. Crystal violet biofilm inhibition reached 82.53% and 87.53%, while AO/EB dead-cell fractions were 83.63% and 89.33%, respectively (p < 0.001 vs. all controls). Under agar diffusion conditions, the nanocomposite showed inhibition zones comparable to GC Tooth Mousse against L. acidophilus at 800 µg/mL. These findings support further investigation of biogenic Ag-HAp-MSN nanocomposite for anti-cariogenic applications.},
}
RevDate: 2026-11-18
CmpDate: 2026-11-17
Dysbiosis in the Aerobic Microbiota of E-Cigarette Users: Evidence From Salivary Microcosm Biofilm.
Clinical and experimental dental research, 12(6):.
OBJECTIVES: Tobacco and nicotine are known to alter the oral microbiome, thereby promoting dysbiosis. The impact of new nicotine forms, such as electronic cigarettes (e-cigs), on oral dysbiosis remains unclear. This study aimed to evaluate the microbial biofilm composition and carbohydrate presence in e-cig users' saliva.
MATERIAL AND METH: Fifty participants with healthy oral mucosa were divided into two groups: E-cig group (EG)-25 regular and exclusive e-cig users; Control group (CG)-25 non-smokers, matched for sex and age. Unstimulated saliva and flavoring samples were collected. The salivary biofilm's biomass and metabolic activity were assessed, along with non-selective counts of general microorganisms, yeasts, Streptococcus mutans group streptococci, and lactobacilli in the microcosm biofilms. Total carbohydrate content in saliva was quantified using the phenol-sulfuric acid method.
RESULTS: The biomass average and the metabolic activity showed an increase in EG. The counts of non-selective microorganisms, yeasts, and mutans group streptococci were higher in EG compared with those in CG. Conversely, EG showed a reduction in lactobacilli counts in all samples. No differences were found in total carbohydrate content in saliva between EG and CG. However, significant carbohydrate presence was noted in the flavoring, particularly in fruit/sweet flavors.
CONCLUSIONS: The e-cig use promotes dysbiosis in the aerobic microbiota through a significant increase in biofilm formation and in the counts of S. mutans and oral yeast. Significant concentrations of glucose were detected in e-cig liquids, especially in sweet flavors.
Additional Links: PMID-43043900
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43043900,
year = {2026},
author = {Carvalho, BFDC and Garcia, MT and do Carmo, PHF and de Carvalho Faria, N and de Souza Silva, FA and Junqueira, JC and Almeida, JD},
title = {Dysbiosis in the Aerobic Microbiota of E-Cigarette Users: Evidence From Salivary Microcosm Biofilm.},
journal = {Clinical and experimental dental research},
volume = {12},
number = {6},
pages = {},
pmid = {43043900},
issn = {2057-4347},
support = {#2020/10362-0//São Paulo Research Foundation (FAPESP)/ ; #2020/10322-9//São Paulo Research Foundation (FAPESP)/ ; #2024/05449-0//São Paulo Research Foundation (FAPESP)/ ; 001//Coordenação de Aperfeiçoamento de Pessoal de Nível Superior/ ; },
mesh = {Humans ; *Biofilms/growth & development/drug effects ; *Saliva/microbiology/chemistry ; *Dysbiosis/microbiology/etiology ; Female ; Adult ; Male ; *Microbiota/drug effects ; *Electronic Nicotine Delivery Systems ; Young Adult ; },
abstract = {OBJECTIVES: Tobacco and nicotine are known to alter the oral microbiome, thereby promoting dysbiosis. The impact of new nicotine forms, such as electronic cigarettes (e-cigs), on oral dysbiosis remains unclear. This study aimed to evaluate the microbial biofilm composition and carbohydrate presence in e-cig users' saliva.
MATERIAL AND METH: Fifty participants with healthy oral mucosa were divided into two groups: E-cig group (EG)-25 regular and exclusive e-cig users; Control group (CG)-25 non-smokers, matched for sex and age. Unstimulated saliva and flavoring samples were collected. The salivary biofilm's biomass and metabolic activity were assessed, along with non-selective counts of general microorganisms, yeasts, Streptococcus mutans group streptococci, and lactobacilli in the microcosm biofilms. Total carbohydrate content in saliva was quantified using the phenol-sulfuric acid method.
RESULTS: The biomass average and the metabolic activity showed an increase in EG. The counts of non-selective microorganisms, yeasts, and mutans group streptococci were higher in EG compared with those in CG. Conversely, EG showed a reduction in lactobacilli counts in all samples. No differences were found in total carbohydrate content in saliva between EG and CG. However, significant carbohydrate presence was noted in the flavoring, particularly in fruit/sweet flavors.
CONCLUSIONS: The e-cig use promotes dysbiosis in the aerobic microbiota through a significant increase in biofilm formation and in the counts of S. mutans and oral yeast. Significant concentrations of glucose were detected in e-cig liquids, especially in sweet flavors.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Biofilms/growth & development/drug effects
*Saliva/microbiology/chemistry
*Dysbiosis/microbiology/etiology
Female
Adult
Male
*Microbiota/drug effects
*Electronic Nicotine Delivery Systems
Young Adult
RevDate: 2026-11-18
Assessing Bacterial Biofilm Capacity on Plastic-Derived Char for Agrochemical Wastewater Bioremediation.
ACS ES&T water, 6(11):7367-7379.
The application of pyrolysis is being extended to inorganic residues like plastics, which are considered an abundant residue nowadays. However, the sorbent capacity of plastic-derived char and its capacity to host biofilm formation that may be applied in bioremediation processes are unexplored. This study aimed to evaluate the char produced by pyrolysis of nonrecyclable post-consumer plastics to develop biofilm formation and its application in a real agrochemical effluent. The experimental design was set up in two phases: (i) adherence ability was measured with Ochrobactrum anthropi AD2 (with known adherence capacity) at optimal growth conditions on nonactivated or washed char, char activated with Na2CO3, and char activated with KOH; and (ii) biofilm formation ability in a real and polluted agrochemical wastewater on the surface of activated chars. The obtained results showed that O. anthropi AD2 biofilms were markedly influenced by the structural and surface characteristics of char, with the activated chars being more successful than nonactivated char. In the second phase, Na2CO3-activated char was the most efficient in the removal of copper, and it showed significantly higher microbial enumeration compared to KOH. The biofilm was composed of members of the Pseudomonas genus. This study suggests the potential of co-systems of biofilm-char as biotreatment of heavy metal-polluted wastewater.
Additional Links: PMID-43048350
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43048350,
year = {2026},
author = {Velilla-Delgado, S and Angeles-de Paz, G and Martín-Lara, MÁ and Pereira, L and Calvo, C and Robledo-Mahón, T},
title = {Assessing Bacterial Biofilm Capacity on Plastic-Derived Char for Agrochemical Wastewater Bioremediation.},
journal = {ACS ES&T water},
volume = {6},
number = {11},
pages = {7367-7379},
pmid = {43048350},
issn = {2690-0637},
abstract = {The application of pyrolysis is being extended to inorganic residues like plastics, which are considered an abundant residue nowadays. However, the sorbent capacity of plastic-derived char and its capacity to host biofilm formation that may be applied in bioremediation processes are unexplored. This study aimed to evaluate the char produced by pyrolysis of nonrecyclable post-consumer plastics to develop biofilm formation and its application in a real agrochemical effluent. The experimental design was set up in two phases: (i) adherence ability was measured with Ochrobactrum anthropi AD2 (with known adherence capacity) at optimal growth conditions on nonactivated or washed char, char activated with Na2CO3, and char activated with KOH; and (ii) biofilm formation ability in a real and polluted agrochemical wastewater on the surface of activated chars. The obtained results showed that O. anthropi AD2 biofilms were markedly influenced by the structural and surface characteristics of char, with the activated chars being more successful than nonactivated char. In the second phase, Na2CO3-activated char was the most efficient in the removal of copper, and it showed significantly higher microbial enumeration compared to KOH. The biofilm was composed of members of the Pseudomonas genus. This study suggests the potential of co-systems of biofilm-char as biotreatment of heavy metal-polluted wastewater.},
}
RevDate: 2026-11-18
CmpDate: 2026-11-18
Assessment of the public health risk of fish offal: serotype diversity, virulence profiles, biofilm formation, and antibiotic resistance of Escherichia coli.
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 57(1):.
Fish, while an important food source for human nutrition, can be contaminated with microorganisms for various reasons. Escherichia coli, a significant microorganism, is transmitted to humans through raw or undercooked meat, dairy products, and vegetables, potentially causing serious infections. Therefore, this study aimed to identify E. coli strains in fish carcasses and offal, analyze their virulence factors, diagnose their antibiotic resistance profiles, and determine their biofilm-formin e hundred fish samples were randomly selected from fish markets in Kayseri, Türkiye (August-December 2023). We serotyped the E. coli isolates obtained from these fish samples, tested them for antibiotic resistance (disk diffusion method), and determined their biofilm-forming capabilities. Furthermore, their gene profiles (virulence and antibiotic resistance genes) were determined using molecular techniques. Suspected E. coli isolates were identified using the trpA gene, and a total of 70 isolates (77%) were confirmed as positive. Additionally, E. coli serotypes O26 (7.1%), O111 (1.4%), O45 (1.4%), and H8 (11.4%) were identified. Antibiotic resistance rates were determined for ampicillin (17%), tetracycline (31%), erythromycin (41%), gentamicin (51%), and enrofloxacin (40%), and multidrug resistance was 37.1%. Virulence gene distributions in the isolates were determined using the stx2 (20%) and hlyA (1.4%) genes. E. coli virulence genes (stx1, eaeA, and hlyA) were tested. Although fish and offal provide an alternative protein source, the high prevalence of E. coli, antibiotic resistance, and virulence factors suggests that these could pose public health risks. These findings indicate that strict hygiene measures may be needed in fish processing and consumption.
Additional Links: PMID-43050074
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43050074,
year = {2026},
author = {Barel, M and Hizlisoy, H and Dishan, A and Ozkaya, Y and Al, S and Saticioglu, IB and Hizlisoy, S and Arslan, RS and Koskeroglu, K},
title = {Assessment of the public health risk of fish offal: serotype diversity, virulence profiles, biofilm formation, and antibiotic resistance of Escherichia coli.},
journal = {Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]},
volume = {57},
number = {1},
pages = {},
pmid = {43050074},
issn = {1678-4405},
support = {TSA-2023-12852//Bilimsel Araştırma Projeleri, Erciyes Üniversitesi/ ; },
mesh = {Animals ; *Biofilms/growth & development ; *Escherichia coli/drug effects/genetics/classification/physiology/isolation & purification/pathogenicity ; Anti-Bacterial Agents/pharmacology ; *Fishes/microbiology ; Virulence Factors/genetics ; Virulence ; Serogroup ; *Drug Resistance, Bacterial ; Humans ; Escherichia coli Infections/microbiology ; Public Health ; Microbial Sensitivity Tests ; Food Microbiology ; },
abstract = {Fish, while an important food source for human nutrition, can be contaminated with microorganisms for various reasons. Escherichia coli, a significant microorganism, is transmitted to humans through raw or undercooked meat, dairy products, and vegetables, potentially causing serious infections. Therefore, this study aimed to identify E. coli strains in fish carcasses and offal, analyze their virulence factors, diagnose their antibiotic resistance profiles, and determine their biofilm-formin e hundred fish samples were randomly selected from fish markets in Kayseri, Türkiye (August-December 2023). We serotyped the E. coli isolates obtained from these fish samples, tested them for antibiotic resistance (disk diffusion method), and determined their biofilm-forming capabilities. Furthermore, their gene profiles (virulence and antibiotic resistance genes) were determined using molecular techniques. Suspected E. coli isolates were identified using the trpA gene, and a total of 70 isolates (77%) were confirmed as positive. Additionally, E. coli serotypes O26 (7.1%), O111 (1.4%), O45 (1.4%), and H8 (11.4%) were identified. Antibiotic resistance rates were determined for ampicillin (17%), tetracycline (31%), erythromycin (41%), gentamicin (51%), and enrofloxacin (40%), and multidrug resistance was 37.1%. Virulence gene distributions in the isolates were determined using the stx2 (20%) and hlyA (1.4%) genes. E. coli virulence genes (stx1, eaeA, and hlyA) were tested. Although fish and offal provide an alternative protein source, the high prevalence of E. coli, antibiotic resistance, and virulence factors suggests that these could pose public health risks. These findings indicate that strict hygiene measures may be needed in fish processing and consumption.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Biofilms/growth & development
*Escherichia coli/drug effects/genetics/classification/physiology/isolation & purification/pathogenicity
Anti-Bacterial Agents/pharmacology
*Fishes/microbiology
Virulence Factors/genetics
Virulence
Serogroup
*Drug Resistance, Bacterial
Humans
Escherichia coli Infections/microbiology
Public Health
Microbial Sensitivity Tests
Food Microbiology
RevDate: 2026-11-18
CmpDate: 2026-11-18
Hops β-Acids Extract: A Novel Toothpaste Ingredient for Superior Biofilm Disruption and More Effective Oral Hygiene.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):1-4.
Thorough removal of oral biofilm remains a challenge even with twice-daily hygiene, due largely to extracellular polymeric substance (EPS) matrix structures in biofilm. EPS provides structural cohesion to biofilm, impeding its removal through mechanical and/or chemical means. Recently, a novel approach to biofilm cleaning was introduced using hops beta (β)-acids (Activ Bio-Cleanser™) as a surfactant in toothpaste formulations. This introductory article highlights evidence presented in this special issue showing the surface-active properties of hops β-acids that allow it to modify the EPS matrix and enhance oral hygiene efficiency. Research presented in this special issue includes mechanistic, ex vivo, and in vivo findings demonstrating the ability of hops β-acids to disrupt biofilm through actions on EPS, enhance removal of adherent biofilm, and improve the accessibility of active ingredients (eg, stannous fluoride). This collective body of research shows the benefits of utilizing hops β-acids as a transformative toothpaste ingredient.
Additional Links: PMID-43051120
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051120,
year = {2026},
author = {St John, S and Reynolds, EC},
title = {Hops β-Acids Extract: A Novel Toothpaste Ingredient for Superior Biofilm Disruption and More Effective Oral Hygiene.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {1-4},
pmid = {43051120},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; *Toothpastes/pharmacology/chemistry ; Humans ; *Oral Hygiene ; *Plant Extracts/pharmacology/therapeutic use ; Surface-Active Agents/pharmacology ; },
abstract = {Thorough removal of oral biofilm remains a challenge even with twice-daily hygiene, due largely to extracellular polymeric substance (EPS) matrix structures in biofilm. EPS provides structural cohesion to biofilm, impeding its removal through mechanical and/or chemical means. Recently, a novel approach to biofilm cleaning was introduced using hops beta (β)-acids (Activ Bio-Cleanser™) as a surfactant in toothpaste formulations. This introductory article highlights evidence presented in this special issue showing the surface-active properties of hops β-acids that allow it to modify the EPS matrix and enhance oral hygiene efficiency. Research presented in this special issue includes mechanistic, ex vivo, and in vivo findings demonstrating the ability of hops β-acids to disrupt biofilm through actions on EPS, enhance removal of adherent biofilm, and improve the accessibility of active ingredients (eg, stannous fluoride). This collective body of research shows the benefits of utilizing hops β-acids as a transformative toothpaste ingredient.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
*Toothpastes/pharmacology/chemistry
Humans
*Oral Hygiene
*Plant Extracts/pharmacology/therapeutic use
Surface-Active Agents/pharmacology
RevDate: 2026-11-18
CmpDate: 2026-11-18
Enhanced Dental Biofilm Removal With Toothpastes Containing Hops β-Acids Extract: In Vivo Studies on Oral Hygiene.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):22-27.
OBJECTIVE: To quantify the dose-dependent cleansing effects of toothpastes formulated with a plant-derived surfactant (hops beta (β)-acids extract) within commercial sodium fluoride (NaF)/pyrophosphate toothpaste matrices on biofilm removal during standard toothbrushing, compared to an otherwise identical placebo control formulation without hops.
METHODS: Two independent, randomized, double-blind, crossover in vivo studies were carried out using digital image analysis (DIA) of biofilm coverage on facial tooth surfaces before and after a single supervised toothbrushing with an assigned toothpaste treatment. Participants from a prequalified team panel at the Procter & Gamble Oral Health Science Center were enrolled. Three toothpaste formulations were evaluated in both studies, all containing 0.243% NaF and pyrophosphate: (1) toothpaste with no hops (placebo control); (2) toothpaste with 0.15% hops β-acids; (3) toothpaste with 0.50% hops β-acids. In study 2, an additional NaF /pyrophosphate toothpaste formulation was included containing 0.50% hops hexahydro-beta acids (HBA), a chemically modified hops extract with reduced surfactant properties. Each toothpaste treatment was used in a single-brushing exercise three times during the study, for a total of nine visits per participant in study 1 and 12 visits per participant in study 2. The use of DIA of biofilm coverage via fluorescence labeling (eg, fluorescein) and long-wave ultraviolet imaging enabled segmentation of pixel classes to quantify biofilm on tooth versus gingival surfaces. Biofilm coverage percentage, spatial distribution (eg, near the gingival margin, interdental areas), and dose-response relationships were evaluated.
RESULTS: Twelve of 13 enrolled participants completed study 1 and 105 brushing sessions were analyzed. In study 2, all 15 enrolled participants completed the trial and 176 brushing sessions were analyzed. Dose-dependent, statistically significant reductions (P < 0.05) in adherent biofilm coverage were observed in both trials following toothbrushing with hops-containing toothpaste formulations, compared with brushing with matched control formulations without hops. Biofilm removal ranged from 80.4% to 85.2% for 0.15% and from 85.4% to 88.8% for 0.50% hops β-acid formulations. The formulation containing a chemically modified hops extract (HBA) demonstrated reduced cleaning efficacy compared with formulations containing native hops β-acids consistent with its reduced hydrophilic-lipophilic balance following hydrogenation. There were no adverse events in either trial, consistent with hops' gentleness on oral soft tissues.
CONCLUSIONS: Incorporation of hops β-acids extract (Activ Bio-Cleanser™) into toothpaste formulations enhances surfactant-driven, physicochemical cleaning behavior, resulting in improved removal of adherent biofilm during toothbrushing.
PRACTICAL IMPLICATIONS: Toothpaste formulated with hops β-acids extract provides greater cleaning via enhanced biofilm removal for patients because of optimized surfactant properties, facilitating more productive daily hygiene.
Additional Links: PMID-43051123
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051123,
year = {2026},
author = {Zsiska, M and Anastasia, MK and Baig, A and St John, S},
title = {Enhanced Dental Biofilm Removal With Toothpastes Containing Hops β-Acids Extract: In Vivo Studies on Oral Hygiene.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {22-27},
pmid = {43051123},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; Humans ; *Toothpastes/therapeutic use ; Double-Blind Method ; *Humulus ; *Plant Extracts/therapeutic use ; Cross-Over Studies ; Sodium Fluoride/therapeutic use ; Female ; Toothbrushing ; Male ; Adult ; Fluoride Treatment ; },
abstract = {OBJECTIVE: To quantify the dose-dependent cleansing effects of toothpastes formulated with a plant-derived surfactant (hops beta (β)-acids extract) within commercial sodium fluoride (NaF)/pyrophosphate toothpaste matrices on biofilm removal during standard toothbrushing, compared to an otherwise identical placebo control formulation without hops.
METHODS: Two independent, randomized, double-blind, crossover in vivo studies were carried out using digital image analysis (DIA) of biofilm coverage on facial tooth surfaces before and after a single supervised toothbrushing with an assigned toothpaste treatment. Participants from a prequalified team panel at the Procter & Gamble Oral Health Science Center were enrolled. Three toothpaste formulations were evaluated in both studies, all containing 0.243% NaF and pyrophosphate: (1) toothpaste with no hops (placebo control); (2) toothpaste with 0.15% hops β-acids; (3) toothpaste with 0.50% hops β-acids. In study 2, an additional NaF /pyrophosphate toothpaste formulation was included containing 0.50% hops hexahydro-beta acids (HBA), a chemically modified hops extract with reduced surfactant properties. Each toothpaste treatment was used in a single-brushing exercise three times during the study, for a total of nine visits per participant in study 1 and 12 visits per participant in study 2. The use of DIA of biofilm coverage via fluorescence labeling (eg, fluorescein) and long-wave ultraviolet imaging enabled segmentation of pixel classes to quantify biofilm on tooth versus gingival surfaces. Biofilm coverage percentage, spatial distribution (eg, near the gingival margin, interdental areas), and dose-response relationships were evaluated.
RESULTS: Twelve of 13 enrolled participants completed study 1 and 105 brushing sessions were analyzed. In study 2, all 15 enrolled participants completed the trial and 176 brushing sessions were analyzed. Dose-dependent, statistically significant reductions (P < 0.05) in adherent biofilm coverage were observed in both trials following toothbrushing with hops-containing toothpaste formulations, compared with brushing with matched control formulations without hops. Biofilm removal ranged from 80.4% to 85.2% for 0.15% and from 85.4% to 88.8% for 0.50% hops β-acid formulations. The formulation containing a chemically modified hops extract (HBA) demonstrated reduced cleaning efficacy compared with formulations containing native hops β-acids consistent with its reduced hydrophilic-lipophilic balance following hydrogenation. There were no adverse events in either trial, consistent with hops' gentleness on oral soft tissues.
CONCLUSIONS: Incorporation of hops β-acids extract (Activ Bio-Cleanser™) into toothpaste formulations enhances surfactant-driven, physicochemical cleaning behavior, resulting in improved removal of adherent biofilm during toothbrushing.
PRACTICAL IMPLICATIONS: Toothpaste formulated with hops β-acids extract provides greater cleaning via enhanced biofilm removal for patients because of optimized surfactant properties, facilitating more productive daily hygiene.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
Humans
*Toothpastes/therapeutic use
Double-Blind Method
*Humulus
*Plant Extracts/therapeutic use
Cross-Over Studies
Sodium Fluoride/therapeutic use
Female
Toothbrushing
Male
Adult
Fluoride Treatment
RevDate: 2026-11-18
CmpDate: 2026-11-18
Impact of Hops β-Acids Extract on eDNA in Oral Biofilm Extracellular Polymeric Substances Revealed by Molecular Probes, Microarray Polymer Profiling, and Scanning Electron Microscopy.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):28-34.
OBJECTIVE: To evaluate the effects of stannous fluoride (SnF2) toothpaste formulations, including one containing hops beta (β)-acids extract, on extracellular DNA (eDNA) within the extracellular polymeric substance (EPS) matrix of human saliva-derived in vitro oral biofilms.
METHODS: Disruption was evaluated using DNA-specific antibodies and high-throughput microarray polymer profiling, with disruption detected by reduction in antibody binding to microarrays (epitope depletion). The impact of different toothpaste formulations, including one with hops β-acids, was analyzed using scanning electron microscopy (SEM) imaging. In vitro-derived biofilms were cultured from pooled human saliva (from healthy volunteers) and printed onto nitrocellulose microarrays. Epitope depletion was used to assess the impact of five different SnF2 toothpaste compositions, including one containing hops β-acids, and a sodium monofluorophosphate toothpaste on the overall abundance and density of oral biofilm DNA within the EPS matrix of in vitro oral biofilms.
RESULTS: A toothpaste composition containing SnF2-gluconate/citrate-hops (0.454% SnF2) impacted both z-form DNA (z-DNA) and single-stranded DNA (ss-DNA) epitopes in oral biofilm EPS. Specifically, this composition elicited the greatest reduction in z-DNA present in oral biofilm EPS across all formulations tested (P < 0.05, aerobic and anaerobic biofilms). This treatment composition also visually reduced the abundance and density of the EPS matrix.
CONCLUSIONS: Addition of hops β-acids drives the selective depletion of z-DNA epitopes, consistent with a model in which hops-containing formulations modify the EPS matrix through physicochemical interactions that impact specific structural domains, thereby contributing to changes in biofilm integrity and organization, observed through SEM.
CLINICAL IMPLICATIONS: These findings provide a molecular-level rationale for formulation strategies that disrupt the EPS of adherent oral biofilms through surfactant-based modification and an experimental framework to determine which components of the EPS are most disrupted.
Additional Links: PMID-43051124
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051124,
year = {2026},
author = {Yau, HCL and Goldberg-Cavalleri, A and Muñoz-Bodnar, A and Rice, H and Lelėnaitė, I and Fletcher, CS and Lant, NJ and Jakubovics, NS and St John, S and Strand, R and Willats, WGT},
title = {Impact of Hops β-Acids Extract on eDNA in Oral Biofilm Extracellular Polymeric Substances Revealed by Molecular Probes, Microarray Polymer Profiling, and Scanning Electron Microscopy.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {28-34},
pmid = {43051124},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; Humans ; Microscopy, Electron, Scanning ; *Toothpastes/pharmacology/chemistry ; Tin Fluorides/pharmacology ; *Extracellular Polymeric Substance Matrix/drug effects ; Saliva/microbiology ; *Plant Extracts/pharmacology ; Extrachromosomal DNA ; Gluconates/pharmacology ; },
abstract = {OBJECTIVE: To evaluate the effects of stannous fluoride (SnF2) toothpaste formulations, including one containing hops beta (β)-acids extract, on extracellular DNA (eDNA) within the extracellular polymeric substance (EPS) matrix of human saliva-derived in vitro oral biofilms.
METHODS: Disruption was evaluated using DNA-specific antibodies and high-throughput microarray polymer profiling, with disruption detected by reduction in antibody binding to microarrays (epitope depletion). The impact of different toothpaste formulations, including one with hops β-acids, was analyzed using scanning electron microscopy (SEM) imaging. In vitro-derived biofilms were cultured from pooled human saliva (from healthy volunteers) and printed onto nitrocellulose microarrays. Epitope depletion was used to assess the impact of five different SnF2 toothpaste compositions, including one containing hops β-acids, and a sodium monofluorophosphate toothpaste on the overall abundance and density of oral biofilm DNA within the EPS matrix of in vitro oral biofilms.
RESULTS: A toothpaste composition containing SnF2-gluconate/citrate-hops (0.454% SnF2) impacted both z-form DNA (z-DNA) and single-stranded DNA (ss-DNA) epitopes in oral biofilm EPS. Specifically, this composition elicited the greatest reduction in z-DNA present in oral biofilm EPS across all formulations tested (P < 0.05, aerobic and anaerobic biofilms). This treatment composition also visually reduced the abundance and density of the EPS matrix.
CONCLUSIONS: Addition of hops β-acids drives the selective depletion of z-DNA epitopes, consistent with a model in which hops-containing formulations modify the EPS matrix through physicochemical interactions that impact specific structural domains, thereby contributing to changes in biofilm integrity and organization, observed through SEM.
CLINICAL IMPLICATIONS: These findings provide a molecular-level rationale for formulation strategies that disrupt the EPS of adherent oral biofilms through surfactant-based modification and an experimental framework to determine which components of the EPS are most disrupted.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
Humans
Microscopy, Electron, Scanning
*Toothpastes/pharmacology/chemistry
Tin Fluorides/pharmacology
*Extracellular Polymeric Substance Matrix/drug effects
Saliva/microbiology
*Plant Extracts/pharmacology
Extrachromosomal DNA
Gluconates/pharmacology
RevDate: 2026-11-18
CmpDate: 2026-11-18
Stannous Fluoride Deposition Into Plaque Biofilm: Effects of Formulation Chemistry and Hops β-Acids Extract Dispersion.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):35-43.
OBJECTIVE: To evaluate how surfactant-mediated biofilm disruption by hops beta (β)-acids extract influences stannous fluoride (SnF2) penetration and interaction with extracellular metabolites, including lipopolysaccharide (LPS).
METHODS: In two studies, oral biofilms were formed in vivo on artificial enamel surfaces mounted in dental appliances worn by volunteers and subsequently treated ex vivo under controlled conditions. Across the studies, biofilms were treated with supernatants of various commercial 0.454% SnF2 dentifrices containing: (1) pyrophosphate; (2) potassium nitrate (KNO3) and pyrophosphate; (3) tripolyphosphate; and (4) gluconate/citrate-stabilized 0.454% SnF2 (Crest) with and without hops β-acids extract (Activ Bio-Cleanser™). Both studies used phosphate-buffered saline as a negative control (NC). Confocal laser scanning microscopy with component-specific fluorescent probes was used to quantify Sn and LPS distribution relative to bacterial biomass, biofilm thickness, and extracellular polymeric substance (EPS) structure. Image analysis was used to quantify Sn and LPS signal within bacterial regions, normalized to bacterial volume or area; statistical comparisons were made across conditions.
RESULTS: SnF2 uptake and penetration varied significantly across formulations. In study 1, the rank order from greatest to least for Sn deposition and LPS neutralization was: gluconate/citrate > KNO3 + pyro > pyro > NC (P < 0.05 between groups). In study 2, the rank order from greatest to least was: gluconate/citrate + hops > gluconate/citrate > tripolyphosphate and KNO3 + pyro > NC (P < 0.05 between groups). Some stabilized SnF2 systems exhibited limited penetration, consistent with diffusion barriers imposed by dense EPS matrices or over-stabilization reducing bioavailability. Gluconate/ citrate-stabilized SnF2-only treated biofilms showed higher deposition per unit bacteria than other SnF2 technologies but uniformly exhibited the majority of uptake in surface regions. In the formulation containing both hops and SnF2, increased Sn penetration and reduced detectable biofilm-associated LPS was observed, consistent with enhanced access of SnF2 to extracellular plaque components following surfactant-enabled biofilm modification. In this case, Sn penetration achieved high relative deposition per unit bacteria in the treated regions throughout the biofilm.
CONCLUSIONS: Hops β-acids extract acts as a co-surfactant in toothpaste, capable of modifying EPS structure to improve accessibility and interaction of SnF2 with extracellular metabolites within oral biofilms. The observed changes in Sn penetration and biofilm-associated, extracellular LPS are consistent with enhanced cleaning with reduced concentration of known tissue irritants.
CLINICAL IMPLICATIONS: These findings provide a mechanistic rationale for formulation strategies that enhance SnF2 accessibility within adherent oral biofilms through surfactant-based modification of EPS supporting more efficient biofilm management during oral hygiene and providing a basis for selecting toothpastes based on their efficacy.
Additional Links: PMID-43051125
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051125,
year = {2026},
author = {St John, S and Strand, R},
title = {Stannous Fluoride Deposition Into Plaque Biofilm: Effects of Formulation Chemistry and Hops β-Acids Extract Dispersion.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {35-43},
pmid = {43051125},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; *Tin Fluorides/pharmacology/pharmacokinetics ; Humans ; Lipopolysaccharides/metabolism ; Polyphosphates/pharmacology ; *Dental Plaque/microbiology/drug therapy ; *Plant Extracts/pharmacology ; Potassium Compounds/pharmacology ; Gluconates/pharmacology ; Diphosphates/pharmacology ; Microscopy, Confocal ; Fluoride Treatment ; Surface-Active Agents/pharmacology ; Nitrates ; Phosphates ; },
abstract = {OBJECTIVE: To evaluate how surfactant-mediated biofilm disruption by hops beta (β)-acids extract influences stannous fluoride (SnF2) penetration and interaction with extracellular metabolites, including lipopolysaccharide (LPS).
METHODS: In two studies, oral biofilms were formed in vivo on artificial enamel surfaces mounted in dental appliances worn by volunteers and subsequently treated ex vivo under controlled conditions. Across the studies, biofilms were treated with supernatants of various commercial 0.454% SnF2 dentifrices containing: (1) pyrophosphate; (2) potassium nitrate (KNO3) and pyrophosphate; (3) tripolyphosphate; and (4) gluconate/citrate-stabilized 0.454% SnF2 (Crest) with and without hops β-acids extract (Activ Bio-Cleanser™). Both studies used phosphate-buffered saline as a negative control (NC). Confocal laser scanning microscopy with component-specific fluorescent probes was used to quantify Sn and LPS distribution relative to bacterial biomass, biofilm thickness, and extracellular polymeric substance (EPS) structure. Image analysis was used to quantify Sn and LPS signal within bacterial regions, normalized to bacterial volume or area; statistical comparisons were made across conditions.
RESULTS: SnF2 uptake and penetration varied significantly across formulations. In study 1, the rank order from greatest to least for Sn deposition and LPS neutralization was: gluconate/citrate > KNO3 + pyro > pyro > NC (P < 0.05 between groups). In study 2, the rank order from greatest to least was: gluconate/citrate + hops > gluconate/citrate > tripolyphosphate and KNO3 + pyro > NC (P < 0.05 between groups). Some stabilized SnF2 systems exhibited limited penetration, consistent with diffusion barriers imposed by dense EPS matrices or over-stabilization reducing bioavailability. Gluconate/ citrate-stabilized SnF2-only treated biofilms showed higher deposition per unit bacteria than other SnF2 technologies but uniformly exhibited the majority of uptake in surface regions. In the formulation containing both hops and SnF2, increased Sn penetration and reduced detectable biofilm-associated LPS was observed, consistent with enhanced access of SnF2 to extracellular plaque components following surfactant-enabled biofilm modification. In this case, Sn penetration achieved high relative deposition per unit bacteria in the treated regions throughout the biofilm.
CONCLUSIONS: Hops β-acids extract acts as a co-surfactant in toothpaste, capable of modifying EPS structure to improve accessibility and interaction of SnF2 with extracellular metabolites within oral biofilms. The observed changes in Sn penetration and biofilm-associated, extracellular LPS are consistent with enhanced cleaning with reduced concentration of known tissue irritants.
CLINICAL IMPLICATIONS: These findings provide a mechanistic rationale for formulation strategies that enhance SnF2 accessibility within adherent oral biofilms through surfactant-based modification of EPS supporting more efficient biofilm management during oral hygiene and providing a basis for selecting toothpastes based on their efficacy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
*Tin Fluorides/pharmacology/pharmacokinetics
Humans
Lipopolysaccharides/metabolism
Polyphosphates/pharmacology
*Dental Plaque/microbiology/drug therapy
*Plant Extracts/pharmacology
Potassium Compounds/pharmacology
Gluconates/pharmacology
Diphosphates/pharmacology
Microscopy, Confocal
Fluoride Treatment
Surface-Active Agents/pharmacology
Nitrates
Phosphates
RevDate: 2026-11-18
Fluvoxamine disrupts Enterococcus faecalis biofilms by downregulating adhesion genes and binding biofilm proteins: a promising strategy for antimicrobial urinary catheter coatings.
Biofouling [Epub ahead of print].
Catheter-associated urinary tract infections (CAUTI) are predominantly driven by biofilm formation on indwelling devices, which significantly complicates treatment and contributes to high morbidity and mortality. The increasing antimicrobial resistance has intensified the need for novel therapeutic and preventive strategies. In this study, we investigated fluvoxamine, a selective serotonin-norepinephrine reuptake inhibitor, for its antibacterial and antibiofilm potential against Enterococcus faecalis, a common CAUTI pathogen. Fluvoxamine exhibited potent antibacterial activity with a minimum inhibitory concentration (MIC) of 12.5 µg/mL. Time-kill kinetics revealed rapid bactericidal activity within 1 h, and combination studies demonstrated synergistic effects with conventional antibiotics. Fluvoxamine significantly inhibited biofilm formation and eradicated up to 89% of preformed mature E. faecalis biofilms. Scanning electron microscopy (SEM) corroborated these findings, revealing substantial disruption of biofilm architecture and morphological damage to bacterial cells. In an in vitro catheter model, fluvoxamine-coated catheter tubes effectively reduced bacterial colonization and maintained antibacterial efficacy for up to 48 h. Confocal laser scanning microscopy (CLSM) combined with FDA/PI staining confirmed reduced biofilm thickness and increased proportion of dead cells. Molecular docking analysis indicated a strong binding affinity of fluvoxamine to key E. faecalis biofilm-associated adhesion proteins. Furthermore, quantitative RT-PCR analysis showed significant downregulation of biofilm-related genes, including GelE, EbpA, AS, and EfaA. Collectively, our findings demonstrate that fluvoxamine possesses promising antibacterial and antibiofilm properties and highlight its potential as a novel catheter-coating agent for the prevention and management of E. faecalis-associated CAUTI.
Additional Links: PMID-43051301
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43051301,
year = {2026},
author = {Poyil, MM and AlFaki, MAW and Hassan, MI},
title = {Fluvoxamine disrupts Enterococcus faecalis biofilms by downregulating adhesion genes and binding biofilm proteins: a promising strategy for antimicrobial urinary catheter coatings.},
journal = {Biofouling},
volume = {},
number = {},
pages = {1-14},
doi = {10.1080/08927014.2026.2763376},
pmid = {43051301},
issn = {1029-2454},
abstract = {Catheter-associated urinary tract infections (CAUTI) are predominantly driven by biofilm formation on indwelling devices, which significantly complicates treatment and contributes to high morbidity and mortality. The increasing antimicrobial resistance has intensified the need for novel therapeutic and preventive strategies. In this study, we investigated fluvoxamine, a selective serotonin-norepinephrine reuptake inhibitor, for its antibacterial and antibiofilm potential against Enterococcus faecalis, a common CAUTI pathogen. Fluvoxamine exhibited potent antibacterial activity with a minimum inhibitory concentration (MIC) of 12.5 µg/mL. Time-kill kinetics revealed rapid bactericidal activity within 1 h, and combination studies demonstrated synergistic effects with conventional antibiotics. Fluvoxamine significantly inhibited biofilm formation and eradicated up to 89% of preformed mature E. faecalis biofilms. Scanning electron microscopy (SEM) corroborated these findings, revealing substantial disruption of biofilm architecture and morphological damage to bacterial cells. In an in vitro catheter model, fluvoxamine-coated catheter tubes effectively reduced bacterial colonization and maintained antibacterial efficacy for up to 48 h. Confocal laser scanning microscopy (CLSM) combined with FDA/PI staining confirmed reduced biofilm thickness and increased proportion of dead cells. Molecular docking analysis indicated a strong binding affinity of fluvoxamine to key E. faecalis biofilm-associated adhesion proteins. Furthermore, quantitative RT-PCR analysis showed significant downregulation of biofilm-related genes, including GelE, EbpA, AS, and EfaA. Collectively, our findings demonstrate that fluvoxamine possesses promising antibacterial and antibiofilm properties and highlight its potential as a novel catheter-coating agent for the prevention and management of E. faecalis-associated CAUTI.},
}
RevDate: 2026-11-15
Spatiotemporal coordination of a bacteria-targeted ultrasound-light cascade for synergistic eradication of MRSA biofilm-associated infections.
Journal of controlled release : official journal of the Controlled Release Society pii:S0168-3659(26)00941-7 [Epub ahead of print].
Restricted delivery of antimicrobial agents into biofilms limits the treatment of implant-associated infections. Here, we developed UBI29-41-functionalized lipid nanobubbles co-loaded with vancomycin (Van) and an aggregation-induced emission (AIE) photosensitizer (UBI-Van/AIE@NBs) for sequential ultrasound (US)-assisted and photodynamic treatment of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. The formulation exhibited a mean hydrodynamic diameter of 480.3 ± 40.8 nm and a positive zeta potential. US increased cumulative Van and AIE release to approximately 82% and 74%, respectively, within 5 min, compared with 27-28% without US. Cell-free probe assays supported AIE-associated reactive oxygen species generation during white-light irradiation. Fluorescence imaging suggested enhanced biofilm association and prolonged signal retention at the infection site. In vitro, sequential US and light exposure reduced residual biofilm biomass and viable bacterial counts more effectively than either stimulus alone, with UBI-Van/AIE@NBs producing the lowest residual biomass and bacterial recovery under combined treatment. In a murine titanium implant-associated MRSA infection model, the combined regimen reduced implant-associated bacterial burden and accelerated wound closure, accompanied by reduced inflammation, improved collagen organization, and increased CD31 staining. The formulation exhibited low cytotoxicity and hemolysis, without apparent major-organ injury or significant changes in serum biochemical parameters under the tested conditions. These findings support integrating peptide functionalization, US-enhanced cargo release, and photodynamic treatment as a preclinical strategy for localized management of implant-associated MRSA biofilm infections.
Additional Links: PMID-43035133
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035133,
year = {2026},
author = {Yao, L and Liu, R and Xing, Q and Hu, Q and Li, Y and Chen, S and Mu, Y and Cao, L and Mu, WH},
title = {Spatiotemporal coordination of a bacteria-targeted ultrasound-light cascade for synergistic eradication of MRSA biofilm-associated infections.},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
volume = {},
number = {},
pages = {115537},
doi = {10.1016/j.jconrel.2026.115537},
pmid = {43035133},
issn = {1873-4995},
abstract = {Restricted delivery of antimicrobial agents into biofilms limits the treatment of implant-associated infections. Here, we developed UBI29-41-functionalized lipid nanobubbles co-loaded with vancomycin (Van) and an aggregation-induced emission (AIE) photosensitizer (UBI-Van/AIE@NBs) for sequential ultrasound (US)-assisted and photodynamic treatment of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. The formulation exhibited a mean hydrodynamic diameter of 480.3 ± 40.8 nm and a positive zeta potential. US increased cumulative Van and AIE release to approximately 82% and 74%, respectively, within 5 min, compared with 27-28% without US. Cell-free probe assays supported AIE-associated reactive oxygen species generation during white-light irradiation. Fluorescence imaging suggested enhanced biofilm association and prolonged signal retention at the infection site. In vitro, sequential US and light exposure reduced residual biofilm biomass and viable bacterial counts more effectively than either stimulus alone, with UBI-Van/AIE@NBs producing the lowest residual biomass and bacterial recovery under combined treatment. In a murine titanium implant-associated MRSA infection model, the combined regimen reduced implant-associated bacterial burden and accelerated wound closure, accompanied by reduced inflammation, improved collagen organization, and increased CD31 staining. The formulation exhibited low cytotoxicity and hemolysis, without apparent major-organ injury or significant changes in serum biochemical parameters under the tested conditions. These findings support integrating peptide functionalization, US-enhanced cargo release, and photodynamic treatment as a preclinical strategy for localized management of implant-associated MRSA biofilm infections.},
}
RevDate: 2026-11-17
CmpDate: 2026-11-15
TiN-coated abutment microtopographies promote gingival fibroblast-mediated soft-tissue sealing and reduce biofilm formation in vitro.
BMC oral health, 26(1):.
BACKGROUND: The establishment of a stable peri-implant soft-tissue seal is critical for the long-term success of dental implants and is strongly influenced by abutment surface properties. This in vitro study systematically evaluated the combined effects of micro-topography and titanium nitride (TiN) coating on human gingival fibroblast (HGF) behavior and bacterial adhesion.
METHODS: Six TiN-coated surfaces with distinct micro-thread geometries-machined (M, M1, M2) and double-acid-etched (T, T1, T2)-were characterized for surface topography and wettability and assessed for HGF viability, adhesion, and mechanotransduction, alongside antibiofilm activity.
RESULTS: All surfaces were biocompatible and moderately hydrophilic. Among all conditions, the T1 surface (50 × 5 μm thread geometry with etching) demonstrated superior HGF viability and adhesion, confirmed by MTT, SEM, and immunofluorescence analyses. This surface may also enhance mechanotransduction, as suggested by increased activation of FAK, YAP, and TAZ and reduced levels of their phosphorylated forms. Additionally, TiN-coated surfaces significantly reduced biofilm formation across the bacterial species tested compared with uncoated surfaces, with T1 showing a marked reduction relative to M1 for most species.
CONCLUSIONS: Collectively, these findings identify the T1 micro-topography as an optimal design for promoting HGF-mediated soft-tissue integration while limiting bacterial colonization, supporting its potential application in novel transmucosal abutments.
Additional Links: PMID-43035729
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035729,
year = {2026},
author = {Romasco, T and Petrovic, S and Vlajic Tovilovic, T and Comuzzi, L and Cipollina, A and Radunović, M and Piattelli, A and Di Pietro, N},
title = {TiN-coated abutment microtopographies promote gingival fibroblast-mediated soft-tissue sealing and reduce biofilm formation in vitro.},
journal = {BMC oral health},
volume = {26},
number = {1},
pages = {},
pmid = {43035729},
issn = {1472-6831},
mesh = {*Biofilms/drug effects/growth & development ; Humans ; *Gingiva/cytology ; *Titanium/pharmacology ; *Fibroblasts/physiology ; Surface Properties ; Bacterial Adhesion/drug effects ; *Dental Abutments ; *Coated Materials, Biocompatible/pharmacology ; In Vitro Techniques ; Cell Survival ; Dental Implants ; Microscopy, Electron, Scanning ; },
abstract = {BACKGROUND: The establishment of a stable peri-implant soft-tissue seal is critical for the long-term success of dental implants and is strongly influenced by abutment surface properties. This in vitro study systematically evaluated the combined effects of micro-topography and titanium nitride (TiN) coating on human gingival fibroblast (HGF) behavior and bacterial adhesion.
METHODS: Six TiN-coated surfaces with distinct micro-thread geometries-machined (M, M1, M2) and double-acid-etched (T, T1, T2)-were characterized for surface topography and wettability and assessed for HGF viability, adhesion, and mechanotransduction, alongside antibiofilm activity.
RESULTS: All surfaces were biocompatible and moderately hydrophilic. Among all conditions, the T1 surface (50 × 5 μm thread geometry with etching) demonstrated superior HGF viability and adhesion, confirmed by MTT, SEM, and immunofluorescence analyses. This surface may also enhance mechanotransduction, as suggested by increased activation of FAK, YAP, and TAZ and reduced levels of their phosphorylated forms. Additionally, TiN-coated surfaces significantly reduced biofilm formation across the bacterial species tested compared with uncoated surfaces, with T1 showing a marked reduction relative to M1 for most species.
CONCLUSIONS: Collectively, these findings identify the T1 micro-topography as an optimal design for promoting HGF-mediated soft-tissue integration while limiting bacterial colonization, supporting its potential application in novel transmucosal abutments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
Humans
*Gingiva/cytology
*Titanium/pharmacology
*Fibroblasts/physiology
Surface Properties
Bacterial Adhesion/drug effects
*Dental Abutments
*Coated Materials, Biocompatible/pharmacology
In Vitro Techniques
Cell Survival
Dental Implants
Microscopy, Electron, Scanning
RevDate: 2026-11-16
CmpDate: 2026-11-16
Functionalized chitosan nanomaterials for biofilm eradication: A review.
Carbohydrate polymers, 393:125979.
Biofilms are highly organized microbial communities that are encased within self-produced extracellular polymeric substances (EPS) composed mainly of polysaccharides, extracellular DNA (eDNA), proteins, and lipids. They are one of the major challenges in clinical medicine due to their resistance to antimicrobial agents. Current treatment approaches used for controlling biofilms have limited efficacy, driving the need for alternative antimicrobial strategies. Chitosan-based nanomaterials have gained attention owing to their cationic property, biocompatibility, biodegradability, and antimicrobial activity. Chitosan nanomaterials have demonstrated enhanced penetration and disruption of biofilms. This review offers an overview of the various stages of biofilm formation and discusses about the important components of biofilms. The role of chitosan-based nanomaterials in combating bacterial biofilms is explained in detail. This review also discusses various chemical modification approaches such as quaternization, thiolation, carboxylation, sulfonation, phosphorylation, alkylation, and acylation, which can enhance the antibacterial and anti-biofilm activities of chitosan. This review collectively reveals the versatile properties of chitosan-based nanomaterials such as nanoparticles, nanogels, nanofibers and nanocomposites for preventing and eradicating bacterial biofilms and offers important insights for developing a new generation of anti-biofilm agents.
Additional Links: PMID-43039564
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43039564,
year = {2026},
author = {Shahabuddin, S and Vedakumari, SW and Prabakaran, L and Pravin, YR and Haribabu, J},
title = {Functionalized chitosan nanomaterials for biofilm eradication: A review.},
journal = {Carbohydrate polymers},
volume = {393},
number = {},
pages = {125979},
doi = {10.1016/j.carbpol.2026.125979},
pmid = {43039564},
issn = {1879-1344},
mesh = {*Biofilms/drug effects ; *Chitosan/chemistry/pharmacology ; *Anti-Bacterial Agents/pharmacology/chemistry ; *Nanostructures/chemistry ; Humans ; Bacteria/drug effects ; },
abstract = {Biofilms are highly organized microbial communities that are encased within self-produced extracellular polymeric substances (EPS) composed mainly of polysaccharides, extracellular DNA (eDNA), proteins, and lipids. They are one of the major challenges in clinical medicine due to their resistance to antimicrobial agents. Current treatment approaches used for controlling biofilms have limited efficacy, driving the need for alternative antimicrobial strategies. Chitosan-based nanomaterials have gained attention owing to their cationic property, biocompatibility, biodegradability, and antimicrobial activity. Chitosan nanomaterials have demonstrated enhanced penetration and disruption of biofilms. This review offers an overview of the various stages of biofilm formation and discusses about the important components of biofilms. The role of chitosan-based nanomaterials in combating bacterial biofilms is explained in detail. This review also discusses various chemical modification approaches such as quaternization, thiolation, carboxylation, sulfonation, phosphorylation, alkylation, and acylation, which can enhance the antibacterial and anti-biofilm activities of chitosan. This review collectively reveals the versatile properties of chitosan-based nanomaterials such as nanoparticles, nanogels, nanofibers and nanocomposites for preventing and eradicating bacterial biofilms and offers important insights for developing a new generation of anti-biofilm agents.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
*Chitosan/chemistry/pharmacology
*Anti-Bacterial Agents/pharmacology/chemistry
*Nanostructures/chemistry
Humans
Bacteria/drug effects
RevDate: 2026-11-14
EPS-associated particle-biofilm matrix development links sustained microplastic accumulation to high-load pore-space loss in constructed wetlands.
Water research, 309(Pt B):127308 pii:S0043-1354(26)01979-2 [Epub ahead of print].
Constructed wetlands (CWs) can efficiently intercept microplastics (MPs), but this apparent removal transfers persistent particles from the water column into the wetland bed. Whether continuous MP accumulation translates directly into structural deterioration, and how biofilm extracellular polymeric substances (EPS) contribute to this process, remain poorly understood. Here, vertical-flow CWs containing sewage-sludge biochar (SB) or gravel were operated for approximately 800 d under polypropylene microplastic (PP-MP) concentrations of 0, 0.5, 5 and 50 mg L[-1]. PP-MP removal exceeded 85% in all exposed systems, with higher monitored removal in SB than in gravel; particle concentrations at the two sampled intervals (0-5 and 10-15 cm) were similar. Within SB, PP-MP concentration explained a significant secondary component of bacterial-community variation (R[2] = 0.054, p = 0.001), while the community shift was strongly aligned with EPS variation. Upper-layer EPS increased from approximately 22.1 µg g[-1] in the unloaded SB control to 30.2 µg g[-1] at 50 mg L[-1] and covaried strongly with retained PP-MPs across treatments (R[2] = 0.78, p = 0.0037). Importantly, particle accumulation did not translate proportionally into pore-space loss. After adjustment for initial porosity, terminal SB porosity was lower than the unloaded SB control by 0.36, 0.62 and 2.33 percentage points at 0.5, 5 and 50 mg L[-1], respectively (Holm-adjusted p = 0.0095, 0.0011 and <0.0001), with terminal SB50 porosity reaching approximately 18.1%. These results are consistent with EPS-associated particle-biofilm interactions and pore occupation, although endpoint associations cannot establish the causal order of particle retention, biofilm development and pore-space change. The findings shift CW evaluation beyond effluent removal toward the long-term fate and structural consequences of retained particulate contaminants.
Additional Links: PMID-43033763
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033763,
year = {2026},
author = {Shen, C and Wang, L and Wu, Q and Man, YB and Wu, Z and Liu, W and Ji, B and Liu, C and Zhang, Y and Shan, S and Zhang, J and Ye, S},
title = {EPS-associated particle-biofilm matrix development links sustained microplastic accumulation to high-load pore-space loss in constructed wetlands.},
journal = {Water research},
volume = {309},
number = {Pt B},
pages = {127308},
doi = {10.1016/j.watres.2026.127308},
pmid = {43033763},
issn = {1879-2448},
abstract = {Constructed wetlands (CWs) can efficiently intercept microplastics (MPs), but this apparent removal transfers persistent particles from the water column into the wetland bed. Whether continuous MP accumulation translates directly into structural deterioration, and how biofilm extracellular polymeric substances (EPS) contribute to this process, remain poorly understood. Here, vertical-flow CWs containing sewage-sludge biochar (SB) or gravel were operated for approximately 800 d under polypropylene microplastic (PP-MP) concentrations of 0, 0.5, 5 and 50 mg L[-1]. PP-MP removal exceeded 85% in all exposed systems, with higher monitored removal in SB than in gravel; particle concentrations at the two sampled intervals (0-5 and 10-15 cm) were similar. Within SB, PP-MP concentration explained a significant secondary component of bacterial-community variation (R[2] = 0.054, p = 0.001), while the community shift was strongly aligned with EPS variation. Upper-layer EPS increased from approximately 22.1 µg g[-1] in the unloaded SB control to 30.2 µg g[-1] at 50 mg L[-1] and covaried strongly with retained PP-MPs across treatments (R[2] = 0.78, p = 0.0037). Importantly, particle accumulation did not translate proportionally into pore-space loss. After adjustment for initial porosity, terminal SB porosity was lower than the unloaded SB control by 0.36, 0.62 and 2.33 percentage points at 0.5, 5 and 50 mg L[-1], respectively (Holm-adjusted p = 0.0095, 0.0011 and <0.0001), with terminal SB50 porosity reaching approximately 18.1%. These results are consistent with EPS-associated particle-biofilm interactions and pore occupation, although endpoint associations cannot establish the causal order of particle retention, biofilm development and pore-space change. The findings shift CW evaluation beyond effluent removal toward the long-term fate and structural consequences of retained particulate contaminants.},
}
RevDate: 2026-11-16
Phenotypic and genotypic investigation of the relationship between quorum sensing genes and biofilm ability in multidrug-resistant Pseudomonas aeruginosa isolates.
Microbial pathogenesis, 222:108922 pii:S0882-4010(26)00648-0 [Epub ahead of print].
BACKGROUND: The clinical persistence of Pseudomonas aeruginosa is largely driven by the interplay between multidrug resistance (MDR), complex biofilm architecture, and quorum sensing (QS) signaling. This study evaluated carbapenemase gene profiles, biofilm forming capacities, and PCR detection of QS-associated gene targets in clinical P. aeruginosa isolates.
METHODS: Fifty-six clinical P. aeruginosa isolates collected between January and June 2024 were analyzed. Antibiotic susceptibility was determined according to EUCAST criteria. Biofilm formation was quantified using a spectrophotometric microplate assay. Six carbapenemase gene targets were investigated by conventional PCR, and QS-associated gene targets (lasI, lasR, rhlI, rhlR) were examined using two previously published primer sets.
RESULTS: Based on recorded R results, 14 of 56 isolates (25.0%) showed resistance to at least one agent in three or more of the five evaluated antimicrobial categories; incomplete testing limited definitive MDR classification. Imipenem resistance was detected in 19 of 50 isolates with available results (38.0%), whereas meropenem resistance was detected in 15 of 51 isolates with available results (29.41%). Biofilm production was prevalent, with 85.71% of isolates demonstrating biofilm-forming capacity (32.1% strong, 51.8% moderate, 1.8% weak). Molecular analysis revealed a high frequency of carbapenemase genes, with blaOXA-48 (64.29%) and blaNDM (53.57%) being the most common, while 69.64% (39/56) of isolates harbored two or more carbapenemase gene targets. QS gene targets were frequently detected, although PCR positivity alone did not establish complete gene integrity or functional activity.
CONCLUSIONS: Carbapenemase and QS gene targets were frequently detected alongside biofilm formation. Their coexistence does not establish functional QS activity, causal relationships, or independent evolution of resistance and virulence. Sequence confirmation and functional studies are needed to clarify these relationships.
Additional Links: PMID-43033876
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033876,
year = {2026},
author = {Kocaağa, M and Temel, A and Aydın, E},
title = {Phenotypic and genotypic investigation of the relationship between quorum sensing genes and biofilm ability in multidrug-resistant Pseudomonas aeruginosa isolates.},
journal = {Microbial pathogenesis},
volume = {222},
number = {},
pages = {108922},
doi = {10.1016/j.micpath.2026.108922},
pmid = {43033876},
issn = {1096-1208},
abstract = {BACKGROUND: The clinical persistence of Pseudomonas aeruginosa is largely driven by the interplay between multidrug resistance (MDR), complex biofilm architecture, and quorum sensing (QS) signaling. This study evaluated carbapenemase gene profiles, biofilm forming capacities, and PCR detection of QS-associated gene targets in clinical P. aeruginosa isolates.
METHODS: Fifty-six clinical P. aeruginosa isolates collected between January and June 2024 were analyzed. Antibiotic susceptibility was determined according to EUCAST criteria. Biofilm formation was quantified using a spectrophotometric microplate assay. Six carbapenemase gene targets were investigated by conventional PCR, and QS-associated gene targets (lasI, lasR, rhlI, rhlR) were examined using two previously published primer sets.
RESULTS: Based on recorded R results, 14 of 56 isolates (25.0%) showed resistance to at least one agent in three or more of the five evaluated antimicrobial categories; incomplete testing limited definitive MDR classification. Imipenem resistance was detected in 19 of 50 isolates with available results (38.0%), whereas meropenem resistance was detected in 15 of 51 isolates with available results (29.41%). Biofilm production was prevalent, with 85.71% of isolates demonstrating biofilm-forming capacity (32.1% strong, 51.8% moderate, 1.8% weak). Molecular analysis revealed a high frequency of carbapenemase genes, with blaOXA-48 (64.29%) and blaNDM (53.57%) being the most common, while 69.64% (39/56) of isolates harbored two or more carbapenemase gene targets. QS gene targets were frequently detected, although PCR positivity alone did not establish complete gene integrity or functional activity.
CONCLUSIONS: Carbapenemase and QS gene targets were frequently detected alongside biofilm formation. Their coexistence does not establish functional QS activity, causal relationships, or independent evolution of resistance and virulence. Sequence confirmation and functional studies are needed to clarify these relationships.},
}
RevDate: 2026-11-14
Elevated c-di-GMP signaling drives biofilm-associated antibiotic resistance in Escherichia coli from bovine mastitis.
Veterinary microbiology, 323:111278 pii:S0378-1135(26)00415-3 [Epub ahead of print].
This study investigates the associations between biofilm formation, antimicrobial resistance (AMR), and cyclic di-GMP (c-di-GMP) signaling in bovine mastitis-associated Escherichia coli. Among 127 clinical isolates, 92.9% exhibited biofilm-forming capacity, with biofilm producers harboring a significantly higher prevalence of genes conferring resistance to β-lactams (blaCTX-M-1) and aminoglycosides [aac(6')-Ib, aph(3')-III], as well as mobile genetic elements (IS26) and plasmid replicon types (IncFIB), compared to non-producers (P < 0.05). Biofilm-positive isolates demonstrated 8.3- and 6.1-fold increases in ampicillin and ceftazidime MICs, respectively, with strong correlations between biofilm biomass and MICs of these antibiotics (r = 0.71-0.84). Elevated c-di-GMP levels in biofilm isolates correlated with enhanced cephalosporin resistance (r = 0.61) but not with aminoglycoside resistance. Genetic analysis revealed a high prevalence and diversity of diguanylate cyclase (DGC) genes across clinical isolates. Functional validation using a yeaJ deletion mutant (a DGC gene) showed that c-di-GMP reduction impaired extracellular matrix production (curli, cellulose), altered colony morphology, and increased susceptibility to ceftazidime. Transcriptomic analysis of the mutant revealed significant changes in pathways related to cationic antimicrobial peptide (CAMP) resistance, peptidoglycan remodeling, and arginine metabolism. These findings suggest that c-di-GMP-mediated biofilm formation in mastitis-associated E. coli may represent an important mechanism contributing to specific antibiotic resistance and adaptive persistence.
Additional Links: PMID-43033738
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033738,
year = {2026},
author = {Zhang, X and Lian, X and Wu, J and Zhang, J and Jiang, T and Qi, M and Han, X},
title = {Elevated c-di-GMP signaling drives biofilm-associated antibiotic resistance in Escherichia coli from bovine mastitis.},
journal = {Veterinary microbiology},
volume = {323},
number = {},
pages = {111278},
doi = {10.1016/j.vetmic.2026.111278},
pmid = {43033738},
issn = {1873-2542},
abstract = {This study investigates the associations between biofilm formation, antimicrobial resistance (AMR), and cyclic di-GMP (c-di-GMP) signaling in bovine mastitis-associated Escherichia coli. Among 127 clinical isolates, 92.9% exhibited biofilm-forming capacity, with biofilm producers harboring a significantly higher prevalence of genes conferring resistance to β-lactams (blaCTX-M-1) and aminoglycosides [aac(6')-Ib, aph(3')-III], as well as mobile genetic elements (IS26) and plasmid replicon types (IncFIB), compared to non-producers (P < 0.05). Biofilm-positive isolates demonstrated 8.3- and 6.1-fold increases in ampicillin and ceftazidime MICs, respectively, with strong correlations between biofilm biomass and MICs of these antibiotics (r = 0.71-0.84). Elevated c-di-GMP levels in biofilm isolates correlated with enhanced cephalosporin resistance (r = 0.61) but not with aminoglycoside resistance. Genetic analysis revealed a high prevalence and diversity of diguanylate cyclase (DGC) genes across clinical isolates. Functional validation using a yeaJ deletion mutant (a DGC gene) showed that c-di-GMP reduction impaired extracellular matrix production (curli, cellulose), altered colony morphology, and increased susceptibility to ceftazidime. Transcriptomic analysis of the mutant revealed significant changes in pathways related to cationic antimicrobial peptide (CAMP) resistance, peptidoglycan remodeling, and arginine metabolism. These findings suggest that c-di-GMP-mediated biofilm formation in mastitis-associated E. coli may represent an important mechanism contributing to specific antibiotic resistance and adaptive persistence.},
}
RevDate: 2026-11-13
CmpDate: 2026-11-13
Decoding multispecies oral biofilms: molecular architecture, host modulation and systems-guided precision anti-biofilm strategies.
Frontiers in cellular and infection microbiology, 16:2002174.
Oral biofilms are spatially ordered microbial communities whose pathogenic behavior is shaped by more than taxonomic composition. Their development reflects the combined effects of adhesin-receptor recognition, interspecies coaggregation, matrix formation, metabolite exchange, local physicochemical gradients and host-derived selection. Here, we synthesize molecular and ecological evidence on the bacterial cell surface-matrix interface and consider how these interactions contribute to cariogenic, periodontal and peri-implant biofilms. Particular attention is given to glucosyltransferase-dependent polysaccharides, extracellular DNA, amyloidogenic proteins, sortase-anchored surface factors and outer membrane vesicles, together with metabolic interactions involving lactate, arginine, hydrogen peroxide and heme. We further evaluate functional-genomic and systems-level approaches (including transposon sequencing, CRISPR interference, metagenomics, metatranscriptomics, metaproteomics, metabolomics, spatial imaging, genome-scale metabolic modeling and machine learning) while distinguishing association and prediction from experimentally demonstrated mechanism. Emerging interventions are assessed according to their biological target and evidence level, including adhesion blockade, specifically targeted antimicrobials, matrix synthesis inhibition and degradation, quorum interference, probiotics, catalytic nanoparticles, antimicrobial photodynamic therapy and antibiofilm dental materials. Across these approaches, reduction in biofilm biomass is not equivalent to ecological restoration or clinical benefit. Key translational barriers include model fidelity, donor-to-donor variation, spatial heterogeneity, treatment durability, endpoint selection and the limited external validation of many computational and preclinical findings. Future precision strategies should therefore integrate microbial identity, matrix architecture, spatial metabolism and host context, with experimental perturbation used to establish causal vulnerabilities before therapeutic translation.
Additional Links: PMID-43022273
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43022273,
year = {2026},
author = {Almusallam, AA and Allemailem, KS},
title = {Decoding multispecies oral biofilms: molecular architecture, host modulation and systems-guided precision anti-biofilm strategies.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {2002174},
pmid = {43022273},
issn = {2235-2988},
mesh = {*Biofilms/drug effects/growth & development ; Humans ; *Mouth/microbiology ; Bacteria/genetics/drug effects ; Microbiota ; },
abstract = {Oral biofilms are spatially ordered microbial communities whose pathogenic behavior is shaped by more than taxonomic composition. Their development reflects the combined effects of adhesin-receptor recognition, interspecies coaggregation, matrix formation, metabolite exchange, local physicochemical gradients and host-derived selection. Here, we synthesize molecular and ecological evidence on the bacterial cell surface-matrix interface and consider how these interactions contribute to cariogenic, periodontal and peri-implant biofilms. Particular attention is given to glucosyltransferase-dependent polysaccharides, extracellular DNA, amyloidogenic proteins, sortase-anchored surface factors and outer membrane vesicles, together with metabolic interactions involving lactate, arginine, hydrogen peroxide and heme. We further evaluate functional-genomic and systems-level approaches (including transposon sequencing, CRISPR interference, metagenomics, metatranscriptomics, metaproteomics, metabolomics, spatial imaging, genome-scale metabolic modeling and machine learning) while distinguishing association and prediction from experimentally demonstrated mechanism. Emerging interventions are assessed according to their biological target and evidence level, including adhesion blockade, specifically targeted antimicrobials, matrix synthesis inhibition and degradation, quorum interference, probiotics, catalytic nanoparticles, antimicrobial photodynamic therapy and antibiofilm dental materials. Across these approaches, reduction in biofilm biomass is not equivalent to ecological restoration or clinical benefit. Key translational barriers include model fidelity, donor-to-donor variation, spatial heterogeneity, treatment durability, endpoint selection and the limited external validation of many computational and preclinical findings. Future precision strategies should therefore integrate microbial identity, matrix architecture, spatial metabolism and host context, with experimental perturbation used to establish causal vulnerabilities before therapeutic translation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
Humans
*Mouth/microbiology
Bacteria/genetics/drug effects
Microbiota
RevDate: 2026-11-13
CmpDate: 2026-11-13
Accumulation of Polyphosphate Inhibits Biofilm Formation in Mycobacteria by Activating RegX3 to Reduce Intracellular c-di-GMP Levels.
ACS infectious diseases, 12(11):3718-3729.
Mycobacterium tuberculosis can persist in the host for prolonged periods. Biofilm formation represents a key strategy that promotes bacterial persistence, enhances antibiotic resistance, and facilitates immune evasion. Thus, targeting biofilm formation holds significant therapeutic potential for tuberculosis. Exopolyphosphatase 1 (PPX1), highly conserved among mycobacteria, hydrolyzes inorganic polyphosphate. Although changes in polyphosphate levels are known to influence mycobacterial biofilm formation, the underlying mechanism remains unclear. In this study, using a Mycobacterium smegmatis model strain, we found that the level of polyphosphate in the Δppx1 mutant significantly increases, concomitant with impaired biofilm formation. Further investigation revealed that elevated polyphosphate enhances the transcriptional activity of the transcription factor RegX3, which in turn represses biofilm formation. Mechanistically, activated RegX3 directly binds to and upregulates the dcpA gene, encoding a bifunctional enzyme that lowers intracellular cyclic di-GMP levels. This reduction ultimately perturbs cell wall lipid synthesis and compromises biofilm formation. In summary, this work reveals a signaling pathway through which polyphosphate governs biofilm formation in M. smegmatis.
Additional Links: PMID-43023846
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023846,
year = {2026},
author = {Huang, T and Zhen, J and Le, TTT and Yan, Y and Huang, F and Xie, J},
title = {Accumulation of Polyphosphate Inhibits Biofilm Formation in Mycobacteria by Activating RegX3 to Reduce Intracellular c-di-GMP Levels.},
journal = {ACS infectious diseases},
volume = {12},
number = {11},
pages = {3718-3729},
doi = {10.1021/acsinfecdis.6c00445},
pmid = {43023846},
issn = {2373-8227},
support = {82072246//National Natural Science Foundation of China (NSFC)/ ; 82472325//National Natural Science Foundation of China (NSFC)/ ; },
mesh = {*Biofilms/growth & development ; *Polyphosphates/metabolism ; *Cyclic GMP/analogs & derivatives/metabolism ; *Mycobacterium smegmatis/genetics/metabolism/physiology ; *Bacterial Proteins/metabolism/genetics ; Gene Expression Regulation, Bacterial ; Acid Anhydride Hydrolases/genetics/metabolism ; *Transcription Factors/metabolism/genetics ; *Mycobacterium tuberculosis/genetics/metabolism/physiology ; },
abstract = {Mycobacterium tuberculosis can persist in the host for prolonged periods. Biofilm formation represents a key strategy that promotes bacterial persistence, enhances antibiotic resistance, and facilitates immune evasion. Thus, targeting biofilm formation holds significant therapeutic potential for tuberculosis. Exopolyphosphatase 1 (PPX1), highly conserved among mycobacteria, hydrolyzes inorganic polyphosphate. Although changes in polyphosphate levels are known to influence mycobacterial biofilm formation, the underlying mechanism remains unclear. In this study, using a Mycobacterium smegmatis model strain, we found that the level of polyphosphate in the Δppx1 mutant significantly increases, concomitant with impaired biofilm formation. Further investigation revealed that elevated polyphosphate enhances the transcriptional activity of the transcription factor RegX3, which in turn represses biofilm formation. Mechanistically, activated RegX3 directly binds to and upregulates the dcpA gene, encoding a bifunctional enzyme that lowers intracellular cyclic di-GMP levels. This reduction ultimately perturbs cell wall lipid synthesis and compromises biofilm formation. In summary, this work reveals a signaling pathway through which polyphosphate governs biofilm formation in M. smegmatis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Polyphosphates/metabolism
*Cyclic GMP/analogs & derivatives/metabolism
*Mycobacterium smegmatis/genetics/metabolism/physiology
*Bacterial Proteins/metabolism/genetics
Gene Expression Regulation, Bacterial
Acid Anhydride Hydrolases/genetics/metabolism
*Transcription Factors/metabolism/genetics
*Mycobacterium tuberculosis/genetics/metabolism/physiology
RevDate: 2026-11-13
Root-inspired selective biofilm control: Design principles for programmable interfaces.
Microbiological research, 315:128823 pii:S0944-5013(26)00387-3 [Epub ahead of print].
Most antifouling technologies delay attachment, kill colonizers, or remove biomass. Plant roots instead preserve water and nutrient exchange while regulating dense microbial communities through zonation, hydrated mucilage, patterned metabolite release, immunity, competition, and selective recruitment. This critical review develops a root-inspired framework for selective biofilm control: a bounded, functionally defined community that remains below application-specific limits for coverage, harmful activity, and asset impairment, and can be reset when those limits are exceeded. We distinguish established rhizosphere biology and materials evidence from proposed engineering translations. We examine renewable hydrated layers, spatial chemical fields, conditional sensing and response, and context-dependent priority effects, integrating them with biofilm matrix, mechanics, dispersal, and polymicrobial tolerance. We propose that programmable interfaces combine a low-fouling base, renewable outer layer, local cues, and feedback based on measured performance. The framework is a design hypothesis rather than a validated integrated technology. Translation requires local-field measurements, causal controls, realistic mixed-community ageing tests, repeated reset cycles, and application-specific safety assessment. Sterile exclusion remains preferable where any viable colonization is unacceptable.
Additional Links: PMID-43025162
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025162,
year = {2026},
author = {Amin, A and Zaman, W and Ullah, A},
title = {Root-inspired selective biofilm control: Design principles for programmable interfaces.},
journal = {Microbiological research},
volume = {315},
number = {},
pages = {128823},
doi = {10.1016/j.micres.2026.128823},
pmid = {43025162},
issn = {1618-0623},
abstract = {Most antifouling technologies delay attachment, kill colonizers, or remove biomass. Plant roots instead preserve water and nutrient exchange while regulating dense microbial communities through zonation, hydrated mucilage, patterned metabolite release, immunity, competition, and selective recruitment. This critical review develops a root-inspired framework for selective biofilm control: a bounded, functionally defined community that remains below application-specific limits for coverage, harmful activity, and asset impairment, and can be reset when those limits are exceeded. We distinguish established rhizosphere biology and materials evidence from proposed engineering translations. We examine renewable hydrated layers, spatial chemical fields, conditional sensing and response, and context-dependent priority effects, integrating them with biofilm matrix, mechanics, dispersal, and polymicrobial tolerance. We propose that programmable interfaces combine a low-fouling base, renewable outer layer, local cues, and feedback based on measured performance. The framework is a design hypothesis rather than a validated integrated technology. Translation requires local-field measurements, causal controls, realistic mixed-community ageing tests, repeated reset cycles, and application-specific safety assessment. Sterile exclusion remains preferable where any viable colonization is unacceptable.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Pyrimidine Metabolic Dysregulation Following pyrR Knockout Attenuates the Anti-Biofilm, Anti-Inflammatory, and Antioxidant Activities of Lacticaseibacillus casei Cell-Free Supernatant.
Biology, 15(21):.
Pathogenic infections caused by intestinal microecological imbalance pose a critical threat to livestock breeding and human health. Multiple probiotic functions of Lacticaseibacillus casei (L. casei), an important probiotic, are modulated by pyrR-mediated pyrimidine metabolism. This study used L. casei isolated from the intestines of Min pigs (a local pig breed from northeastern China) and its pyrR gene knockout mutant (named L. casei ΔpyrR, ΔpyrR) to investigate their antibacterial, anti-inflammatory, and antioxidant capacities. The results showed that the mutant exhibited significantly attenuated effects compared with the wild-type in disrupting pre-formed biofilms, damaging bacterial morphology, and downregulating the expression of related genes (biofilm and flagellar genes) in Staphylococcus aureus (S. aureus) and Salmonella typhimurium (S. typhimurium). The mutant-derived supernatant also exhibited impaired anti-inflammatory effects in S. typhimurium-challenged IPEC-J2 cells: it was less effective at restraining pathogen-induced IL-1β upregulation and boosting the production of host-derived TGF-β and IL-10, accompanied by altered regulation of the host STING signaling pathway. However, existing data cannot fully distinguish whether STING alteration corresponds to suppressed inflammation or impaired immunity. Additionally, pyrimidine metabolism in L. casei suppresses pathogen-induced reactive oxygen species (ROS) accumulation. These findings are consistent with pyrR-mediated pyrimidine synthesis contributing to the probiotic functions of L. casei, providing an experimental basis for optimizing probiotic preparations and substituting antibiotics.
Additional Links: PMID-43026925
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026925,
year = {2026},
author = {Jiang, Y and Han, F and He, X and Zhao, S and Sun, M and Zhang, L and Yu, K and Zhao, Y and Zou, Z and Wang, W and Chen, H and Jiang, X and Liu, D},
title = {Pyrimidine Metabolic Dysregulation Following pyrR Knockout Attenuates the Anti-Biofilm, Anti-Inflammatory, and Antioxidant Activities of Lacticaseibacillus casei Cell-Free Supernatant.},
journal = {Biology},
volume = {15},
number = {21},
pages = {},
pmid = {43026925},
issn = {2079-7737},
support = {JQ2024C004//Heilongjiang Natural Science Foundation for Distinguished Young Scholars/ ; CARS-35//National System of Modern Agricultural Industry Technology/ ; },
abstract = {Pathogenic infections caused by intestinal microecological imbalance pose a critical threat to livestock breeding and human health. Multiple probiotic functions of Lacticaseibacillus casei (L. casei), an important probiotic, are modulated by pyrR-mediated pyrimidine metabolism. This study used L. casei isolated from the intestines of Min pigs (a local pig breed from northeastern China) and its pyrR gene knockout mutant (named L. casei ΔpyrR, ΔpyrR) to investigate their antibacterial, anti-inflammatory, and antioxidant capacities. The results showed that the mutant exhibited significantly attenuated effects compared with the wild-type in disrupting pre-formed biofilms, damaging bacterial morphology, and downregulating the expression of related genes (biofilm and flagellar genes) in Staphylococcus aureus (S. aureus) and Salmonella typhimurium (S. typhimurium). The mutant-derived supernatant also exhibited impaired anti-inflammatory effects in S. typhimurium-challenged IPEC-J2 cells: it was less effective at restraining pathogen-induced IL-1β upregulation and boosting the production of host-derived TGF-β and IL-10, accompanied by altered regulation of the host STING signaling pathway. However, existing data cannot fully distinguish whether STING alteration corresponds to suppressed inflammation or impaired immunity. Additionally, pyrimidine metabolism in L. casei suppresses pathogen-induced reactive oxygen species (ROS) accumulation. These findings are consistent with pyrR-mediated pyrimidine synthesis contributing to the probiotic functions of L. casei, providing an experimental basis for optimizing probiotic preparations and substituting antibiotics.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Integrated Phenotypic and Genotypic Analysis Reveals Distinct Patterns of Biofilm Formation and Antimicrobial Resistance in Poultry-Derived Campylobacter jejuni and Campylobacter coli.
Foods (Basel, Switzerland), 15(21):.
Campylobacter (C.) jejuni and C. coli are major foodborne bacterial pathogens, and multiple mechanisms, including biofilm formation, antimicrobial resistance (AMR), and genetic variability, contribute to their persistence in poultry-associated environments. However, the relationships among these traits remain poorly understood. This study investigated 120 Campylobacter isolates (78 C. jejuni and 42 C. coli) from retail raw chicken meat by integrating assessments of biofilm formation under two different atmospheric conditions, antibiotic susceptibility profiles, AMR and virulence-associated determinants, and repetitive sequence-based polymerase chain reaction (rep-PCR)-based genetic diversity. Biofilm formation was highly heterogeneous, with atmospheric composition being associated with biofilm biomass accumulation rather than the overall occurrence of biofilm-forming isolates. Although comparable proportions of biofilm formers were detected under microaerophilic (47.5%) and aerobic carbon dioxide (CO2)-enriched (45.8%) conditions, increased oxygen was associated with isolate-specific shifts toward increased biofilm biomass, with no significant overall difference. High resistance frequencies were observed for tetracycline (TE) and ciprofloxacin (CIP), with TE + CIP representing the predominant combined resistance phenotype; however, biofilm formers did not show broader AMR profiles and were less often resistant to multiple antimicrobial classes. Genotype-phenotype analyses showed strong associations between gyrA mutation and CIP resistance and between tet(O) detection and TE resistance, whereas the multidrug efflux-associated gene cmeB showed only a weak, species-dependent association with antimicrobial response complexity and not with a single resistance phenotype. Overall, biofilm formation was mainly associated with species, with a weaker association with rep-PCR cluster, and was not associated positively with AMR among this collection of poultry-associated Campylobacter isolates. These findings support assessing biofilm-forming capacity and AMR separately in these bacteria, rather than relying on one trait to infer the other. They also suggest that Campylobacter, inherently susceptible to antimicrobials, may favor biofilm formation as an alternative survival strategy.
Additional Links: PMID-43027447
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027447,
year = {2026},
author = {Kostoglou, D and Mucka, E and Andritsos, ND and Giaouris, E},
title = {Integrated Phenotypic and Genotypic Analysis Reveals Distinct Patterns of Biofilm Formation and Antimicrobial Resistance in Poultry-Derived Campylobacter jejuni and Campylobacter coli.},
journal = {Foods (Basel, Switzerland)},
volume = {15},
number = {21},
pages = {},
pmid = {43027447},
issn = {2304-8158},
support = {5046750//EPAnEk-NRSF 2014-2020/ ; },
abstract = {Campylobacter (C.) jejuni and C. coli are major foodborne bacterial pathogens, and multiple mechanisms, including biofilm formation, antimicrobial resistance (AMR), and genetic variability, contribute to their persistence in poultry-associated environments. However, the relationships among these traits remain poorly understood. This study investigated 120 Campylobacter isolates (78 C. jejuni and 42 C. coli) from retail raw chicken meat by integrating assessments of biofilm formation under two different atmospheric conditions, antibiotic susceptibility profiles, AMR and virulence-associated determinants, and repetitive sequence-based polymerase chain reaction (rep-PCR)-based genetic diversity. Biofilm formation was highly heterogeneous, with atmospheric composition being associated with biofilm biomass accumulation rather than the overall occurrence of biofilm-forming isolates. Although comparable proportions of biofilm formers were detected under microaerophilic (47.5%) and aerobic carbon dioxide (CO2)-enriched (45.8%) conditions, increased oxygen was associated with isolate-specific shifts toward increased biofilm biomass, with no significant overall difference. High resistance frequencies were observed for tetracycline (TE) and ciprofloxacin (CIP), with TE + CIP representing the predominant combined resistance phenotype; however, biofilm formers did not show broader AMR profiles and were less often resistant to multiple antimicrobial classes. Genotype-phenotype analyses showed strong associations between gyrA mutation and CIP resistance and between tet(O) detection and TE resistance, whereas the multidrug efflux-associated gene cmeB showed only a weak, species-dependent association with antimicrobial response complexity and not with a single resistance phenotype. Overall, biofilm formation was mainly associated with species, with a weaker association with rep-PCR cluster, and was not associated positively with AMR among this collection of poultry-associated Campylobacter isolates. These findings support assessing biofilm-forming capacity and AMR separately in these bacteria, rather than relying on one trait to infer the other. They also suggest that Campylobacter, inherently susceptible to antimicrobials, may favor biofilm formation as an alternative survival strategy.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.
International journal of molecular sciences, 27(21):.
Jojoba oil (Simmondsia chinensis) is widely used in cosmetic and pharmaceutical formulations, yet approaches to enhance its biological activity remain insufficiently explored. This study investigated whether infrared (IR) treatment could modify the chemical profile and in vitro biological properties of jojoba oil. A thermal control matched to the IR temperature-time profile was included to separate bulk heating from IR-specific effects. Crude (untreated) and IR-treated oil (30 min, 50 mW/cm[2]) were characterized by Fourier-transform infrared spectroscopy (FTIR) and gas chromatography-mass spectrometry (GC-MS), followed by evaluation of antimicrobial, antibiofilm, inhibition of protein denaturation, fibroblast scratch-closure, and antiproliferative activity against SK-OV-3 cells. IR treatment altered the FTIR profile and produced substantial changes in the GC-MS-detectable composition, including the detection of a peak tentatively assigned to 9-hexadecenoic acid, 9-octadecenyl ester (27.45% relative peak area), and 9-eicosyne (8.97% relative peak area); these values represent relative chromatographic abundance, not absolute concentrations. Compared with crude oil, IR-treated jojoba oil exhibited two- to fourfold lower minimum inhibitory concentrations (MIC), reaching 7.8 µg/mL against Candida albicans, and inhibited Staphylococcus aureus biofilm formation by 96.8%. It also enhanced fibroblast scratch closure (84.1% vs. 67.0%) and showed greater inhibition of protein denaturation (IC50, 4.43 vs. 6.52 µg/mL). Against SK-OV-3 ovarian cancer cells, IR-treated oil reduced the IC50 from 114.5 to 78.7 µg/mL and produced marked G0/G1 accumulation (97.9%). This response was accompanied by increased BAX (3.67-fold) and CASP3 (5.73-fold) expression and decreased BCL2 expression (0.61-fold). Collectively, these findings demonstrate that IR treatment, beyond a matched thermal control, substantially modifies jojoba oil and enhances multiple in vitro biological activities. The novelty is the linkage between IR-induced chemical alteration and functional biological changes, not the mere combination of assays.
Additional Links: PMID-43027669
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027669,
year = {2026},
author = {Qanash, H and Al-Rajhi, AMH and Bazaid, AS and Almarshadi, F and Almimoni, NM and Althagafi, HA and Almotayri, AM and Yahya, R and El-Hawary, SF and Aldarhami, A},
title = {Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.},
journal = {International journal of molecular sciences},
volume = {27},
number = {21},
pages = {},
pmid = {43027669},
issn = {1422-0067},
support = {PNURSP2026R217//Princess Nourah bint Abdulrahman University/ ; },
mesh = {Humans ; *Biofilms/drug effects ; Female ; *Ovarian Neoplasms/drug therapy/metabolism/pathology ; Cell Line, Tumor ; *Infrared Rays ; Spectroscopy, Fourier Transform Infrared ; *Plant Oils/pharmacology/chemistry ; *Anti-Infective Agents/pharmacology/chemistry ; Gas Chromatography-Mass Spectrometry ; Cell Proliferation/drug effects ; Microbial Sensitivity Tests ; },
abstract = {Jojoba oil (Simmondsia chinensis) is widely used in cosmetic and pharmaceutical formulations, yet approaches to enhance its biological activity remain insufficiently explored. This study investigated whether infrared (IR) treatment could modify the chemical profile and in vitro biological properties of jojoba oil. A thermal control matched to the IR temperature-time profile was included to separate bulk heating from IR-specific effects. Crude (untreated) and IR-treated oil (30 min, 50 mW/cm[2]) were characterized by Fourier-transform infrared spectroscopy (FTIR) and gas chromatography-mass spectrometry (GC-MS), followed by evaluation of antimicrobial, antibiofilm, inhibition of protein denaturation, fibroblast scratch-closure, and antiproliferative activity against SK-OV-3 cells. IR treatment altered the FTIR profile and produced substantial changes in the GC-MS-detectable composition, including the detection of a peak tentatively assigned to 9-hexadecenoic acid, 9-octadecenyl ester (27.45% relative peak area), and 9-eicosyne (8.97% relative peak area); these values represent relative chromatographic abundance, not absolute concentrations. Compared with crude oil, IR-treated jojoba oil exhibited two- to fourfold lower minimum inhibitory concentrations (MIC), reaching 7.8 µg/mL against Candida albicans, and inhibited Staphylococcus aureus biofilm formation by 96.8%. It also enhanced fibroblast scratch closure (84.1% vs. 67.0%) and showed greater inhibition of protein denaturation (IC50, 4.43 vs. 6.52 µg/mL). Against SK-OV-3 ovarian cancer cells, IR-treated oil reduced the IC50 from 114.5 to 78.7 µg/mL and produced marked G0/G1 accumulation (97.9%). This response was accompanied by increased BAX (3.67-fold) and CASP3 (5.73-fold) expression and decreased BCL2 expression (0.61-fold). Collectively, these findings demonstrate that IR treatment, beyond a matched thermal control, substantially modifies jojoba oil and enhances multiple in vitro biological activities. The novelty is the linkage between IR-induced chemical alteration and functional biological changes, not the mere combination of assays.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Biofilms/drug effects
Female
*Ovarian Neoplasms/drug therapy/metabolism/pathology
Cell Line, Tumor
*Infrared Rays
Spectroscopy, Fourier Transform Infrared
*Plant Oils/pharmacology/chemistry
*Anti-Infective Agents/pharmacology/chemistry
Gas Chromatography-Mass Spectrometry
Cell Proliferation/drug effects
Microbial Sensitivity Tests
RevDate: 2026-11-14
CmpDate: 2026-11-14
Phytochemical Profiling of Mint and Basil Extracts and Their Association with Wastewater Biofilm-Associated Structures.
Molecules (Basel, Switzerland), 31(21):.
Microbial biofilms in treated wastewater are a concern for water reuse because microorganisms can remain associated with surfaces after treatment. This study examined the flavonoid composition of methanolic extracts of peppermint (Mentha × piperita), spearmint (Mentha spicata), chocolate mint (Mentha × piperita f. citrata 'Chocolate'), and basil (Ocimum basilicum) and investigated their association with Bacillus thuringiensis biofilms formed on silicon wafers in treated wastewater supplemented with Luria-Bertani (LB) broth. The final concentration of each plant extract was 0.3% (v/v). Ultra-performance liquid chromatography coupled with high-resolution tandem mass spectrometry (UPLC-HRMS/MS) was used to identify and quantify selected flavonoids. Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX) were used to examine surface morphology, bacterial-cell dimensions, and elemental composition. The extracts showed distinct phytochemical profiles. Luteolin-7-O-rutinoside was the major quantified flavonoid in the three mint extracts, whereas basil contained predominantly kaempferol-3-O-rutinoside and kaempferol-3-O-glucoside. SEM images showed differences in surface-associated structures among untreated, methanol-control, and plant-extract-treated samples. The longitudinal dimensions of selected dispersed bacterial cells also varied among the treatments. Thickness measurements were obtained for the untreated and methanol-control samples, while scattered, poorly defined structures in representative plant-extract-treated samples did not permit reliable thickness measurements. EDX analysis showed variation in the relative elemental composition of selected surface regions, with differences observed among treatments and between the two wastewater conditions. These findings provide a chemical and surface-characterization profile of the tested plant extracts and their association with B. thuringiensis biofilm-associated structures.
Additional Links: PMID-43029153
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43029153,
year = {2026},
author = {Sengupta, B and Ogunlewe, O and Aziekwu, NA and Fiffick, K and Friedfeld, R and Bess-Grunewald, C and Tovar, P and Baker, P and Dao, TT and Robertson, K and Janusa, M and Kim, P},
title = {Phytochemical Profiling of Mint and Basil Extracts and Their Association with Wastewater Biofilm-Associated Structures.},
journal = {Molecules (Basel, Switzerland)},
volume = {31},
number = {21},
pages = {},
pmid = {43029153},
issn = {1420-3049},
support = {AN-0008//Welch Foundation/ ; },
mesh = {*Biofilms/drug effects/growth & development ; *Plant Extracts/chemistry/pharmacology ; *Wastewater/microbiology/chemistry ; *Ocimum basilicum/chemistry ; *Phytochemicals/chemistry/pharmacology/analysis ; Flavonoids/chemistry ; Tandem Mass Spectrometry ; *Mentha/chemistry ; },
abstract = {Microbial biofilms in treated wastewater are a concern for water reuse because microorganisms can remain associated with surfaces after treatment. This study examined the flavonoid composition of methanolic extracts of peppermint (Mentha × piperita), spearmint (Mentha spicata), chocolate mint (Mentha × piperita f. citrata 'Chocolate'), and basil (Ocimum basilicum) and investigated their association with Bacillus thuringiensis biofilms formed on silicon wafers in treated wastewater supplemented with Luria-Bertani (LB) broth. The final concentration of each plant extract was 0.3% (v/v). Ultra-performance liquid chromatography coupled with high-resolution tandem mass spectrometry (UPLC-HRMS/MS) was used to identify and quantify selected flavonoids. Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX) were used to examine surface morphology, bacterial-cell dimensions, and elemental composition. The extracts showed distinct phytochemical profiles. Luteolin-7-O-rutinoside was the major quantified flavonoid in the three mint extracts, whereas basil contained predominantly kaempferol-3-O-rutinoside and kaempferol-3-O-glucoside. SEM images showed differences in surface-associated structures among untreated, methanol-control, and plant-extract-treated samples. The longitudinal dimensions of selected dispersed bacterial cells also varied among the treatments. Thickness measurements were obtained for the untreated and methanol-control samples, while scattered, poorly defined structures in representative plant-extract-treated samples did not permit reliable thickness measurements. EDX analysis showed variation in the relative elemental composition of selected surface regions, with differences observed among treatments and between the two wastewater conditions. These findings provide a chemical and surface-characterization profile of the tested plant extracts and their association with B. thuringiensis biofilm-associated structures.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
*Plant Extracts/chemistry/pharmacology
*Wastewater/microbiology/chemistry
*Ocimum basilicum/chemistry
*Phytochemicals/chemistry/pharmacology/analysis
Flavonoids/chemistry
Tandem Mass Spectrometry
*Mentha/chemistry
RevDate: 2026-11-14
CmpDate: 2026-11-14
Influence of Surface Modification and Artificial Aging on Streptococcus mutans Biofilm Formation and Oral Cell Responses to Orthodontic PMMA: An In Vitro Study.
Materials (Basel, Switzerland), 19(21):.
BACKGROUND/OBJECTIVES: Photoreactive zwitterionic PMBPAz coatings have previously been used to modify dental PMMA, but their integrated performance on clinically polished orthodontic PMMA under a specified composite-aging challenge remains insufficiently characterized. This in vitro study compared untreated, polished, and PMBPAz-MPC-coated PMMA before and after laboratory aging.
MATERIALS AND METHODS: Heat-polymerized PMMA specimens were tested for early Streptococcus mutans adhesion, 24 h biofilm indices, surface chemistry and wettability, protein adsorption, mechanical properties, and human gingival fibroblast responses. A separate four-time-point MPC-PMMA series evaluated artificial saliva immersion alone, while the composite-aged groups also underwent thermocycling and simulated toothbrushing.
RESULTS: Compared with polished PMMA, MPC-PMMA showed lower 2 h adhesion by 0.73 log10 CFU/cm[2] (81%) before aging and 0.62 log10 CFU/cm[2] (76%) after composite aging; the corresponding decreases in crystal violet biomass were 44.6% and 37.9%. In the saliva-only series, coating-associated XPS phosphorus decreased from 3.8 to 3.3 at.%, and the contact angle increased from 18.6° to 21.7° at T28; following composite aging, the corresponding values were 2.9 at.% and 24.3°. Extract-exposed fibroblasts showed group-dependent changes in LDH and inflammatory mediators.
CONCLUSIONS: Under the specified in vitro conditions, PMBPAz-MPC treatment of polished orthodontic PMMA was associated with reduced early S. mutans colonization, including after composite aging. The findings do not establish clinical efficacy or long-term biological safety.
Additional Links: PMID-43030947
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43030947,
year = {2026},
author = {Giannini, L and Farronato, M and Manti, A and Cattaneo, G and Dipalma, G and Maspero, C},
title = {Influence of Surface Modification and Artificial Aging on Streptococcus mutans Biofilm Formation and Oral Cell Responses to Orthodontic PMMA: An In Vitro Study.},
journal = {Materials (Basel, Switzerland)},
volume = {19},
number = {21},
pages = {},
pmid = {43030947},
issn = {1996-1944},
support = {XXXX//Italian ministry of health/ ; },
abstract = {BACKGROUND/OBJECTIVES: Photoreactive zwitterionic PMBPAz coatings have previously been used to modify dental PMMA, but their integrated performance on clinically polished orthodontic PMMA under a specified composite-aging challenge remains insufficiently characterized. This in vitro study compared untreated, polished, and PMBPAz-MPC-coated PMMA before and after laboratory aging.
MATERIALS AND METHODS: Heat-polymerized PMMA specimens were tested for early Streptococcus mutans adhesion, 24 h biofilm indices, surface chemistry and wettability, protein adsorption, mechanical properties, and human gingival fibroblast responses. A separate four-time-point MPC-PMMA series evaluated artificial saliva immersion alone, while the composite-aged groups also underwent thermocycling and simulated toothbrushing.
RESULTS: Compared with polished PMMA, MPC-PMMA showed lower 2 h adhesion by 0.73 log10 CFU/cm[2] (81%) before aging and 0.62 log10 CFU/cm[2] (76%) after composite aging; the corresponding decreases in crystal violet biomass were 44.6% and 37.9%. In the saliva-only series, coating-associated XPS phosphorus decreased from 3.8 to 3.3 at.%, and the contact angle increased from 18.6° to 21.7° at T28; following composite aging, the corresponding values were 2.9 at.% and 24.3°. Extract-exposed fibroblasts showed group-dependent changes in LDH and inflammatory mediators.
CONCLUSIONS: Under the specified in vitro conditions, PMBPAz-MPC treatment of polished orthodontic PMMA was associated with reduced early S. mutans colonization, including after composite aging. The findings do not establish clinical efficacy or long-term biological safety.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Biofilm formation and antibiofilm strategies in the Achromobacter genus: a scoping review.
Frontiers in cellular and infection microbiology, 16:1942991.
Biofilm formation plays a major role in bacterial persistence across clinical and environmental settings, with particular significance in chronic infections. Achromobacter spp. are environment-borne emerging opportunistic pathogens increasingly recognized in biofilm-associated diseases. This scoping review summarizes evidence on the prevalence and determinants of biofilm formation in Achromobacter and examines the antibiofilm effects of various strategies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, a comprehensive search of the PubMed-MEDLINE database was conducted from inception to June 2026 using the terms "Achromobacter" AND "biofilm". Of 124 records identified, 79 studies were included. Data interpretation was challenged by methodological heterogeneity and variable confidence in species identification. In vitro, ex vivo, and in vivo models have been used, yielding complementary but sometimes conflicting results, underscoring the need for standardized protocols. However, biofilm formation appears to be widespread in Achromobacter. Statistical analyses of results from comparable studies showed that biofilm-forming capacity is independent of the clinical (cystic fibrosis or not) origin of the isolates while Achromobacter xylosoxidans, the most commonly isolated species in human infections, displays a higher prevalence of biofilm-producing isolates than other species. Biofilm formation may vary over time during chronic colonization or environmental persistence, probably reflecting distinct selective pressures. Among them, polymicrobial environments are hotspots of biotic interactions, where Achromobacter sp. can affect the biofilm formation of other pathogens like Pseudomonas aeruginosa. Combating Achromobacter biofilm can rely on antibiotics, particularly carbapenems, trimethoprim-sulfamethoxazole, and cefiderocol while some non-antibiotic approaches also show promising experimental antibiofilm activity.
Additional Links: PMID-43032096
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032096,
year = {2026},
author = {Jean-Pierre, V and Jumas-Bilak, E and Lavigne, JP and Marchandin, H},
title = {Biofilm formation and antibiofilm strategies in the Achromobacter genus: a scoping review.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {1942991},
doi = {10.3389/fcimb.2026.1942991},
pmid = {43032096},
issn = {2235-2988},
mesh = {*Biofilms/drug effects/growth & development ; *Achromobacter/drug effects/physiology ; *Anti-Bacterial Agents/pharmacology ; Humans ; Cefiderocol ; Gram-Negative Bacterial Infections/microbiology/drug therapy ; },
abstract = {Biofilm formation plays a major role in bacterial persistence across clinical and environmental settings, with particular significance in chronic infections. Achromobacter spp. are environment-borne emerging opportunistic pathogens increasingly recognized in biofilm-associated diseases. This scoping review summarizes evidence on the prevalence and determinants of biofilm formation in Achromobacter and examines the antibiofilm effects of various strategies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, a comprehensive search of the PubMed-MEDLINE database was conducted from inception to June 2026 using the terms "Achromobacter" AND "biofilm". Of 124 records identified, 79 studies were included. Data interpretation was challenged by methodological heterogeneity and variable confidence in species identification. In vitro, ex vivo, and in vivo models have been used, yielding complementary but sometimes conflicting results, underscoring the need for standardized protocols. However, biofilm formation appears to be widespread in Achromobacter. Statistical analyses of results from comparable studies showed that biofilm-forming capacity is independent of the clinical (cystic fibrosis or not) origin of the isolates while Achromobacter xylosoxidans, the most commonly isolated species in human infections, displays a higher prevalence of biofilm-producing isolates than other species. Biofilm formation may vary over time during chronic colonization or environmental persistence, probably reflecting distinct selective pressures. Among them, polymicrobial environments are hotspots of biotic interactions, where Achromobacter sp. can affect the biofilm formation of other pathogens like Pseudomonas aeruginosa. Combating Achromobacter biofilm can rely on antibiotics, particularly carbapenems, trimethoprim-sulfamethoxazole, and cefiderocol while some non-antibiotic approaches also show promising experimental antibiofilm activity.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
*Achromobacter/drug effects/physiology
*Anti-Bacterial Agents/pharmacology
Humans
Cefiderocol
Gram-Negative Bacterial Infections/microbiology/drug therapy
RevDate: 2026-11-14
CmpDate: 2026-11-14
Dual opposing regulatory axes of EnvZ/OmpR control biofilm-mediated tolerance and OmpF-dependent resistance to β-lactams in Phytobacter diazotrophicus.
Frontiers in microbiology, 17:1928582.
BACKGROUND: Phytobacter diazotrophicus (P. diazotrophicus) is an infrequent opportunistic pathogen. Its biofilm-forming potential and the regulatory function of the EnvZ/OmpR two-component system linking biofilm formation and β-lactam resistance have yet to be elucidated. Herein, we confirmed biofilm production in P. diazotrophicus and generated envZ/ompR knockout mutants to dissect the dual regulatory roles of this two-component system.
METHODS: In this study, biofilm formation was qualitatively and quantitatively evaluated through direct visual observation, Gram staining, scanning electron microscopy (SEM), and turbidity measurement. The minimum inhibitory concentrations (MICs) of 12 kinds of β-lactam antibiotics were determined using the MH agar plate dilution method. Gene deletion strains were constructed by homologous recombination. Quantitative reverse transcription PCR (qRT-PCR) and electrophoretic mobility shift assays (EMSA) were performed to explore the regulatory mechanism of the EnvZ/OmpR system. In addition, swimming motility assays were used to characterize biofilm-associated motility phenotypes, and ethidium bromide (EB) accumulation assays were applied to assess bacterial outer membrane permeability.
RESULTS: P. diazotrophicus formed robust biofilms on coverslips at the air-liquid-solid interface when cultured in BHI medium, whereas biofilm formation was absent in LB medium. Relative to planktonic counterparts, biofilm-embedded cells displayed significantly elevated MICs to piperacillin, carbenicillin, and meropenem, demonstrating that biofilm matrices confer specific tolerance to these three β-lactams. Deletion of either envZ or ompR completely abolished biofilm formation compared with the wild type. qPCR assays confirmed marked transcriptional repression of csgD and fliC in the ΔompR mutant. EMSA assays further proved that OmpR directly interacts with the promoters of fliC and csgD. Consistent with this regulatory pattern, loss of fliC drastically compromised bacterial swimming motility, which is critical for biofilm assembly. In contrast to the biofilm-associated tolerance phenotype, the ΔenvZ and ΔompR mutants displayed increased resistance to eight other β-lactam agents. The MICs of the ΔenvZ and ΔompR mutants increased by 2-fold and 4-fold, respectively, for cefotaxime. Their MICs increased by 4-, 4-, 2-, 2-, 4-, 4-, and 2-fold against cefalotin, cefoxitin, cefuroxime, ceftazidime, cefepime, aztreonam, and ertapenem, respectively. Transcriptomic profiling revealed that four outer membrane porin genes (ompF, ompC, ompF2, phoE) were significantly downregulated upon ompR deletion. Single gene knockout validation showed that only the ΔompF mutant presented elevated MICs (4-, 8-, 4-, 16-, 4-, 2-, 8-, and 8-fold) to the above eight antibiotics; mutants lacking ompC, ompF2, or phoE exhibited no change in antimicrobial resistance. Additional EMSA results verified direct binding of OmpR to the promoter regions of ompF. EB accumulation assays revealed drastically reduced fluorescence intensity in the ΔompF mutant versus the wild type, confirming that OmpF governs outer membrane permeability.
CONCLUSION: This study reveals a dual antagonistic regulatory mechanism of the EnvZ/OmpR system in modulating β-lactam resistance in clinical P. diazotrophicus. EnvZ/OmpR promotes biofilm formation via the csgD-fliC axis to enhance tolerance to three specific β-lactams, while it upregulates ompF to maintain outer membrane permeability and sensitize bacteria to other eight antibiotics. This study first revealed that OmpR directly regulated fliC expression. These findings clarify the molecular basis of heterogeneous β-lactam susceptibility and provide novel insights into clinical infection control of this rare pathogen.
Additional Links: PMID-43032100
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032100,
year = {2026},
author = {Lin, J and Chen, W and Wang, G},
title = {Dual opposing regulatory axes of EnvZ/OmpR control biofilm-mediated tolerance and OmpF-dependent resistance to β-lactams in Phytobacter diazotrophicus.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1928582},
doi = {10.3389/fmicb.2026.1928582},
pmid = {43032100},
issn = {1664-302X},
abstract = {BACKGROUND: Phytobacter diazotrophicus (P. diazotrophicus) is an infrequent opportunistic pathogen. Its biofilm-forming potential and the regulatory function of the EnvZ/OmpR two-component system linking biofilm formation and β-lactam resistance have yet to be elucidated. Herein, we confirmed biofilm production in P. diazotrophicus and generated envZ/ompR knockout mutants to dissect the dual regulatory roles of this two-component system.
METHODS: In this study, biofilm formation was qualitatively and quantitatively evaluated through direct visual observation, Gram staining, scanning electron microscopy (SEM), and turbidity measurement. The minimum inhibitory concentrations (MICs) of 12 kinds of β-lactam antibiotics were determined using the MH agar plate dilution method. Gene deletion strains were constructed by homologous recombination. Quantitative reverse transcription PCR (qRT-PCR) and electrophoretic mobility shift assays (EMSA) were performed to explore the regulatory mechanism of the EnvZ/OmpR system. In addition, swimming motility assays were used to characterize biofilm-associated motility phenotypes, and ethidium bromide (EB) accumulation assays were applied to assess bacterial outer membrane permeability.
RESULTS: P. diazotrophicus formed robust biofilms on coverslips at the air-liquid-solid interface when cultured in BHI medium, whereas biofilm formation was absent in LB medium. Relative to planktonic counterparts, biofilm-embedded cells displayed significantly elevated MICs to piperacillin, carbenicillin, and meropenem, demonstrating that biofilm matrices confer specific tolerance to these three β-lactams. Deletion of either envZ or ompR completely abolished biofilm formation compared with the wild type. qPCR assays confirmed marked transcriptional repression of csgD and fliC in the ΔompR mutant. EMSA assays further proved that OmpR directly interacts with the promoters of fliC and csgD. Consistent with this regulatory pattern, loss of fliC drastically compromised bacterial swimming motility, which is critical for biofilm assembly. In contrast to the biofilm-associated tolerance phenotype, the ΔenvZ and ΔompR mutants displayed increased resistance to eight other β-lactam agents. The MICs of the ΔenvZ and ΔompR mutants increased by 2-fold and 4-fold, respectively, for cefotaxime. Their MICs increased by 4-, 4-, 2-, 2-, 4-, 4-, and 2-fold against cefalotin, cefoxitin, cefuroxime, ceftazidime, cefepime, aztreonam, and ertapenem, respectively. Transcriptomic profiling revealed that four outer membrane porin genes (ompF, ompC, ompF2, phoE) were significantly downregulated upon ompR deletion. Single gene knockout validation showed that only the ΔompF mutant presented elevated MICs (4-, 8-, 4-, 16-, 4-, 2-, 8-, and 8-fold) to the above eight antibiotics; mutants lacking ompC, ompF2, or phoE exhibited no change in antimicrobial resistance. Additional EMSA results verified direct binding of OmpR to the promoter regions of ompF. EB accumulation assays revealed drastically reduced fluorescence intensity in the ΔompF mutant versus the wild type, confirming that OmpF governs outer membrane permeability.
CONCLUSION: This study reveals a dual antagonistic regulatory mechanism of the EnvZ/OmpR system in modulating β-lactam resistance in clinical P. diazotrophicus. EnvZ/OmpR promotes biofilm formation via the csgD-fliC axis to enhance tolerance to three specific β-lactams, while it upregulates ompF to maintain outer membrane permeability and sensitize bacteria to other eight antibiotics. This study first revealed that OmpR directly regulated fliC expression. These findings clarify the molecular basis of heterogeneous β-lactam susceptibility and provide novel insights into clinical infection control of this rare pathogen.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Transcriptional profiling and coexpression integration for the filtering of relevant bacterial sRNA-mRNA interactions: application to Staphylococcus aureus biofilm.
Bioinformatics advances, 6(1):vbag309 pii:vbag309.
MOTIVATION: Small regulatory ribonucleic acids coordinate bacterial gene expression and contribute to biofilm development, virulence, and stress adaptation. Integrating sequence-based predictions with expression evidence can help prioritize candidate regulatory interactions for experimental investigation.
RESULTS: We characterized these regulators across six Staphylococcus aureus strains by integrating newly generated transcriptome data from Bmb9393 with public datasets from five additional strains. Sequence homology and covariance models supported candidate annotation and genomic-context characterization. Differential expression and weighted gene coexpression analysis identified conserved and strain-specific patterns, including 10 small regulatory transcripts consistently upregulated and 4 downregulated in biofilm. Combining four interaction-prediction tools with differential-expression consensus and coexpression evidence reduced 1 731 060 candidate interactions to 1290 prioritized pairs under calibrated thresholds. Comparisons across three threshold schemes showed nested target retention but substantial changes in selected regulatory partners. The 31 literature-curated interactions used for threshold calibration did not constitute independent validation, and none survived all down-stream filters. The resulting candidates provide hypotheses for experimental investigation of biofilm-associated regulation.
The open-source graphical application integrates documented processed inputs and exports intermediate results for traceability. Source code, documentation, and links to study inputs and reference outputs are available at https://github.com/carolina5massena/Integrative-RNA-Seq-and-Co-expression-Analyses-Uncover-Confident-sRNA.
Additional Links: PMID-43032527
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032527,
year = {2026},
author = {Ribeiro, CAM and Quispe Saji, GDR and Cerqueira E Costa, MO and Viana, AS and Carvalho, MF and Figueiredo, AMS and Galán-Vásquez, E and Martínez-Hernández, JE and Nicolás, MF},
title = {Transcriptional profiling and coexpression integration for the filtering of relevant bacterial sRNA-mRNA interactions: application to Staphylococcus aureus biofilm.},
journal = {Bioinformatics advances},
volume = {6},
number = {1},
pages = {vbag309},
doi = {10.1093/bioadv/vbag309},
pmid = {43032527},
issn = {2635-0041},
abstract = {MOTIVATION: Small regulatory ribonucleic acids coordinate bacterial gene expression and contribute to biofilm development, virulence, and stress adaptation. Integrating sequence-based predictions with expression evidence can help prioritize candidate regulatory interactions for experimental investigation.
RESULTS: We characterized these regulators across six Staphylococcus aureus strains by integrating newly generated transcriptome data from Bmb9393 with public datasets from five additional strains. Sequence homology and covariance models supported candidate annotation and genomic-context characterization. Differential expression and weighted gene coexpression analysis identified conserved and strain-specific patterns, including 10 small regulatory transcripts consistently upregulated and 4 downregulated in biofilm. Combining four interaction-prediction tools with differential-expression consensus and coexpression evidence reduced 1 731 060 candidate interactions to 1290 prioritized pairs under calibrated thresholds. Comparisons across three threshold schemes showed nested target retention but substantial changes in selected regulatory partners. The 31 literature-curated interactions used for threshold calibration did not constitute independent validation, and none survived all down-stream filters. The resulting candidates provide hypotheses for experimental investigation of biofilm-associated regulation.
The open-source graphical application integrates documented processed inputs and exports intermediate results for traceability. Source code, documentation, and links to study inputs and reference outputs are available at https://github.com/carolina5massena/Integrative-RNA-Seq-and-Co-expression-Analyses-Uncover-Confident-sRNA.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Phage cocktail-loaded hydrogel coating prevents the biofilm formation of MDR Acinetobacter baumannii on indwelling medical devices.
Frontiers in microbiology, 17:1990693.
INTRODUCTION: Indwelling catheters and implantable medical devices are vital in clinical care, but are often complicated by device-associated infections, especially caused by Acinetobacter baumannii. This pathogen readily colonizes device surfaces and forms biofilms, limiting the efficacy of current preventive strategies such as antimicrobial coatings and surface modifications.
METHODS: To address this, we developed a sodium alginate and polyvinyl alcohol-based hydrogel loaded with a bacteriophage cocktail against MDR Acinetobacter baumannii. Physicochemical characterisation of the hydrogel was tested, and the gel was coated onto the medical devices, including urinary catheter and Endotracheal tube.
RESULTS & DISCUSSION: The system exhibited good biostability of the encapsulated phages and its sustained release behaviour, supporting the biomedical potential. The in vitro antibacterial assay demonstrated a clear zone of bacterial inhibition on the tested agar plates, and the antibiofilm assay showed a 4-5 log reduction in bacterial count in the Foley's urinary catheter and a 4-7 log reduction on endotracheal tube surfaces at their respective physiological pH. In summary, the developed SA-PVA bacteriophage cocktail-loaded hydrogel exhibited strong antibacterial and antibiofilm efficacy along with sustained phage release, highlighting its potential as a translational strategy for preventing MDR A. baumannii-associated device-related infections.
Additional Links: PMID-43032820
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032820,
year = {2026},
author = {Rai, NK and Suchithra, KV and Mohan Raj, JR and Patil, P and Mohana Kumar, B and Shetty, VA},
title = {Phage cocktail-loaded hydrogel coating prevents the biofilm formation of MDR Acinetobacter baumannii on indwelling medical devices.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1990693},
doi = {10.3389/fmicb.2026.1990693},
pmid = {43032820},
issn = {1664-302X},
abstract = {INTRODUCTION: Indwelling catheters and implantable medical devices are vital in clinical care, but are often complicated by device-associated infections, especially caused by Acinetobacter baumannii. This pathogen readily colonizes device surfaces and forms biofilms, limiting the efficacy of current preventive strategies such as antimicrobial coatings and surface modifications.
METHODS: To address this, we developed a sodium alginate and polyvinyl alcohol-based hydrogel loaded with a bacteriophage cocktail against MDR Acinetobacter baumannii. Physicochemical characterisation of the hydrogel was tested, and the gel was coated onto the medical devices, including urinary catheter and Endotracheal tube.
RESULTS & DISCUSSION: The system exhibited good biostability of the encapsulated phages and its sustained release behaviour, supporting the biomedical potential. The in vitro antibacterial assay demonstrated a clear zone of bacterial inhibition on the tested agar plates, and the antibiofilm assay showed a 4-5 log reduction in bacterial count in the Foley's urinary catheter and a 4-7 log reduction on endotracheal tube surfaces at their respective physiological pH. In summary, the developed SA-PVA bacteriophage cocktail-loaded hydrogel exhibited strong antibacterial and antibiofilm efficacy along with sustained phage release, highlighting its potential as a translational strategy for preventing MDR A. baumannii-associated device-related infections.},
}
RevDate: 2026-11-12
CmpDate: 2026-11-12
Lactobacillus acidophilus ATCC 4356-derived metabolites inhibit biofilm formation and motility in Listeria monocytogenes.
Antonie van Leeuwenhoek, 119(12):.
Listeria monocytogenes is a major foodborne pathogen whose persistence in food-processing environments is strongly associated with its ability to survive under a wide range of environmental conditions and form biofilms on different surfaces. Metabolites produced by beneficial lactic acid bacteria may represent a natural source of antimicrobial and antibiofilm compounds capable of affecting bacterial behavior even at subinhibitory concentrations. This study investigated the effects of the cell-free supernatant of the probiotic strain Lactobacillus acidophilus ATCC 4356 (La-CFS) on growth, biofilm formation, motility, and the expression of selected quorum sensing- and motility-associated genes in L. monocytogenes. The antibacterial activity and minimum inhibitory concentration (MIC) of La-CFS were determined against multiple L. monocytogenes strains. Extracellular signaling activity was evaluated using the AI-2-responsive Vibrio harveyi BB170 bioluminescence reporter assay, while the effects of sub-MIC concentrations on biofilm formation and swimming and swarming motility were assessed using phenotypic assays. The expression of luxS, agrC, flaA, and motA was analyzed by RT-qPCR. La-CFS inhibited the growth of all tested L. monocytogenes strains, whereas sub-MIC concentrations induced a transient delay in bacterial growth without significantly affecting the final optical density. Cell-free supernatants from the evaluated L. monocytogenes strains induced bioluminescence in the V. harveyi BB170 reporter assay, indicating extracellular signaling activity detectable by an AI-2-responsive system. At sub-MIC concentrations, La-CFS significantly reduced biofilm formation and impaired swimming and swarming motility in a strain- and concentration-dependent manner. Transcriptional analysis of L. monocytogenes CLIST 3833 exposed to La-CFS at 0.5 × MIC for 24 h revealed significant downregulation of the motility-associated genes flaA and motA (p < 0.05), whereas the expression of luxS and agrC was not significantly altered. These findings demonstrate that metabolites present in the cell-free supernatant of L. acidophilus ATCC 4356 can impair biofilm formation and motility in L. monocytogenes, supporting further investigation of La-CFS as a potential source of bioactive compounds for controlling the persistence of this pathogen in food-processing environments.
Additional Links: PMID-43018822
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43018822,
year = {2026},
author = {da Cunha Rezende, SD and Rotta, IS and Perini, HF and Alves, PHO and da Silva, MV and Vallim, DC and de Castro Lisboa Pereira, R and de Almeida, FA and Pinto, UM and Paiva, AD},
title = {Lactobacillus acidophilus ATCC 4356-derived metabolites inhibit biofilm formation and motility in Listeria monocytogenes.},
journal = {Antonie van Leeuwenhoek},
volume = {119},
number = {12},
pages = {},
pmid = {43018822},
issn = {1572-9699},
support = {APQ 01597-22.//Fundação de Amparo à Pesquisa do Estado de Minas Gerais/ ; },
mesh = {*Biofilms/drug effects/growth & development ; *Listeria monocytogenes/drug effects/physiology/genetics/growth & development ; *Lactobacillus acidophilus/metabolism ; Gene Expression Regulation, Bacterial/drug effects ; Quorum Sensing/drug effects ; Microbial Sensitivity Tests ; *Anti-Bacterial Agents/pharmacology/metabolism ; Bacterial Proteins/genetics/metabolism ; },
abstract = {Listeria monocytogenes is a major foodborne pathogen whose persistence in food-processing environments is strongly associated with its ability to survive under a wide range of environmental conditions and form biofilms on different surfaces. Metabolites produced by beneficial lactic acid bacteria may represent a natural source of antimicrobial and antibiofilm compounds capable of affecting bacterial behavior even at subinhibitory concentrations. This study investigated the effects of the cell-free supernatant of the probiotic strain Lactobacillus acidophilus ATCC 4356 (La-CFS) on growth, biofilm formation, motility, and the expression of selected quorum sensing- and motility-associated genes in L. monocytogenes. The antibacterial activity and minimum inhibitory concentration (MIC) of La-CFS were determined against multiple L. monocytogenes strains. Extracellular signaling activity was evaluated using the AI-2-responsive Vibrio harveyi BB170 bioluminescence reporter assay, while the effects of sub-MIC concentrations on biofilm formation and swimming and swarming motility were assessed using phenotypic assays. The expression of luxS, agrC, flaA, and motA was analyzed by RT-qPCR. La-CFS inhibited the growth of all tested L. monocytogenes strains, whereas sub-MIC concentrations induced a transient delay in bacterial growth without significantly affecting the final optical density. Cell-free supernatants from the evaluated L. monocytogenes strains induced bioluminescence in the V. harveyi BB170 reporter assay, indicating extracellular signaling activity detectable by an AI-2-responsive system. At sub-MIC concentrations, La-CFS significantly reduced biofilm formation and impaired swimming and swarming motility in a strain- and concentration-dependent manner. Transcriptional analysis of L. monocytogenes CLIST 3833 exposed to La-CFS at 0.5 × MIC for 24 h revealed significant downregulation of the motility-associated genes flaA and motA (p < 0.05), whereas the expression of luxS and agrC was not significantly altered. These findings demonstrate that metabolites present in the cell-free supernatant of L. acidophilus ATCC 4356 can impair biofilm formation and motility in L. monocytogenes, supporting further investigation of La-CFS as a potential source of bioactive compounds for controlling the persistence of this pathogen in food-processing environments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
*Listeria monocytogenes/drug effects/physiology/genetics/growth & development
*Lactobacillus acidophilus/metabolism
Gene Expression Regulation, Bacterial/drug effects
Quorum Sensing/drug effects
Microbial Sensitivity Tests
*Anti-Bacterial Agents/pharmacology/metabolism
Bacterial Proteins/genetics/metabolism
RevDate: 2026-11-12
Targeting Pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: preclinical safety and efficacy study.
EBioMedicine, 134:106537 pii:S2352-3964(26)00421-4 [Epub ahead of print].
BACKGROUND: The endotracheal tube (ETT) compromises the host's bronchial defences and facilitates the formation of microbial biofilms and Ventilator-associated pneumonia (VAP). Although antibiotics remain the cornerstone treatment, their efficacy is often compromised by poor biofilm penetration and the prevalence of multidrug-resistant bacteria. This reveals the need to develop novel non-antibiotic therapeutic strategies. We previously engineered a non-pathogenic strain of the pulmonary bacteria Mycoplasma pneumoniae (CV2) to express anti-biofilm and bactericidal enzymes (VAP platform).
METHODS: We evaluated the safety of an improved version of CV2 (CV8, Mycochassis) in a miniature pig model, and its efficacy with the VAP platform (CV8_VAP) in a piglet model of Pseudomonas aeruginosa-induced VAP. CV8_VAP was administered via intralobe instillation or nebulisation. We assessed the platform's ability to degrade biofilms formed on ETTs in vivo and its impact on the airway microbiota. We evaluated bacterial load in the lungs, inflammatory responses, histopathological and clinical outcomes. Statistics included t-tests, ANOVA, Kruskal-Wallis, Mann-Whitney U and mixed-effects rank-based methods.
FINDINGS: VAP platform reduced ETT biofilm thickness and P. aeruginosa load in lungs, with the nebulised route showing enhanced efficacy. Shannon diversity remained statistically comparable across groups in both ETTs and lung tissue. Inflammatory markers in the lung were markedly decreased, suggesting a local immunomodulatory effect. One animal receiving nebulised CV8_VAP died from a suspected anaphylactic-like reaction; no other serious adverse events were attributable to treatment.
INTERPRETATION: These findings suggest CV8_VAP as a promising, non-antibiotic therapeutic strategy for treating VAP caused by P. aeruginosa.
FUNDING: "La Caixa" Foundation, and the European Research Council under the European Union's Horizon 2020 research and innovation program.
Additional Links: PMID-43019617
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43019617,
year = {2026},
author = {Fernández-Barat, L and Motos, A and Segura-Morales, C and Kiarostami, K and Cabrera, R and Soler-Comas, A and Broto, A and Mazzolini, R and Galli, F and Llonch, B and Macip, G and Vazquez, N and Calabretta, D and Arrieta, M and Lluch-Senar, M and Rigol, M and Serrano, L and Rodríguez-Arce, I and Torres, A},
title = {Targeting Pseudomonas aeruginosa ventilator-associated pneumonia with a non-antibiotic and biofilm-disrupting live biotherapeutic: preclinical safety and efficacy study.},
journal = {EBioMedicine},
volume = {134},
number = {},
pages = {106537},
doi = {10.1016/j.ebiom.2026.106537},
pmid = {43019617},
issn = {2352-3964},
abstract = {BACKGROUND: The endotracheal tube (ETT) compromises the host's bronchial defences and facilitates the formation of microbial biofilms and Ventilator-associated pneumonia (VAP). Although antibiotics remain the cornerstone treatment, their efficacy is often compromised by poor biofilm penetration and the prevalence of multidrug-resistant bacteria. This reveals the need to develop novel non-antibiotic therapeutic strategies. We previously engineered a non-pathogenic strain of the pulmonary bacteria Mycoplasma pneumoniae (CV2) to express anti-biofilm and bactericidal enzymes (VAP platform).
METHODS: We evaluated the safety of an improved version of CV2 (CV8, Mycochassis) in a miniature pig model, and its efficacy with the VAP platform (CV8_VAP) in a piglet model of Pseudomonas aeruginosa-induced VAP. CV8_VAP was administered via intralobe instillation or nebulisation. We assessed the platform's ability to degrade biofilms formed on ETTs in vivo and its impact on the airway microbiota. We evaluated bacterial load in the lungs, inflammatory responses, histopathological and clinical outcomes. Statistics included t-tests, ANOVA, Kruskal-Wallis, Mann-Whitney U and mixed-effects rank-based methods.
FINDINGS: VAP platform reduced ETT biofilm thickness and P. aeruginosa load in lungs, with the nebulised route showing enhanced efficacy. Shannon diversity remained statistically comparable across groups in both ETTs and lung tissue. Inflammatory markers in the lung were markedly decreased, suggesting a local immunomodulatory effect. One animal receiving nebulised CV8_VAP died from a suspected anaphylactic-like reaction; no other serious adverse events were attributable to treatment.
INTERPRETATION: These findings suggest CV8_VAP as a promising, non-antibiotic therapeutic strategy for treating VAP caused by P. aeruginosa.
FUNDING: "La Caixa" Foundation, and the European Research Council under the European Union's Horizon 2020 research and innovation program.},
}
RevDate: 2026-11-12
Polymer-biofilm interface enables exceptional hydrovoltaic electricity generation.
Biosensors & bioelectronics, 318:119413 pii:S0956-5663(26)01046-8 [Epub ahead of print].
Sustainable hygroelectricity generation has emerged as a revolutionary technology capable of harvesting the latent heat from ambient environments and converting it into direct-current electricity. Recently, microbial biofilms have been regarded as promising hydrovoltaic materials for their low-cost, facile fabrication and environmentally friendly nature. However, external moisture dependence and ultra-high internal resistance have greatly limited the output performance of microbial biofilm-based hydrovoltaic electricity generators (BioHEGs). Herein, a core@shell structured biohybrid system (S. o@PPy) was constructed by in situ polymerization of pyrrole monomers on the surface of Shewanella oneidensis (S. o) cells. The presence of polymer-biofilm interfaces resulted in a remarkable performance of hygroelectricity generation originated from the built-in conductivity of hole-doped polypyrrole (PPy), as well as the reduced internal resistance and improved water adsorption capacity of S. o biofilms. Hence, the S. o@PPy BioHEG generated a stable short-circuit current of ca. 33.5 μA at the optimal condition, which is significantly higher than all BioHEGs documented hitherto. Moreover, a novel mechanism of asymmetric charge redistribution was confirmed by density functional theory (DFT) calculations. These results support a new perspective of hydrovoltaic effects and provide a viable strategy for advancing BioHEGs towards more practical scenarios such as humidity sensing and electronic power supply.
Additional Links: PMID-43019651
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43019651,
year = {2026},
author = {Yan, ZW and Cai, FY and Chen, TT and He, YY and He, QX and Rensing, C and Piccini, G and Lü, J and Zhou, S},
title = {Polymer-biofilm interface enables exceptional hydrovoltaic electricity generation.},
journal = {Biosensors & bioelectronics},
volume = {318},
number = {},
pages = {119413},
doi = {10.1016/j.bios.2026.119413},
pmid = {43019651},
issn = {1873-4235},
abstract = {Sustainable hygroelectricity generation has emerged as a revolutionary technology capable of harvesting the latent heat from ambient environments and converting it into direct-current electricity. Recently, microbial biofilms have been regarded as promising hydrovoltaic materials for their low-cost, facile fabrication and environmentally friendly nature. However, external moisture dependence and ultra-high internal resistance have greatly limited the output performance of microbial biofilm-based hydrovoltaic electricity generators (BioHEGs). Herein, a core@shell structured biohybrid system (S. o@PPy) was constructed by in situ polymerization of pyrrole monomers on the surface of Shewanella oneidensis (S. o) cells. The presence of polymer-biofilm interfaces resulted in a remarkable performance of hygroelectricity generation originated from the built-in conductivity of hole-doped polypyrrole (PPy), as well as the reduced internal resistance and improved water adsorption capacity of S. o biofilms. Hence, the S. o@PPy BioHEG generated a stable short-circuit current of ca. 33.5 μA at the optimal condition, which is significantly higher than all BioHEGs documented hitherto. Moreover, a novel mechanism of asymmetric charge redistribution was confirmed by density functional theory (DFT) calculations. These results support a new perspective of hydrovoltaic effects and provide a viable strategy for advancing BioHEGs towards more practical scenarios such as humidity sensing and electronic power supply.},
}
RevDate: 2026-11-13
Biofilm-targeted chitosan therapeutics against Candida auris: from molecular mechanisms to smart hydrogels and digital mycology.
Future microbiology [Epub ahead of print].
Candida auris is a multidrug-resistant fungal pathogen that forms persistent biofilms on medical devices and hospital surfaces, and current antifungals often fail against it. Chitosan, a natural cationic polysaccharide derived from chitin, has emerged as a promising biomaterial against these biofilms. This narrative review draws on literature from PubMed, Scopus, and Google Scholar (January 2009-April 2026) to examine how chitosan disrupts C. auris biofilms and where the evidence actually stands. We cover chitosan's antifungal mechanisms, membrane disruption, reactive oxygen species generation, and interference with quorum sensing, along with its formulation into nanoparticles, nanocomposites, and hydrogels. Much of this mechanistic evidence comes from C. albicans and other Candida species rather than C. auris itself, a gap we highlight throughout. Smart, stimuli-responsive hydrogels designed to release drugs within the acidic biofilm microenvironment show particular promise, as do chitosan-antifungal combinations reporting synergistic activity, though C. auris-specific validation remains limited. Overall, chitosan-based biomaterials represent a scientifically sound but still largely preclinical strategy. Their translational future depends on dedicated C. auris in vivo efficacy studies, toxicity data, and eventual clinical trials.
Additional Links: PMID-43021518
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43021518,
year = {2026},
author = {Kamran, M and Ahmar, MA and Shah, NA and Amir, A},
title = {Biofilm-targeted chitosan therapeutics against Candida auris: from molecular mechanisms to smart hydrogels and digital mycology.},
journal = {Future microbiology},
volume = {},
number = {},
pages = {1-14},
doi = {10.1080/17460913.2026.2763606},
pmid = {43021518},
issn = {1746-0921},
abstract = {Candida auris is a multidrug-resistant fungal pathogen that forms persistent biofilms on medical devices and hospital surfaces, and current antifungals often fail against it. Chitosan, a natural cationic polysaccharide derived from chitin, has emerged as a promising biomaterial against these biofilms. This narrative review draws on literature from PubMed, Scopus, and Google Scholar (January 2009-April 2026) to examine how chitosan disrupts C. auris biofilms and where the evidence actually stands. We cover chitosan's antifungal mechanisms, membrane disruption, reactive oxygen species generation, and interference with quorum sensing, along with its formulation into nanoparticles, nanocomposites, and hydrogels. Much of this mechanistic evidence comes from C. albicans and other Candida species rather than C. auris itself, a gap we highlight throughout. Smart, stimuli-responsive hydrogels designed to release drugs within the acidic biofilm microenvironment show particular promise, as do chitosan-antifungal combinations reporting synergistic activity, though C. auris-specific validation remains limited. Overall, chitosan-based biomaterials represent a scientifically sound but still largely preclinical strategy. Their translational future depends on dedicated C. auris in vivo efficacy studies, toxicity data, and eventual clinical trials.},
}
RevDate: 2026-11-13
CmpDate: 2026-11-13
Bacterial contamination, antibiotic resistance, and biofilm formation on operating rooms surfaces at Jimma Medical Center, Southwest Ethiopia.
Infection prevention in practice, 8(4):100610.
BACKGROUND: Microbial contamination in hospitals, especially in operating theatres and specialized units, greatly contributes to the increasing number of hospital-acquired infections, which pose high morbidity and mortality risks for postoperative patients. Therefore, this study aimed to assess bacterial colonization on surfaces and in the air of operating rooms at Jimma Medical Center (JMC), southwest Ethiopia.
METHODS: A cross-sectional study was conducted from April to August 2022, during which a total of 239 samples were collected, including 159 swabs from frequently touched surfaces and 80 air samples. Bacterial isolation and identification were performed using standard bacteriological techniques. Antimicrobial susceptibility test was performed using the Kirby-Bauer disc diffusion method. Extended-spectrum beta-lactamase (ESBL) and carbapenemase production were detected using combination disc and modified carbapenem inactivation methods. Methicillin-resistant Staphylococcus aureus and biofilm formation were identified using cefoxitin discs and a 96-well microtitre plate assay. Data were analysed using IBM SPSS Stastics for windows, version 25.0 (IBM Crop, Armonk, NY, USA) descriptive statistics and χ[2] test was applied, with a P value <0.05 considered statistically significant.
RESULTS: A total of 243 bacterial isolates were recovered. Gram-positive bacteria were predominant 218 of 243 cases (89.7%), with coagulase-negative staphylococci (CONSs) in 96 of 218 (39.5%) and S. aureus 76 of 218 (31.3%) cases being the most common. Methicillin resistance was found in 19 of 76 cases (25%) of S. aureus and 18 of 96 cases (18.8%) of CONSs. Among Gram-negative isolates, 6 of 25 cases (24.0%) were carbapenemase producers, and 3 of 14 (21.4%) of Enterobacteriaceae produced ESBL. Overall, 63 of 243 (25.9%) of isolates were multi-drug resistant, and 34 of 47 (72.3%) demonstrated biofilm formation.
CONCLUSION: The inanimate hospital environments in JMC operating rooms are colonized with potentially pathogenic bacteria, and the load of bacteria on surfaces and in the air were higher than standards. It is crucial to maintain strict infection prevention and control measures.
Additional Links: PMID-43022271
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43022271,
year = {2026},
author = {Fikadu, S and Tamrat, R and Kassa, T},
title = {Bacterial contamination, antibiotic resistance, and biofilm formation on operating rooms surfaces at Jimma Medical Center, Southwest Ethiopia.},
journal = {Infection prevention in practice},
volume = {8},
number = {4},
pages = {100610},
pmid = {43022271},
issn = {2590-0889},
abstract = {BACKGROUND: Microbial contamination in hospitals, especially in operating theatres and specialized units, greatly contributes to the increasing number of hospital-acquired infections, which pose high morbidity and mortality risks for postoperative patients. Therefore, this study aimed to assess bacterial colonization on surfaces and in the air of operating rooms at Jimma Medical Center (JMC), southwest Ethiopia.
METHODS: A cross-sectional study was conducted from April to August 2022, during which a total of 239 samples were collected, including 159 swabs from frequently touched surfaces and 80 air samples. Bacterial isolation and identification were performed using standard bacteriological techniques. Antimicrobial susceptibility test was performed using the Kirby-Bauer disc diffusion method. Extended-spectrum beta-lactamase (ESBL) and carbapenemase production were detected using combination disc and modified carbapenem inactivation methods. Methicillin-resistant Staphylococcus aureus and biofilm formation were identified using cefoxitin discs and a 96-well microtitre plate assay. Data were analysed using IBM SPSS Stastics for windows, version 25.0 (IBM Crop, Armonk, NY, USA) descriptive statistics and χ[2] test was applied, with a P value <0.05 considered statistically significant.
RESULTS: A total of 243 bacterial isolates were recovered. Gram-positive bacteria were predominant 218 of 243 cases (89.7%), with coagulase-negative staphylococci (CONSs) in 96 of 218 (39.5%) and S. aureus 76 of 218 (31.3%) cases being the most common. Methicillin resistance was found in 19 of 76 cases (25%) of S. aureus and 18 of 96 cases (18.8%) of CONSs. Among Gram-negative isolates, 6 of 25 cases (24.0%) were carbapenemase producers, and 3 of 14 (21.4%) of Enterobacteriaceae produced ESBL. Overall, 63 of 243 (25.9%) of isolates were multi-drug resistant, and 34 of 47 (72.3%) demonstrated biofilm formation.
CONCLUSION: The inanimate hospital environments in JMC operating rooms are colonized with potentially pathogenic bacteria, and the load of bacteria on surfaces and in the air were higher than standards. It is crucial to maintain strict infection prevention and control measures.},
}
RevDate: 2026-11-11
CmpDate: 2026-11-11
Enhancing meropenem activity with sub-inhibitory hydrogen peroxide: synergistic antibacterial effects, biofilm suppression, and modulation of pslA gene expression in Pseudomonas aeruginosa.
World journal of microbiology & biotechnology, 42(11):.
The resistance associated with biofilm formation limits the therapeutic effect of meropenem (MEM) against Pseudomonas aeruginosa. The current study examined whether sub-minimum inhibitory concentrations (sub-MICs) of hydrogen peroxide (H2O2) potentiate MEM's efficacy through favorable pharmacodynamic interactions and effects on biofilm-associated virulence. Clinical isolates of P. aeruginosa (64 isolates) were evaluated for MEM susceptibility and biofilm production ability. The interaction between H2O2 and MEM was checked using the checkerboard microdilution method and fractional inhibitory concentration index (FICI). The impact of serial sub-MICs of the agents on biofilm production was evaluated in strongly biofilm-forming MEM-resistant isolates, and pslA gene expression was quantified using real-time PCR. MEM resistance was found in 39.06% of the isolated P. aeruginosa (64 isolates), and biofilm production was negatively correlated with MEM susceptibility (r = -0.39, p = 0.0011). H2O2 and MEM at sub-MIC levels inhibited biofilm formation in a concentration -dependent manner. Sub-MIC H2O2 reduced the MIC of MEM against resistant isolates (P < 0.05). FICI analysis showed that the combination created its highest pharmacodynamic interaction at 1/8 sub-MIC H2O2 (0.48 ± 0.14), indicating a synergistic effect of H2O2, while the other sub-MIC H2O2 showed additive interactions (FICI > 0.5-1.0). The combined treatment inhibited biofilm formation more than either agent alone (H2O2 or MEM) and produced the highest downregulation of pslA gene expression. Sub-inhibitory H2O2 enhances the antibacterial efficacy of MEM through favorable pharmacodynamic interactions while suppressing biofilm formation and pslA gene expression. Thus, in vitro, a low concentration of H2O2 is a promising adjuvant strategy for potentiating meropenem activity against MEM-resistant P. aeruginosa.
Additional Links: PMID-43013211
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43013211,
year = {2026},
author = {Ahmed, RH and Zgair, AK},
title = {Enhancing meropenem activity with sub-inhibitory hydrogen peroxide: synergistic antibacterial effects, biofilm suppression, and modulation of pslA gene expression in Pseudomonas aeruginosa.},
journal = {World journal of microbiology & biotechnology},
volume = {42},
number = {11},
pages = {},
pmid = {43013211},
issn = {1573-0972},
mesh = {*Pseudomonas aeruginosa/drug effects/genetics/isolation & purification ; *Hydrogen Peroxide/pharmacology ; *Biofilms/drug effects/growth & development ; Meropenem/pharmacology ; *Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests ; Gene Expression Regulation, Bacterial/drug effects ; Drug Synergism ; *Bacterial Proteins/genetics/metabolism ; *Thienamycins/pharmacology ; Humans ; Drug Resistance, Bacterial ; Pseudomonas Infections/microbiology ; },
abstract = {The resistance associated with biofilm formation limits the therapeutic effect of meropenem (MEM) against Pseudomonas aeruginosa. The current study examined whether sub-minimum inhibitory concentrations (sub-MICs) of hydrogen peroxide (H2O2) potentiate MEM's efficacy through favorable pharmacodynamic interactions and effects on biofilm-associated virulence. Clinical isolates of P. aeruginosa (64 isolates) were evaluated for MEM susceptibility and biofilm production ability. The interaction between H2O2 and MEM was checked using the checkerboard microdilution method and fractional inhibitory concentration index (FICI). The impact of serial sub-MICs of the agents on biofilm production was evaluated in strongly biofilm-forming MEM-resistant isolates, and pslA gene expression was quantified using real-time PCR. MEM resistance was found in 39.06% of the isolated P. aeruginosa (64 isolates), and biofilm production was negatively correlated with MEM susceptibility (r = -0.39, p = 0.0011). H2O2 and MEM at sub-MIC levels inhibited biofilm formation in a concentration -dependent manner. Sub-MIC H2O2 reduced the MIC of MEM against resistant isolates (P < 0.05). FICI analysis showed that the combination created its highest pharmacodynamic interaction at 1/8 sub-MIC H2O2 (0.48 ± 0.14), indicating a synergistic effect of H2O2, while the other sub-MIC H2O2 showed additive interactions (FICI > 0.5-1.0). The combined treatment inhibited biofilm formation more than either agent alone (H2O2 or MEM) and produced the highest downregulation of pslA gene expression. Sub-inhibitory H2O2 enhances the antibacterial efficacy of MEM through favorable pharmacodynamic interactions while suppressing biofilm formation and pslA gene expression. Thus, in vitro, a low concentration of H2O2 is a promising adjuvant strategy for potentiating meropenem activity against MEM-resistant P. aeruginosa.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Pseudomonas aeruginosa/drug effects/genetics/isolation & purification
*Hydrogen Peroxide/pharmacology
*Biofilms/drug effects/growth & development
Meropenem/pharmacology
*Anti-Bacterial Agents/pharmacology
Microbial Sensitivity Tests
Gene Expression Regulation, Bacterial/drug effects
Drug Synergism
*Bacterial Proteins/genetics/metabolism
*Thienamycins/pharmacology
Humans
Drug Resistance, Bacterial
Pseudomonas Infections/microbiology
RevDate: 2026-11-11
CmpDate: 2026-11-11
Microbial community steady state driven by metabolic integration under combined stress: A case study of moving bed biofilm reactor.
Journal of environmental sciences (China), 170:528-538.
This study investigates microbial community responses in moving bed biofilm reactors under combined stress from dynamic temperature (10-35 °C) and emerging contaminants (ECs). The three-stage adaptation process of microbial community "stress perception-metabolic integration-steady state establishment" is revealed. At low temperature (10 °C), microorganisms concentrate metabolic resources on core functions including energy metabolism and nitrogen transformation, while suitable temperature (25-35 °C) activates contaminant degradation pathways, enabling synergistic metabolism of carbon, nitrogen and ECs. ECs serve as environmental selection pressures that drive directional succession of microbial communities toward specialized taxa with degradation capabilities such as Azospira, which demonstrates dual functionality in simultaneous denitrification and ECs degradation. Molecular mechanism studies demonstrate that ECs exert bidirectional regulation on nitrogen metabolism: while promoting the expression of nitrogen assimilation genes, they also competitively inhibit the activity of key denitrification enzymes, ultimately leading to nitrite accumulation. Metagenomic binning confirms that microorganisms achieve functional steady state through ecological structure classification and metabolic function optimization. From a multi-scale perspective, this study elucidates the adaptation patterns of microbial systems under complex environmental stress, providing an important theoretical foundation for enhancing microbial resilience and process efficiency in wastewater treatment systems.
Additional Links: PMID-43014934
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43014934,
year = {2026},
author = {Chen, Z and Li, Q and Jin, L and Fang, X and Ren, H and Huang, H},
title = {Microbial community steady state driven by metabolic integration under combined stress: A case study of moving bed biofilm reactor.},
journal = {Journal of environmental sciences (China)},
volume = {170},
number = {},
pages = {528-538},
doi = {10.1016/j.jes.2026.03.019},
pmid = {43014934},
issn = {1001-0742},
mesh = {*Bioreactors/microbiology ; *Biofilms ; *Waste Disposal, Fluid/methods ; Nitrogen/metabolism ; *Microbiota ; Stress, Physiological ; },
abstract = {This study investigates microbial community responses in moving bed biofilm reactors under combined stress from dynamic temperature (10-35 °C) and emerging contaminants (ECs). The three-stage adaptation process of microbial community "stress perception-metabolic integration-steady state establishment" is revealed. At low temperature (10 °C), microorganisms concentrate metabolic resources on core functions including energy metabolism and nitrogen transformation, while suitable temperature (25-35 °C) activates contaminant degradation pathways, enabling synergistic metabolism of carbon, nitrogen and ECs. ECs serve as environmental selection pressures that drive directional succession of microbial communities toward specialized taxa with degradation capabilities such as Azospira, which demonstrates dual functionality in simultaneous denitrification and ECs degradation. Molecular mechanism studies demonstrate that ECs exert bidirectional regulation on nitrogen metabolism: while promoting the expression of nitrogen assimilation genes, they also competitively inhibit the activity of key denitrification enzymes, ultimately leading to nitrite accumulation. Metagenomic binning confirms that microorganisms achieve functional steady state through ecological structure classification and metabolic function optimization. From a multi-scale perspective, this study elucidates the adaptation patterns of microbial systems under complex environmental stress, providing an important theoretical foundation for enhancing microbial resilience and process efficiency in wastewater treatment systems.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Bioreactors/microbiology
*Biofilms
*Waste Disposal, Fluid/methods
Nitrogen/metabolism
*Microbiota
Stress, Physiological
RevDate: 2026-11-11
CmpDate: 2026-11-11
Integrative phosphorus removal-enrichment in mainstream and vivianite recovery process of municipal wastewater by sequencing batch biofilm reactor and fluidized bed crystallization.
Journal of environmental sciences (China), 170:822-833.
The current phosphorus recovery process in wastewater treatment plants faces several challenges, including process complexity and low recovery efficiency. This study examined the combined application of sequencing batch biofilm reactor (SBBR) and fluidized bed crystallization (FBC) processes for high-efficiency phosphorus enrichment. Furthermore, the key environmental factors influencing phosphorus removal and recovery via the SBBR process were investigated. The concept of phosphorus storage capacity was introduced, and a novel control strategy for phosphorus harvesting was developed. The redox conditions in the phosphorus enrichment solution produced by the SBBR are compatible with those required for vivianite formation in the FBC system. The two processes were successfully integrated, enabling direct vivianite formation in the liquid phase, which led to stable phosphorus crystallization recovery efficiency and high purity of vivianite. This study provides technical and theoretical foundations for achieving efficient phosphorus recovery from mainstream processes as well as enhanced vivianite recovery.
Additional Links: PMID-43014962
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43014962,
year = {2026},
author = {Li, L and Chen, Z and Huang, Y and Pan, Y},
title = {Integrative phosphorus removal-enrichment in mainstream and vivianite recovery process of municipal wastewater by sequencing batch biofilm reactor and fluidized bed crystallization.},
journal = {Journal of environmental sciences (China)},
volume = {170},
number = {},
pages = {822-833},
doi = {10.1016/j.jes.2026.03.021},
pmid = {43014962},
issn = {1001-0742},
mesh = {*Phosphorus/analysis/chemistry ; *Wastewater/chemistry ; *Waste Disposal, Fluid/methods ; Bioreactors ; Biofilms ; Crystallization ; *Water Pollutants, Chemical/analysis ; },
abstract = {The current phosphorus recovery process in wastewater treatment plants faces several challenges, including process complexity and low recovery efficiency. This study examined the combined application of sequencing batch biofilm reactor (SBBR) and fluidized bed crystallization (FBC) processes for high-efficiency phosphorus enrichment. Furthermore, the key environmental factors influencing phosphorus removal and recovery via the SBBR process were investigated. The concept of phosphorus storage capacity was introduced, and a novel control strategy for phosphorus harvesting was developed. The redox conditions in the phosphorus enrichment solution produced by the SBBR are compatible with those required for vivianite formation in the FBC system. The two processes were successfully integrated, enabling direct vivianite formation in the liquid phase, which led to stable phosphorus crystallization recovery efficiency and high purity of vivianite. This study provides technical and theoretical foundations for achieving efficient phosphorus recovery from mainstream processes as well as enhanced vivianite recovery.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Phosphorus/analysis/chemistry
*Wastewater/chemistry
*Waste Disposal, Fluid/methods
Bioreactors
Biofilms
Crystallization
*Water Pollutants, Chemical/analysis
RevDate: 2026-11-12
CmpDate: 2026-11-12
Ultrasound-activated phase-change nanodroplets for root canal biofilm eradication: mechanistic Investigation and experimental validation.
Frontiers in bioengineering and biotechnology, 14:1882780.
Refractory root canal infections pose a major clinical challenge, as conventional treatments fail to eradicate biofilms in the complex narrow root canal structure. This study proposed a novel strategy of ultrasound-activated phase-change nanodroplets (PCNDs) for biofilm elimination and elucidated its physicochemical and biomechanical mechanisms. A coupled Yang-Church-Pitt (YCP) dynamic model was established to simulate the complete phase transition-cavitation-energy release process of PCNDs under ultrasonic irradiation. Ex vivo experiments on E. faecalis biofilms confirmed that PCNDs efficiently disrupted biofilms via cavitation effects, with efficacy positively correlated with ultrasonic intensity but no significant frequency influence. Minimal temperature of approximately 2 °C rises during treatment verified the strategy's biosafety, preventing dental hard tissue damage. The YCP model accurately predicted the system's cavitation characteristics and thermal dynamics, and simulated cavitation energy was strongly correlated with experimental biofilm elimination efficiency. This work validated the safety and efficacy of ultrasound-activated PCNDs for root canal biofilm removal; the YCP model provided a theoretical framework for optimizing ultrasonic parameters, offering a novel mechanistically informed approach for managing refractory root canal infections.
Additional Links: PMID-43016546
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43016546,
year = {2026},
author = {Qian, X and Dang, J and Shi, Z and Zhang, J},
title = {Ultrasound-activated phase-change nanodroplets for root canal biofilm eradication: mechanistic Investigation and experimental validation.},
journal = {Frontiers in bioengineering and biotechnology},
volume = {14},
number = {},
pages = {1882780},
pmid = {43016546},
issn = {2296-4185},
abstract = {Refractory root canal infections pose a major clinical challenge, as conventional treatments fail to eradicate biofilms in the complex narrow root canal structure. This study proposed a novel strategy of ultrasound-activated phase-change nanodroplets (PCNDs) for biofilm elimination and elucidated its physicochemical and biomechanical mechanisms. A coupled Yang-Church-Pitt (YCP) dynamic model was established to simulate the complete phase transition-cavitation-energy release process of PCNDs under ultrasonic irradiation. Ex vivo experiments on E. faecalis biofilms confirmed that PCNDs efficiently disrupted biofilms via cavitation effects, with efficacy positively correlated with ultrasonic intensity but no significant frequency influence. Minimal temperature of approximately 2 °C rises during treatment verified the strategy's biosafety, preventing dental hard tissue damage. The YCP model accurately predicted the system's cavitation characteristics and thermal dynamics, and simulated cavitation energy was strongly correlated with experimental biofilm elimination efficiency. This work validated the safety and efficacy of ultrasound-activated PCNDs for root canal biofilm removal; the YCP model provided a theoretical framework for optimizing ultrasonic parameters, offering a novel mechanistically informed approach for managing refractory root canal infections.},
}
RevDate: 2026-11-12
CmpDate: 2026-11-12
Curcumin and piperine emulsomes as combinational treatment approach to enhance the anti-biofilm, anti-microbial, and wound healing activities of curcumin.
Journal of food science and technology, 63(12):2299-2312.
UNLABELLED: Curcumin, a polyphenolic substance from turmeric, is known for its anti-inflammatory, antioxidant, and antimicrobial properties. However, its poor bioavailability limits clinical application. Piperine, an alkaloid from black pepper, enhances curcumin's bioavailability. Advanced drug delivery systems like emulsomes can improve curcumin's efficacy by providing targeted and prolonged delivery. This study investigated the combined effects of curcumin and piperine emulsomes on anti-biofilm, antimicrobial, and wound healing activities. The physicochemical properties of the emulsomes were characterized using dynamic light scattering (DLS), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The antibacterial activity against biofilm-forming pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa, was evaluated using the well diffusion assay. Kinetics and mechanisms of antibacterial action were analyzed with time-kill assays and membrane degradation studies. Anti-biofilm activity was assessed using the crystal violet assay, and wound healing efficacy was tested in an in vitro scratch assay with 3T3 fibroblast cells. In all assays, the curcumin and piperine emulsomes demonstrated superior activity compared to curcumin alone and blank controls. Hence, we can conclude that curcumin and piperine emulsomes can significantly enhance curcumin's antimicrobial, anti-biofilm, and wound healing effects, offering a promising combinational treatment approach for microbial infections and wound management.
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s13197-025-06327-7.
Additional Links: PMID-43016901
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43016901,
year = {2026},
author = {Ramalingam, N and Swaminathan, S and Ramalingam, R},
title = {Curcumin and piperine emulsomes as combinational treatment approach to enhance the anti-biofilm, anti-microbial, and wound healing activities of curcumin.},
journal = {Journal of food science and technology},
volume = {63},
number = {12},
pages = {2299-2312},
pmid = {43016901},
issn = {0022-1155},
abstract = {UNLABELLED: Curcumin, a polyphenolic substance from turmeric, is known for its anti-inflammatory, antioxidant, and antimicrobial properties. However, its poor bioavailability limits clinical application. Piperine, an alkaloid from black pepper, enhances curcumin's bioavailability. Advanced drug delivery systems like emulsomes can improve curcumin's efficacy by providing targeted and prolonged delivery. This study investigated the combined effects of curcumin and piperine emulsomes on anti-biofilm, antimicrobial, and wound healing activities. The physicochemical properties of the emulsomes were characterized using dynamic light scattering (DLS), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The antibacterial activity against biofilm-forming pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa, was evaluated using the well diffusion assay. Kinetics and mechanisms of antibacterial action were analyzed with time-kill assays and membrane degradation studies. Anti-biofilm activity was assessed using the crystal violet assay, and wound healing efficacy was tested in an in vitro scratch assay with 3T3 fibroblast cells. In all assays, the curcumin and piperine emulsomes demonstrated superior activity compared to curcumin alone and blank controls. Hence, we can conclude that curcumin and piperine emulsomes can significantly enhance curcumin's antimicrobial, anti-biofilm, and wound healing effects, offering a promising combinational treatment approach for microbial infections and wound management.
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s13197-025-06327-7.},
}
RevDate: 2026-11-12
CmpDate: 2026-11-12
Fluorinated galactose analogues inhibit Streptococcus pneumoniae biofilm formation.
Access microbiology, 8(11):.
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, causing invasive diseases such as pneumonia, sepsis and meningitis, but also less severe localized infections like otitis media. To enable pneumococcal survival in the nutritionally challenging nasopharyngeal niche, it possesses an extensive repertoire of genes dedicated to the utilization of a wide range of carbohydrates. Galactose, the predominant carbohydrate found in the respiratory tract, is important in pneumococcal colonization and virulence and therefore represents an attractive target for the development of new treatments. In this preliminary study, we investigated the potential of fluorinated galactose analogues as a strategy for preventing and treating pneumococcal biofilms. The analogues were tested against planktonic pneumococci, and their effects on in vitro biofilms were assessed through biomass and viability measurements with validation through confocal and scanning electron microscopy. Their effect on adhesion of pneumococcus to Detroit562 pharyngeal epithelial cells and cytotoxicity was also assessed. Treatment with up to 2% wt/v galactose fluorinated at the C-3 (Gal-3F) and C-6 (Gal-6F) positions had no effect on final planktonic growth after 24 h within glucose-rich BHI medium; however, a reduction in mid-exponential growth rate was observed with 2% Gal-3F. Correlating with the transition towards biofilm formation involving a switch to galactose metabolism, 1-2% wt/v Gal-3F successfully inhibited biofilm formation for four out of five strains tested; however, no activity was observed against 48-h established biofilms, and there was no inhibition of epithelial adhesion. The equivalent concentrations of Gal-6F had no effect on pneumococcal biofilms, suggesting that the site of fluorination is important in activity. The inhibition of biofilm formation by Gal-3F confirms that targeting galactose metabolism is a potentially viable strategy for treating pneumococcal infection and that the rational design of fluorinated glycomimetics offers an alternative approach to targeting pneumococcal biofilms.
Additional Links: PMID-43016963
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43016963,
year = {2026},
author = {Spencer, DL and Fairchild, C and Webb, JS and Linclau, B and Faust, SN and Allan, RN},
title = {Fluorinated galactose analogues inhibit Streptococcus pneumoniae biofilm formation.},
journal = {Access microbiology},
volume = {8},
number = {11},
pages = {},
pmid = {43016963},
issn = {2516-8290},
abstract = {Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, causing invasive diseases such as pneumonia, sepsis and meningitis, but also less severe localized infections like otitis media. To enable pneumococcal survival in the nutritionally challenging nasopharyngeal niche, it possesses an extensive repertoire of genes dedicated to the utilization of a wide range of carbohydrates. Galactose, the predominant carbohydrate found in the respiratory tract, is important in pneumococcal colonization and virulence and therefore represents an attractive target for the development of new treatments. In this preliminary study, we investigated the potential of fluorinated galactose analogues as a strategy for preventing and treating pneumococcal biofilms. The analogues were tested against planktonic pneumococci, and their effects on in vitro biofilms were assessed through biomass and viability measurements with validation through confocal and scanning electron microscopy. Their effect on adhesion of pneumococcus to Detroit562 pharyngeal epithelial cells and cytotoxicity was also assessed. Treatment with up to 2% wt/v galactose fluorinated at the C-3 (Gal-3F) and C-6 (Gal-6F) positions had no effect on final planktonic growth after 24 h within glucose-rich BHI medium; however, a reduction in mid-exponential growth rate was observed with 2% Gal-3F. Correlating with the transition towards biofilm formation involving a switch to galactose metabolism, 1-2% wt/v Gal-3F successfully inhibited biofilm formation for four out of five strains tested; however, no activity was observed against 48-h established biofilms, and there was no inhibition of epithelial adhesion. The equivalent concentrations of Gal-6F had no effect on pneumococcal biofilms, suggesting that the site of fluorination is important in activity. The inhibition of biofilm formation by Gal-3F confirms that targeting galactose metabolism is a potentially viable strategy for treating pneumococcal infection and that the rational design of fluorinated glycomimetics offers an alternative approach to targeting pneumococcal biofilms.},
}
RevDate: 2026-11-12
Serum vitamin D, innate immunity markers, and biofilm presence as determinants of therapeutic strategies in diabetic foot infections: A comparative cross-sectional study.
Nutrition and health [Epub ahead of print].
BackgroundSevere diabetic foot infections (DFIs) often require surgical management (SM), whereas less severe infections may be managed medically (MM). Vitamin D, its receptor (VDR), and LL-37 play key roles in innate immunity, wound healing, and antimicrobial defense.AimTo determine the association between serum vitamin D, VDR, and LL-37 levels and the prevalence of biofilm-forming bacteria in SM and MM in patients with DFIs.Methods207 patients with DFIs were recruited from the Department of General Surgery, Kasturba Hospital, Manipal, India, between September 2022 and September 2025. Treatment allocation (SM or MM) was determined by the attending surgeons based on DFI severity. At 24 h after treatment initiation, blood samples were collected for vitamin D assessment (electrochemiluminescence immunoassay) and VDR and LL-37 quantification using enzyme-linked immunosorbent assay. Biofilm formation was analyzed using the tissue culture plate method.ResultsOf the 207 participants, 169 (81.64%) required SM and 38 (18.36%) received MM. Patients with SM had significantly lower median levels of vitamin D (12.6 vs. 24.3 ng/mL), VDR (0.69 vs. 1.34 ng/mL), and LL-37 (1.28 vs. 2.46 ng/mL) compared to those with MM (all p < 0.001). SM was significantly associated with DFI severity (p = 0.004) and CRP levels (p = 0.034) after adjusting confounders. Among the 182 biofilm-forming bacterial isolates, 87.4% were isolated from patients undergoing SM and 12.6% from those receiving MM (p < 0.001).SummaryLower serum vitamin D, VDR, and LL-37 levels, together with a higher prevalence of biofilm-forming bacteria, were associated with greater DFI severity and an increased likelihood of SM.
Additional Links: PMID-43017885
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43017885,
year = {2026},
author = {Benson, R and Jacob Kurian, S and Seetharam Shiva, P and Banerjee, B and Sudha Gururaj, VK and Kunhikatta, V and Velladath, SU and Rodrigues, GS and Hariharapura, RC and Rao, M and Munisamy, M and Vishwanath, S and Mukhopadhyay, C and Miraj, SS},
title = {Serum vitamin D, innate immunity markers, and biofilm presence as determinants of therapeutic strategies in diabetic foot infections: A comparative cross-sectional study.},
journal = {Nutrition and health},
volume = {},
number = {},
pages = {2601060261505233},
doi = {10.1177/02601060261505233},
pmid = {43017885},
issn = {2047-945X},
abstract = {BackgroundSevere diabetic foot infections (DFIs) often require surgical management (SM), whereas less severe infections may be managed medically (MM). Vitamin D, its receptor (VDR), and LL-37 play key roles in innate immunity, wound healing, and antimicrobial defense.AimTo determine the association between serum vitamin D, VDR, and LL-37 levels and the prevalence of biofilm-forming bacteria in SM and MM in patients with DFIs.Methods207 patients with DFIs were recruited from the Department of General Surgery, Kasturba Hospital, Manipal, India, between September 2022 and September 2025. Treatment allocation (SM or MM) was determined by the attending surgeons based on DFI severity. At 24 h after treatment initiation, blood samples were collected for vitamin D assessment (electrochemiluminescence immunoassay) and VDR and LL-37 quantification using enzyme-linked immunosorbent assay. Biofilm formation was analyzed using the tissue culture plate method.ResultsOf the 207 participants, 169 (81.64%) required SM and 38 (18.36%) received MM. Patients with SM had significantly lower median levels of vitamin D (12.6 vs. 24.3 ng/mL), VDR (0.69 vs. 1.34 ng/mL), and LL-37 (1.28 vs. 2.46 ng/mL) compared to those with MM (all p < 0.001). SM was significantly associated with DFI severity (p = 0.004) and CRP levels (p = 0.034) after adjusting confounders. Among the 182 biofilm-forming bacterial isolates, 87.4% were isolated from patients undergoing SM and 12.6% from those receiving MM (p < 0.001).SummaryLower serum vitamin D, VDR, and LL-37 levels, together with a higher prevalence of biofilm-forming bacteria, were associated with greater DFI severity and an increased likelihood of SM.},
}
RevDate: 2026-11-12
Incyclinide exhibits potent antibacterial and anti-biofilm activity against Staphylococcus aureus.
Microbiology spectrum [Epub ahead of print].
Methicillin-resistant Staphylococcus aureus (MRSA) and biofilm-associated infections remain major therapeutic challenges. Here, we investigated the antibacterial activity and mechanism of Incyclinide against S. aureus. Incyclinide showed potent activity against 40 clinical isolates, with a minimum inhibitory concentration (MIC) of 2 µM for 81.25% of MSSA isolates and 91.66% of MRSA isolates. In representative MSSA and MRSA strains, 1× MIC completely inhibited planktonic growth, while time-kill assays demonstrated concentration-dependent bactericidal activity; at 8× MIC, bacterial counts decreased by 3.2 log10 CFU/mL in NCTC 8325 and 4.3 log10 CFU/mL in USA300 after 24 h. Incyclinide also markedly reduced the biomass of mature, pre-established biofilms. Proteomic profiling of Incyclinide-treated USA300 identified 59 differentially expressed proteins enriched in membrane-related functions. Transmission electron microscopy and fluorescence assays revealed severe cell envelope damage, increased membrane permeability, and membrane depolarization. Exogenous phospholipids antagonized antibacterial activity, with phosphatidylethanolamine and cardiolipin showing stronger effects than phosphatidylglycerol. In addition, resistance induction and whole-genome sequencing identified recurrent clpX mutations; clpX deletion increased the MIC from 2 to 8 µM, whereas complementation restored susceptibility. Molecular docking suggested favorable binding between Incyclinide and ClpX, with a predicted binding energy of -9.4 kcal/mol. Incyclinide also exhibited low hemolytic activity, negligible cytotoxicity toward BEAS-2B and human umbilical vein endothelial cell up to 128 µM, and significant protection in a Galleria mellonella infection model. Collectively, these findings identify Incyclinide as a promising anti-S. aureus agent with potent activity against MRSA and mature biofilms, acting primarily through membrane disruption, with ClpX potentially contributing to susceptibility.IMPORTANCEMethicillin-resistant Staphylococcus aureus (MRSA) and biofilm-associated infections pose significant clinical challenges due to limited therapeutic options. Here, we identify Incyclinide, a tetracycline derivative, as a potent anti-S. aureus agent. It exhibits potent bactericidal activity against clinical MRSA isolates and effectively eradicates mature biofilms. Mechanistically, Incyclinide disrupts membrane integrity, causing depolarization and leakage. Notably, we identify the essential chaperone ClpX as a key molecular determinant of susceptibility through genetic and docking studies. Incyclinide demonstrates a favorable safety profile and superior efficacy compared with vancomycin in a Galleria mellonella infection model. Our findings highlight Incyclinide as a promising candidate featuring a dual membrane-targeting and intracellular mechanism, offering a strategic advantage against drug-resistant and biofilm-embedded pathogens.
Additional Links: PMID-43018135
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43018135,
year = {2026},
author = {Xi, H and Yuan, J and Wang, Y and Dai, Q and Liu, P and Zeng, T and Liu, M and Zhang, W and Zhao, R},
title = {Incyclinide exhibits potent antibacterial and anti-biofilm activity against Staphylococcus aureus.},
journal = {Microbiology spectrum},
volume = {},
number = {},
pages = {e0203326},
doi = {10.1128/spectrum.02033-26},
pmid = {43018135},
issn = {2165-0497},
abstract = {Methicillin-resistant Staphylococcus aureus (MRSA) and biofilm-associated infections remain major therapeutic challenges. Here, we investigated the antibacterial activity and mechanism of Incyclinide against S. aureus. Incyclinide showed potent activity against 40 clinical isolates, with a minimum inhibitory concentration (MIC) of 2 µM for 81.25% of MSSA isolates and 91.66% of MRSA isolates. In representative MSSA and MRSA strains, 1× MIC completely inhibited planktonic growth, while time-kill assays demonstrated concentration-dependent bactericidal activity; at 8× MIC, bacterial counts decreased by 3.2 log10 CFU/mL in NCTC 8325 and 4.3 log10 CFU/mL in USA300 after 24 h. Incyclinide also markedly reduced the biomass of mature, pre-established biofilms. Proteomic profiling of Incyclinide-treated USA300 identified 59 differentially expressed proteins enriched in membrane-related functions. Transmission electron microscopy and fluorescence assays revealed severe cell envelope damage, increased membrane permeability, and membrane depolarization. Exogenous phospholipids antagonized antibacterial activity, with phosphatidylethanolamine and cardiolipin showing stronger effects than phosphatidylglycerol. In addition, resistance induction and whole-genome sequencing identified recurrent clpX mutations; clpX deletion increased the MIC from 2 to 8 µM, whereas complementation restored susceptibility. Molecular docking suggested favorable binding between Incyclinide and ClpX, with a predicted binding energy of -9.4 kcal/mol. Incyclinide also exhibited low hemolytic activity, negligible cytotoxicity toward BEAS-2B and human umbilical vein endothelial cell up to 128 µM, and significant protection in a Galleria mellonella infection model. Collectively, these findings identify Incyclinide as a promising anti-S. aureus agent with potent activity against MRSA and mature biofilms, acting primarily through membrane disruption, with ClpX potentially contributing to susceptibility.IMPORTANCEMethicillin-resistant Staphylococcus aureus (MRSA) and biofilm-associated infections pose significant clinical challenges due to limited therapeutic options. Here, we identify Incyclinide, a tetracycline derivative, as a potent anti-S. aureus agent. It exhibits potent bactericidal activity against clinical MRSA isolates and effectively eradicates mature biofilms. Mechanistically, Incyclinide disrupts membrane integrity, causing depolarization and leakage. Notably, we identify the essential chaperone ClpX as a key molecular determinant of susceptibility through genetic and docking studies. Incyclinide demonstrates a favorable safety profile and superior efficacy compared with vancomycin in a Galleria mellonella infection model. Our findings highlight Incyclinide as a promising candidate featuring a dual membrane-targeting and intracellular mechanism, offering a strategic advantage against drug-resistant and biofilm-embedded pathogens.},
}
RevDate: 2026-11-12
CmpDate: 2026-11-12
Biofilm-responsive nanogels: a closed-loop system for on-demand antimicrobial release for chronic wounds.
Mikrochimica acta, 193(12):.
Infections caused by biofilms present one of the major challenges in wound care due to their resistance to antibiotics and their slow healing. Chronic wounds, surgical site infections, and medical device infections are often characterized by biofilm, which forms an extracellular matrix that limits drug diffusion and sustains microorganisms. Nanotechnology has led to the development of nanogels as a novel drug delivery method that improves drug penetration into biofilms and supports sustained drug release. Stimuli-responsive nanogels, which are responsive to physiological changes in the chronic wound environment, including low pH values, enzymatic activities, and excessive production of reactive oxygen species, have shown their effectiveness in solving the problem of the development of bacterial infection. This review provides an overview of the use of biofilms in the physiology of wounds and highlights the significance of nanogels in biofilm-responsive closed-loop system therapy. The use of nanogels as one of the ways to create intelligent systems that can operate like sensors and monitor the wound microenvironment based on its changes and deliver drugs to the wound on demand in response to these changes is considered. Furthermore, recent developments in intelligent wound care systems with respect to patents and clinical trials are critically assessed. However, substantial progress has been made in this area; for moving these systems to clinical settings, further investigation is needed to optimize their sensitivity, therapeutic efficacy, long-term safety, and stability.
Additional Links: PMID-43018759
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43018759,
year = {2026},
author = {Kaul, S and Sharma, A and Jain, N and Bawari, S and Chaudhary, A and Nagaich, U},
title = {Biofilm-responsive nanogels: a closed-loop system for on-demand antimicrobial release for chronic wounds.},
journal = {Mikrochimica acta},
volume = {193},
number = {12},
pages = {},
pmid = {43018759},
issn = {1436-5073},
mesh = {Humans ; *Biofilms/drug effects ; *Nanogels/chemistry ; *Anti-Bacterial Agents/chemistry/pharmacology ; Wound Healing/drug effects ; Drug Liberation ; Animals ; Drug Delivery Systems ; Polyethylene Glycols ; Polyethyleneimine ; },
abstract = {Infections caused by biofilms present one of the major challenges in wound care due to their resistance to antibiotics and their slow healing. Chronic wounds, surgical site infections, and medical device infections are often characterized by biofilm, which forms an extracellular matrix that limits drug diffusion and sustains microorganisms. Nanotechnology has led to the development of nanogels as a novel drug delivery method that improves drug penetration into biofilms and supports sustained drug release. Stimuli-responsive nanogels, which are responsive to physiological changes in the chronic wound environment, including low pH values, enzymatic activities, and excessive production of reactive oxygen species, have shown their effectiveness in solving the problem of the development of bacterial infection. This review provides an overview of the use of biofilms in the physiology of wounds and highlights the significance of nanogels in biofilm-responsive closed-loop system therapy. The use of nanogels as one of the ways to create intelligent systems that can operate like sensors and monitor the wound microenvironment based on its changes and deliver drugs to the wound on demand in response to these changes is considered. Furthermore, recent developments in intelligent wound care systems with respect to patents and clinical trials are critically assessed. However, substantial progress has been made in this area; for moving these systems to clinical settings, further investigation is needed to optimize their sensitivity, therapeutic efficacy, long-term safety, and stability.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Biofilms/drug effects
*Nanogels/chemistry
*Anti-Bacterial Agents/chemistry/pharmacology
Wound Healing/drug effects
Drug Liberation
Animals
Drug Delivery Systems
Polyethylene Glycols
Polyethyleneimine
RevDate: 2026-11-10
CmpDate: 2026-11-10
Phage-Based Biofilm Control in Engineered Water Environments.
Environmental science & technology, 60(44):31195-31210.
Biofilms represent a predominant bacterial lifestyle and contribute to the ecological stability and biochemical functioning in water systems. Paradoxically, excessive biofilm formation threatens water security and public health by causing biofouling, harboring pathogens, and facilitating the transmission of antimicrobial resistance. Phage treatment offers a promising strategy for the targeted regulation of biofilm microecology without generating harmful disinfection byproducts. However, its performance in environmental settings can be constrained by spatiotemporal heterogeneity, suboptimal phage exposure, and the evolution of phage resistance in bacteria, creating additional challenges for engineering applications. Here, we synthesize phage-based biofilm control as a multilevel intervention paradigm organized by biological bottlenecks. We examine strategies that improve transport and host access, enhance targeting and productive lysis, induce biofilm disruption through prophage activation, and perturb biofilm communities through keystone-centered interactions. We then align these intervention principles with distinct biofilm scenarios and operational constraints in engineered water environments. Emerging technologies are evaluated according to their roles in target identification, validation under application-relevant conditions, and treatment monitoring. Finally, we propose a closed-loop framework encompassing system diagnosis, intervention design and validation, monitored deployment, and adaptive management. Overall, this Review provides an integrated roadmap for advancing scalable and sustainable phage-based biofilm control in engineered water environments.
Additional Links: PMID-43007189
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007189,
year = {2026},
author = {Zhang, X and Ruan, C and Balcazar, JL and Liao, J and Shen, H and Shen, Y and Alvarez, PJJ and Yu, P},
title = {Phage-Based Biofilm Control in Engineered Water Environments.},
journal = {Environmental science & technology},
volume = {60},
number = {44},
pages = {31195-31210},
doi = {10.1021/acs.est.6c07569},
pmid = {43007189},
issn = {1520-5851},
support = {2025C02214//Key Research and Development Program of Zhejiang Province/ ; 52522003//National Natural Science Foundation of China/ ; },
mesh = {*Biofilms ; *Bacteriophages ; Water Microbiology ; },
abstract = {Biofilms represent a predominant bacterial lifestyle and contribute to the ecological stability and biochemical functioning in water systems. Paradoxically, excessive biofilm formation threatens water security and public health by causing biofouling, harboring pathogens, and facilitating the transmission of antimicrobial resistance. Phage treatment offers a promising strategy for the targeted regulation of biofilm microecology without generating harmful disinfection byproducts. However, its performance in environmental settings can be constrained by spatiotemporal heterogeneity, suboptimal phage exposure, and the evolution of phage resistance in bacteria, creating additional challenges for engineering applications. Here, we synthesize phage-based biofilm control as a multilevel intervention paradigm organized by biological bottlenecks. We examine strategies that improve transport and host access, enhance targeting and productive lysis, induce biofilm disruption through prophage activation, and perturb biofilm communities through keystone-centered interactions. We then align these intervention principles with distinct biofilm scenarios and operational constraints in engineered water environments. Emerging technologies are evaluated according to their roles in target identification, validation under application-relevant conditions, and treatment monitoring. Finally, we propose a closed-loop framework encompassing system diagnosis, intervention design and validation, monitored deployment, and adaptive management. Overall, this Review provides an integrated roadmap for advancing scalable and sustainable phage-based biofilm control in engineered water environments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms
*Bacteriophages
Water Microbiology
RevDate: 2026-11-10
CmpDate: 2026-11-10
Evaluation of antibiotic resistance profiles, biofilm formation capacity and molecular detection of resistance genes in clinical P. aeruginosa isolates recovered from hospitalized patients in Ilam, Iran.
Molecular biology reports, 53(1):.
BACKGROUND: P. aeruginosa is a leading cause of healthcare-associated infections and is recognized by the WHO as a critical priority pathogen due to its intrinsic and acquired resistance mechanisms and its remarkable capacity for biofilm formation. This study aimed to evaluate antibiotic resistance profiles, biofilm formation capacity, and the molecular detection of resistance genes in clinical P. aeruginosa isolates recovered from hospitalized patients in Ilam, Iran.
METHODS: A total of 44 non-duplicate P. aeruginosa isolates were collected from urine, blood, and sputum specimens between November 2023 and August 2024. Identification used standard microbiological and biochemical tests. Antimicrobial susceptibility was determined by Kirby-Bauer disk diffusion following CLSI guidelines, and colistin MIC was determined by broth microdilution. Biofilm formation was assessed using a microtiter plate assay with crystal violet staining. Major resistance genes, including β-lactamases ([bla]-GES, [bla]-CTX, [bla]-SHV, [bla]-TEM), metallo-β-lactamases ([bla]-NDM, [bla]-VIM, [bla]-IMP), and fluoroquinolone resistance determinants (parC, parE), were detected via PCR.
RESULTS: The isolates exhibited high resistance rates to aztreonam (100%), gentamicin (68.2%), and imipenem (59.1%), while amikacin remained the most effective agent (95.5% susceptible). Following broth microdilution, colistin resistance was only 2.3%. Molecular analysis revealed that [bla]-GES (100%) and parC (95.5%) were the most prevalent resistance genes. followed by [bla]-CTX (55.5%), [bla]-SHV (45.5%), [bla]-TEM (45.5%), parE (36.4%), [bla]-NDM (13.6%), [bla]-VIM (13.6%), and [bla]-IMP (4.5%). Biofilm formation was observed in all isolates: 68.2% weak, 31.8% moderate; no strong producers were identified. A significant association was found between anatomical specimen source and biofilm strength (p = 0.011), with sputum isolates showing the highest moderate biofilm formation (75%). However, no significant association was observed between biofilm phenotype and antibiotic resistance.
CONCLUSION: The coexistence of MDR-associated genes and biofilm-forming ability underscores P. aeruginosa as a critical MDR pathogen. The high prevalence of [bla-]GES and parC, combined with the association between respiratory origin and moderate biofilm formation, highlights its adaptive success. Continuous surveillance, antimicrobial stewardship, routine colistin MIC testing, and anti-biofilm therapeutic approaches are essential to mitigate the clinical impact of MDR P. aeruginosa infections.
Additional Links: PMID-43007550
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007550,
year = {2026},
author = {Haddadi, MH and Sadeghifard, N and Mohebi, R and Yazdanmanesh, M and Ghafourian, S and Valadbeigi, H},
title = {Evaluation of antibiotic resistance profiles, biofilm formation capacity and molecular detection of resistance genes in clinical P. aeruginosa isolates recovered from hospitalized patients in Ilam, Iran.},
journal = {Molecular biology reports},
volume = {53},
number = {1},
pages = {},
pmid = {43007550},
issn = {1573-4978},
mesh = {*Biofilms/drug effects/growth & development ; Humans ; *Pseudomonas aeruginosa/genetics/drug effects/isolation & purification ; Iran ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests/methods ; *Pseudomonas Infections/microbiology/drug therapy ; *Drug Resistance, Bacterial/genetics ; beta-Lactamases/genetics ; Drug Resistance, Multiple, Bacterial/genetics ; },
abstract = {BACKGROUND: P. aeruginosa is a leading cause of healthcare-associated infections and is recognized by the WHO as a critical priority pathogen due to its intrinsic and acquired resistance mechanisms and its remarkable capacity for biofilm formation. This study aimed to evaluate antibiotic resistance profiles, biofilm formation capacity, and the molecular detection of resistance genes in clinical P. aeruginosa isolates recovered from hospitalized patients in Ilam, Iran.
METHODS: A total of 44 non-duplicate P. aeruginosa isolates were collected from urine, blood, and sputum specimens between November 2023 and August 2024. Identification used standard microbiological and biochemical tests. Antimicrobial susceptibility was determined by Kirby-Bauer disk diffusion following CLSI guidelines, and colistin MIC was determined by broth microdilution. Biofilm formation was assessed using a microtiter plate assay with crystal violet staining. Major resistance genes, including β-lactamases ([bla]-GES, [bla]-CTX, [bla]-SHV, [bla]-TEM), metallo-β-lactamases ([bla]-NDM, [bla]-VIM, [bla]-IMP), and fluoroquinolone resistance determinants (parC, parE), were detected via PCR.
RESULTS: The isolates exhibited high resistance rates to aztreonam (100%), gentamicin (68.2%), and imipenem (59.1%), while amikacin remained the most effective agent (95.5% susceptible). Following broth microdilution, colistin resistance was only 2.3%. Molecular analysis revealed that [bla]-GES (100%) and parC (95.5%) were the most prevalent resistance genes. followed by [bla]-CTX (55.5%), [bla]-SHV (45.5%), [bla]-TEM (45.5%), parE (36.4%), [bla]-NDM (13.6%), [bla]-VIM (13.6%), and [bla]-IMP (4.5%). Biofilm formation was observed in all isolates: 68.2% weak, 31.8% moderate; no strong producers were identified. A significant association was found between anatomical specimen source and biofilm strength (p = 0.011), with sputum isolates showing the highest moderate biofilm formation (75%). However, no significant association was observed between biofilm phenotype and antibiotic resistance.
CONCLUSION: The coexistence of MDR-associated genes and biofilm-forming ability underscores P. aeruginosa as a critical MDR pathogen. The high prevalence of [bla-]GES and parC, combined with the association between respiratory origin and moderate biofilm formation, highlights its adaptive success. Continuous surveillance, antimicrobial stewardship, routine colistin MIC testing, and anti-biofilm therapeutic approaches are essential to mitigate the clinical impact of MDR P. aeruginosa infections.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects/growth & development
Humans
*Pseudomonas aeruginosa/genetics/drug effects/isolation & purification
Iran
Anti-Bacterial Agents/pharmacology
Microbial Sensitivity Tests/methods
*Pseudomonas Infections/microbiology/drug therapy
*Drug Resistance, Bacterial/genetics
beta-Lactamases/genetics
Drug Resistance, Multiple, Bacterial/genetics
RevDate: 2026-11-10
Bio-electric field accelerated the formation of electroactive biofilm and the selection of Geobacter during start-up period.
Bioresource technology pii:S0960-8524(26)02303-5 [Epub ahead of print].
Prolonged startup severely restricts practical deployment of microbial electrochemical systems (MESs). Conventional strategies to accelerate electroactive biofilm (EAB) formation require costly chemicals or complex electrode modification. Herein, we report a facile strategy using a sustained low-strength bulk electric field (EF, 8 mV/cm, maintained for 75 % of each operational cycle) to accelerate EAB formation and selectively enrich Geobacter during the start-up period of MES. After 4-day EF acclimation, treated EABs yielded 4.2-fold higher turnover cyclic voltammetry redox current and 41 % lower charge-transfer resistance relative to the no-EF control. The EF-stimulated EAB also reached 1.64-fold higher biomass, with electroactive microorganisms constituting 96.8 % of the biofilm community (64.1 % in controls); Geobacter surged from an initial 1.3 % to 77.0 %, compared with only 32.7 % in controls. Unlike electrode-electrolyte interfacial polarization, the full-volume bulk EF may enrich negatively-charged electroactive bacteria presumably via electric-field-driven directional transport that promotes adhesion and proliferation. This additive-free approach enables mature EAB formation on electrodes within days, representing a promising laboratory-scale concept for prefabricating functional EAB-coated electrodes; further validation is required for real-world on-site MES implementation.
Additional Links: PMID-43008865
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43008865,
year = {2026},
author = {Wang, N and Liang, D and Zhang, Z and Li, Y and He, W and Feng, Y},
title = {Bio-electric field accelerated the formation of electroactive biofilm and the selection of Geobacter during start-up period.},
journal = {Bioresource technology},
volume = {},
number = {},
pages = {136221},
doi = {10.1016/j.biortech.2026.136221},
pmid = {43008865},
issn = {1873-2976},
abstract = {Prolonged startup severely restricts practical deployment of microbial electrochemical systems (MESs). Conventional strategies to accelerate electroactive biofilm (EAB) formation require costly chemicals or complex electrode modification. Herein, we report a facile strategy using a sustained low-strength bulk electric field (EF, 8 mV/cm, maintained for 75 % of each operational cycle) to accelerate EAB formation and selectively enrich Geobacter during the start-up period of MES. After 4-day EF acclimation, treated EABs yielded 4.2-fold higher turnover cyclic voltammetry redox current and 41 % lower charge-transfer resistance relative to the no-EF control. The EF-stimulated EAB also reached 1.64-fold higher biomass, with electroactive microorganisms constituting 96.8 % of the biofilm community (64.1 % in controls); Geobacter surged from an initial 1.3 % to 77.0 %, compared with only 32.7 % in controls. Unlike electrode-electrolyte interfacial polarization, the full-volume bulk EF may enrich negatively-charged electroactive bacteria presumably via electric-field-driven directional transport that promotes adhesion and proliferation. This additive-free approach enables mature EAB formation on electrodes within days, representing a promising laboratory-scale concept for prefabricating functional EAB-coated electrodes; further validation is required for real-world on-site MES implementation.},
}
RevDate: 2026-11-11
CmpDate: 2026-11-11
The bone-biofilm interface: decoding the bidirectional crosstalk in orthopedic implant infections.
Frontiers in cellular and infection microbiology, 16:1912867.
Implant-associated orthopedic infections remain difficult to eradicate because biofilm persistence is coupled to progressive changes in bone and local immunity. This narrative review presents the Bone-biofilm Interface (BBI) as an integrative framework linking microbial biofilms, implant properties, bone cells, immune cells, and the mineralized matrix. Its contribution is primarily organizational: it consolidates evidence on intracellular bacterial reservoirs, inflammatory osteolysis, immune dysfunction, and biofilm adaptation within a single spatial and functional unit. The framework also advances testable, but not yet clinically established, hypotheses concerning ion-mediated matrix remodeling, the dual role of osteoclasts as resorptive cells and potential bacterial reservoirs, and niche-dependent transitions between dormancy and resuscitation. We further consider how polymicrobial communities, temporal evolution, and implant material properties may modify these interactions. The available evidence is weighted according to source, with human observations distinguished from animal and in vitro studies. Established clinical management, including surgical source control and guideline-based antimicrobial therapy, remains central; proposed approaches involving microenvironment modulation, metabolic interference, immune reprogramming, anti-resorptive agents, and responsive biomaterials should be viewed as investigational adjuncts. By clarifying evidence boundaries and translational readiness, the BBI framework provides a structured research agenda for testing how disruption of host-microbe crosstalk might complement current treatment of chronic implant-associated infection.
Additional Links: PMID-43011360
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43011360,
year = {2026},
author = {Zhu, H and Hou, Z and Huang, H and Hu, H and Wan, L},
title = {The bone-biofilm interface: decoding the bidirectional crosstalk in orthopedic implant infections.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {1912867},
pmid = {43011360},
issn = {2235-2988},
mesh = {*Biofilms/growth & development ; Humans ; *Prosthesis-Related Infections/microbiology/immunology ; Animals ; *Prostheses and Implants/microbiology ; *Bone-Implant Interface/microbiology ; *Bone and Bones/microbiology ; Host-Pathogen Interactions ; },
abstract = {Implant-associated orthopedic infections remain difficult to eradicate because biofilm persistence is coupled to progressive changes in bone and local immunity. This narrative review presents the Bone-biofilm Interface (BBI) as an integrative framework linking microbial biofilms, implant properties, bone cells, immune cells, and the mineralized matrix. Its contribution is primarily organizational: it consolidates evidence on intracellular bacterial reservoirs, inflammatory osteolysis, immune dysfunction, and biofilm adaptation within a single spatial and functional unit. The framework also advances testable, but not yet clinically established, hypotheses concerning ion-mediated matrix remodeling, the dual role of osteoclasts as resorptive cells and potential bacterial reservoirs, and niche-dependent transitions between dormancy and resuscitation. We further consider how polymicrobial communities, temporal evolution, and implant material properties may modify these interactions. The available evidence is weighted according to source, with human observations distinguished from animal and in vitro studies. Established clinical management, including surgical source control and guideline-based antimicrobial therapy, remains central; proposed approaches involving microenvironment modulation, metabolic interference, immune reprogramming, anti-resorptive agents, and responsive biomaterials should be viewed as investigational adjuncts. By clarifying evidence boundaries and translational readiness, the BBI framework provides a structured research agenda for testing how disruption of host-microbe crosstalk might complement current treatment of chronic implant-associated infection.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
Humans
*Prosthesis-Related Infections/microbiology/immunology
Animals
*Prostheses and Implants/microbiology
*Bone-Implant Interface/microbiology
*Bone and Bones/microbiology
Host-Pathogen Interactions
RevDate: 2026-11-11
CmpDate: 2026-11-11
Analysis of biofilm complexity in 3D: an open-source framework for quantitative fractal, textural and statistical analysis of colony biofilm morphology in three dimensions.
Royal Society open science, 13(11):260853.
Quantitative image analysis is central to understanding microbial growth, morphology and spatial organization. However, conventional metrics such as mean intensity or object count often do not capture the complex structural heterogeneity and patterning characteristic of microbial colonies and biofilms. To address this limitation, analysis of biofilm complexity in 3D (ABC3D), an open-source Python framework for automated extraction of fractal, textural and statistical descriptors from volumetric microscopy images, is reported. ABC3D computes a set of parameters including fractal dimension, lacunarity, entropy, grey-level co-occurrence matrix features and relative wavelet sub-band energies from three-dimensional image datasets. ABC3D is demonstrated in Escherichia coli macrocolony biofilms, where the first two principal components captured 75.5% of architectural variance. Nutrient environment, genetic background and their interaction significantly influenced biofilm architecture, indicating that structural responses to nutrient conditions are strain-dependent. Analysis of individual parameters revealed coordinated changes in fractal, textural and spatial-frequency features rather than uniform changes in a single measure of complexity. ABC3D provides researchers with an accessible, quantitative approach to assessing biofilm morphology in microscopy datasets.
Additional Links: PMID-43012029
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43012029,
year = {2026},
author = {McConnell, G},
title = {Analysis of biofilm complexity in 3D: an open-source framework for quantitative fractal, textural and statistical analysis of colony biofilm morphology in three dimensions.},
journal = {Royal Society open science},
volume = {13},
number = {11},
pages = {260853},
pmid = {43012029},
issn = {2054-5703},
abstract = {Quantitative image analysis is central to understanding microbial growth, morphology and spatial organization. However, conventional metrics such as mean intensity or object count often do not capture the complex structural heterogeneity and patterning characteristic of microbial colonies and biofilms. To address this limitation, analysis of biofilm complexity in 3D (ABC3D), an open-source Python framework for automated extraction of fractal, textural and statistical descriptors from volumetric microscopy images, is reported. ABC3D computes a set of parameters including fractal dimension, lacunarity, entropy, grey-level co-occurrence matrix features and relative wavelet sub-band energies from three-dimensional image datasets. ABC3D is demonstrated in Escherichia coli macrocolony biofilms, where the first two principal components captured 75.5% of architectural variance. Nutrient environment, genetic background and their interaction significantly influenced biofilm architecture, indicating that structural responses to nutrient conditions are strain-dependent. Analysis of individual parameters revealed coordinated changes in fractal, textural and spatial-frequency features rather than uniform changes in a single measure of complexity. ABC3D provides researchers with an accessible, quantitative approach to assessing biofilm morphology in microscopy datasets.},
}
RevDate: 2026-11-09
Plant-derived compounds targeting growth, virulence, and biofilm formation in Streptococcus agalactiae.
Fitoterapia pii:S0367-326X(26)00475-2 [Epub ahead of print].
Streptococcus agalactiae (Group B Streptococcus, GBS) is still a major cause of infections in newborns and poses risks due to maternal colonization. It also has economic impacts on livestock and aquaculture. The increasing incidence of resistance to common antibiotics and the lack of a licensed, effective vaccine highlight the urgent need for new ways to prevent and treat these infections. Plant-derived phytochemicals have attracted considerable attention for their wide-ranging antibacterial properties, multiple mechanisms of action, and lower chances of causing resistance. This review summarizes phytochemicals reported over the past decade that inhibit the growth, virulence, and biofilm formation of S. agalactiae. Compounds such as phenylpropanoids, flavonoids, terpenoids, alkaloids, saponins, and essential oils (EOs) show antibacterial, antibiofilm, and anti-virulence effects. They act through several mechanisms: disruption of the cell membrane, inhibition of sortase A and pili production, reduced expression of virulence genes, and modulation of host immune responses. Furthermore, many phytochemicals have additive or synergistic effects when used with traditional antibiotics, helping to restore sensitivity in antibiotic-resistant strains. Overall, the available evidence highlights eugenol as a promising candidate due to its strong effects against bacteria and biofilms, effectiveness against resistant strains, and significant synergistic potential. Other compounds, including cinnamon oil, baicalin, rutin, and certain EOs, also show promise as alternatives or supplements for managing S. agalactiae infections in clinical, veterinary, and aquaculture settings.
Additional Links: PMID-43003145
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43003145,
year = {2026},
author = {Qamsari, MM and Ghaderi, L},
title = {Plant-derived compounds targeting growth, virulence, and biofilm formation in Streptococcus agalactiae.},
journal = {Fitoterapia},
volume = {},
number = {},
pages = {107555},
doi = {10.1016/j.fitote.2026.107555},
pmid = {43003145},
issn = {1873-6971},
abstract = {Streptococcus agalactiae (Group B Streptococcus, GBS) is still a major cause of infections in newborns and poses risks due to maternal colonization. It also has economic impacts on livestock and aquaculture. The increasing incidence of resistance to common antibiotics and the lack of a licensed, effective vaccine highlight the urgent need for new ways to prevent and treat these infections. Plant-derived phytochemicals have attracted considerable attention for their wide-ranging antibacterial properties, multiple mechanisms of action, and lower chances of causing resistance. This review summarizes phytochemicals reported over the past decade that inhibit the growth, virulence, and biofilm formation of S. agalactiae. Compounds such as phenylpropanoids, flavonoids, terpenoids, alkaloids, saponins, and essential oils (EOs) show antibacterial, antibiofilm, and anti-virulence effects. They act through several mechanisms: disruption of the cell membrane, inhibition of sortase A and pili production, reduced expression of virulence genes, and modulation of host immune responses. Furthermore, many phytochemicals have additive or synergistic effects when used with traditional antibiotics, helping to restore sensitivity in antibiotic-resistant strains. Overall, the available evidence highlights eugenol as a promising candidate due to its strong effects against bacteria and biofilms, effectiveness against resistant strains, and significant synergistic potential. Other compounds, including cinnamon oil, baicalin, rutin, and certain EOs, also show promise as alternatives or supplements for managing S. agalactiae infections in clinical, veterinary, and aquaculture settings.},
}
RevDate: 2026-11-09
Effective and sustainable oral biofilm resistance and elimination by means of drug-deliverable chitosan-Sn[2+]-carboxymethyl starch nanocomposite gel.
International journal of biological macromolecules pii:S0141-8130(26)05173-1 [Epub ahead of print].
Oral bacterial biofilm is the primary etiological factors of many dental diseases such as dental caries. Though tropical drug delivery (TDD) can increase drug concentration on tooth surface and promote drug penetrate into biofilm, a TDD scaffold with biofilm targeting and sustainable drug release ability is still highly expected to increase its anti-biofilm performance. In this paper, a drug-deliverable nanocomposite gel was simply prepared via complex coacervation process using carboxymethyl starch (CMS), stannous fluoride (SnF2) and chitosan (CS). After careful tuning of carboxymethyl grafting ratio and precursor concentration, the optimized nanocomposite displayed a core-shell structure with uniform size (400-500 nm). Typical antibiotic minocycline hydrochloride (MH) was well encapsulated in the nanocomposite and exhibited controlled release behavior in a simulated oral condition. Such drug-deliverable nanocomposite gel successfully resisted the erosion of saliva and exhibited enhanced association with S. mutans biofilms following incorporation of CS into its outer layer. S. mutans biofilm no matter pre-formed on hydroxyapatite (HAP) or not could be sustainably eliminated by the nanocomposite and the antibacterial activity (efficacy >80%) remained effective for at least 72 h. Our findings may offer valuable insight into the development of sustained anti-biofilm systems for oral applications.
Additional Links: PMID-43003212
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43003212,
year = {2026},
author = {Hong, L and Zhang, Y and Zhang, Q and Wang, L and Li, Y and Wu, S and Yang, C and Wan, J and Yang, C},
title = {Effective and sustainable oral biofilm resistance and elimination by means of drug-deliverable chitosan-Sn[2+]-carboxymethyl starch nanocomposite gel.},
journal = {International journal of biological macromolecules},
volume = {},
number = {},
pages = {155220},
doi = {10.1016/j.ijbiomac.2026.155220},
pmid = {43003212},
issn = {1879-0003},
abstract = {Oral bacterial biofilm is the primary etiological factors of many dental diseases such as dental caries. Though tropical drug delivery (TDD) can increase drug concentration on tooth surface and promote drug penetrate into biofilm, a TDD scaffold with biofilm targeting and sustainable drug release ability is still highly expected to increase its anti-biofilm performance. In this paper, a drug-deliverable nanocomposite gel was simply prepared via complex coacervation process using carboxymethyl starch (CMS), stannous fluoride (SnF2) and chitosan (CS). After careful tuning of carboxymethyl grafting ratio and precursor concentration, the optimized nanocomposite displayed a core-shell structure with uniform size (400-500 nm). Typical antibiotic minocycline hydrochloride (MH) was well encapsulated in the nanocomposite and exhibited controlled release behavior in a simulated oral condition. Such drug-deliverable nanocomposite gel successfully resisted the erosion of saliva and exhibited enhanced association with S. mutans biofilms following incorporation of CS into its outer layer. S. mutans biofilm no matter pre-formed on hydroxyapatite (HAP) or not could be sustainably eliminated by the nanocomposite and the antibacterial activity (efficacy >80%) remained effective for at least 72 h. Our findings may offer valuable insight into the development of sustained anti-biofilm systems for oral applications.},
}
RevDate: 2026-11-10
Efficacy of chitosan-supported biofilm vaccine against Vibrio parahaemolyticus in Penaeus vannamei.
Developmental and comparative immunology, 185:105762 pii:S0145-305X(26)00218-1 [Epub ahead of print].
Pacific white-leg shrimp, Penaeus vannamei, were immunized by immersion with formalin-inactivated biofilm (BF) and free-cell (FC) preparations of Vibrio parahaemolyticus at 10[6] CFU/mL for 30 days and evaluated for immune responses, biochemical changes, and disease resistance. Biofilm production was optimized using chitosan particles (10 mg/mL) in tryptone soy broth supplemented with 2% NaCl for 72 h, as confirmed by crystal violet staining, viable bacterial enumeration, and FE-SEM. The optimized biofilm was subsequently used to formulate the inactivated BF vaccine. Following challenge with V. parahaemolyticus (10[6] CFU/mL), the BF vaccine provided significantly higher protection, with an RPS of 57.15%, compared with FC vaccine group (42.87%). The BF group also exhibited significantly higher total haemocyte count at 72 h post-infection (hpi). Vaccination modulated key innate immune and antioxidant responses, including respiratory burst activity, superoxide dismutase, prophenoloxidase, and catalase activities. In addition, vaccinated shrimp showed improved biochemical profiles, with lower SGOT and SGPT activities and higher total protein, albumin, and globulin levels compared with controls. Overall, the chitosan-supported biofilm vaccine enhanced immunogenicity, improved physiological condition, and conferred greater protection against V. parahaemolyticus infection than the free-cell vaccine. These findings highlight its potential as an immersion-based vaccination strategy for sustainable disease management in P. vannamei aquaculture.
Additional Links: PMID-43003277
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43003277,
year = {2026},
author = {Thentamilraja, P and Sivasankar, P and Chrisolite, B and Subash, P and Anix Vivek, S and Priyadharshini, M and Dharsika, R and Mohamed Mansoor, M and Selvamagheswaran, M and Mageshkumar, P},
title = {Efficacy of chitosan-supported biofilm vaccine against Vibrio parahaemolyticus in Penaeus vannamei.},
journal = {Developmental and comparative immunology},
volume = {185},
number = {},
pages = {105762},
doi = {10.1016/j.dci.2026.105762},
pmid = {43003277},
issn = {1879-0089},
abstract = {Pacific white-leg shrimp, Penaeus vannamei, were immunized by immersion with formalin-inactivated biofilm (BF) and free-cell (FC) preparations of Vibrio parahaemolyticus at 10[6] CFU/mL for 30 days and evaluated for immune responses, biochemical changes, and disease resistance. Biofilm production was optimized using chitosan particles (10 mg/mL) in tryptone soy broth supplemented with 2% NaCl for 72 h, as confirmed by crystal violet staining, viable bacterial enumeration, and FE-SEM. The optimized biofilm was subsequently used to formulate the inactivated BF vaccine. Following challenge with V. parahaemolyticus (10[6] CFU/mL), the BF vaccine provided significantly higher protection, with an RPS of 57.15%, compared with FC vaccine group (42.87%). The BF group also exhibited significantly higher total haemocyte count at 72 h post-infection (hpi). Vaccination modulated key innate immune and antioxidant responses, including respiratory burst activity, superoxide dismutase, prophenoloxidase, and catalase activities. In addition, vaccinated shrimp showed improved biochemical profiles, with lower SGOT and SGPT activities and higher total protein, albumin, and globulin levels compared with controls. Overall, the chitosan-supported biofilm vaccine enhanced immunogenicity, improved physiological condition, and conferred greater protection against V. parahaemolyticus infection than the free-cell vaccine. These findings highlight its potential as an immersion-based vaccination strategy for sustainable disease management in P. vannamei aquaculture.},
}
RevDate: 2026-11-10
CmpDate: 2026-11-10
Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell-Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis.
Microbial biotechnology, 19(11):.
Biofilm formation and phenotypic drug tolerance contribute to the persistence and treatment challenges associated with Mycobacterium tuberculosis (M. tb). Although M. tb lacks canonical quorum-sensing systems, it exhibits coordinated metabolic and cell-envelope adaptations during biofilm development, suggesting the existence of alternative mechanisms linking cellular metabolism to multicellular behaviour. Here, using a combination of functional genomics, metabolic perturbation and systems-level analyses, we identify riboflavin metabolism as a regulatory axis influencing biofilm development and antimicrobial susceptibility in M. tb. CRISPRi-mediated knockdown and targeted overexpression of riboflavin biosynthetic genes markedly altered biofilm architecture, cell morphology, envelope ultrastructure, membrane permeability and lipid composition, with ribA2 and ribF emerging as potential metabolic vulnerabilities. Exogenous riboflavin enhanced biofilm formation, whereas the riboflavin antimetabolite roseoflavin suppressed this phenotype. Notably, cell-free supernatants from late-stage cultures, accumulated higher levels of riboflavin and restored biofilm formation in a riboflavin-biosynthesis-deficient strain, supporting a diffusible regulatory function beyond the established metabolic roles of riboflavin-derived FMN and FAD. Integrated transcriptomic and lipidomic analyses revealed coordinated reprogramming of biofilm-associated regulatory pathways, cell-envelope lipid metabolism and the F420 biosynthetic network, accompanied by increased susceptibility to anti-tuberculosis drugs. Molecular docking further identified potential interactions of riboflavin with regulatory proteins associated with biofilm and stress-response pathways. Together, these findings establish riboflavin metabolism as a previously underappreciated regulatory layer connecting microbial metabolism, biofilm development, cell-envelope homeostasis and drug tolerance. This metabolic axis provides a potential framework for developing microbial biotechnology-based strategies to interfere with biofilm-associated persistence and improve the efficacy of anti-tuberculosis therapeutics.
Additional Links: PMID-43004729
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43004729,
year = {2026},
author = {Dhanwal, A and Tripathi, V and Sengupta, S and Augustin, L and Bansal, M and Gandotra, S and Agarwal, N and Dey, RJ},
title = {Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell-Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis.},
journal = {Microbial biotechnology},
volume = {19},
number = {11},
pages = {},
pmid = {43004729},
issn = {1751-7915},
support = {BT/RLF/Re-entry/18/2016//Department of Biotechnology, Ministry of Science and Technology, India/ ; 09/1026(16304)/2023-EMR-I//Council of Scientific and Industrial Research, India/ ; },
mesh = {*Biofilms/growth & development/drug effects ; *Mycobacterium tuberculosis/drug effects/metabolism/genetics/physiology ; *Riboflavin/metabolism ; Homeostasis ; Antitubercular Agents/pharmacology ; *Cell Membrane/metabolism ; *Cell Wall/metabolism ; Microbial Sensitivity Tests ; Gene Expression Regulation, Bacterial ; },
abstract = {Biofilm formation and phenotypic drug tolerance contribute to the persistence and treatment challenges associated with Mycobacterium tuberculosis (M. tb). Although M. tb lacks canonical quorum-sensing systems, it exhibits coordinated metabolic and cell-envelope adaptations during biofilm development, suggesting the existence of alternative mechanisms linking cellular metabolism to multicellular behaviour. Here, using a combination of functional genomics, metabolic perturbation and systems-level analyses, we identify riboflavin metabolism as a regulatory axis influencing biofilm development and antimicrobial susceptibility in M. tb. CRISPRi-mediated knockdown and targeted overexpression of riboflavin biosynthetic genes markedly altered biofilm architecture, cell morphology, envelope ultrastructure, membrane permeability and lipid composition, with ribA2 and ribF emerging as potential metabolic vulnerabilities. Exogenous riboflavin enhanced biofilm formation, whereas the riboflavin antimetabolite roseoflavin suppressed this phenotype. Notably, cell-free supernatants from late-stage cultures, accumulated higher levels of riboflavin and restored biofilm formation in a riboflavin-biosynthesis-deficient strain, supporting a diffusible regulatory function beyond the established metabolic roles of riboflavin-derived FMN and FAD. Integrated transcriptomic and lipidomic analyses revealed coordinated reprogramming of biofilm-associated regulatory pathways, cell-envelope lipid metabolism and the F420 biosynthetic network, accompanied by increased susceptibility to anti-tuberculosis drugs. Molecular docking further identified potential interactions of riboflavin with regulatory proteins associated with biofilm and stress-response pathways. Together, these findings establish riboflavin metabolism as a previously underappreciated regulatory layer connecting microbial metabolism, biofilm development, cell-envelope homeostasis and drug tolerance. This metabolic axis provides a potential framework for developing microbial biotechnology-based strategies to interfere with biofilm-associated persistence and improve the efficacy of anti-tuberculosis therapeutics.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development/drug effects
*Mycobacterium tuberculosis/drug effects/metabolism/genetics/physiology
*Riboflavin/metabolism
Homeostasis
Antitubercular Agents/pharmacology
*Cell Membrane/metabolism
*Cell Wall/metabolism
Microbial Sensitivity Tests
Gene Expression Regulation, Bacterial
RevDate: 2026-11-10
CmpDate: 2026-11-10
Translational plausibility of honey-derived antimicrobial biomaterials against biofilm-associated infections.
Frontiers in microbiology, 17:1971766.
Chronic biofilm-associated infections drive antimicrobial resistance (AMR) via prolonged systemic antibiotic therapy that is often ineffective. Honeys from Apis mellifera and stingless bees (Meliponini) exhibit antimicrobial and anti-biofilm activity via complementary mechanisms: osmotic stress, low pH, hydrogen peroxide, methylglyoxal, bee defensin-1, and phenolic and organic compounds. This is most effective when concentrated at the application site. Yet honey therapeutics are often framed as systemic nutraceuticals despite biologically incoherent pharmacokinetics. We propose translational plausibility, an analytical framework built on four interdependent dimensions: spatial, temporal, dose, and compositional coherence that distinguishes microbiologically defensible interventions from speculative ones, applicable beyond honey to natural-product antimicrobials. Applied to honey, the framework identifies topical, localized application as the only translationally coherent clinical route. Reframed as ecological therapeutic biomaterials, honeys address interconnected AMR priorities: disrupting polymicrobial ESKAPE biofilms, preserving distant microbiotas, reducing systemic antibiotic use in wound care, potentiating antibiotics, and supporting stewardship. Planetary health benefits, pollinator conservation, meliponiculture, and equitable access emerge as corollaries, not primary justification.
Additional Links: PMID-43005153
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43005153,
year = {2026},
author = {Machado, A and Majtan, J and Álvarez-Suárez, JM},
title = {Translational plausibility of honey-derived antimicrobial biomaterials against biofilm-associated infections.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1971766},
pmid = {43005153},
issn = {1664-302X},
abstract = {Chronic biofilm-associated infections drive antimicrobial resistance (AMR) via prolonged systemic antibiotic therapy that is often ineffective. Honeys from Apis mellifera and stingless bees (Meliponini) exhibit antimicrobial and anti-biofilm activity via complementary mechanisms: osmotic stress, low pH, hydrogen peroxide, methylglyoxal, bee defensin-1, and phenolic and organic compounds. This is most effective when concentrated at the application site. Yet honey therapeutics are often framed as systemic nutraceuticals despite biologically incoherent pharmacokinetics. We propose translational plausibility, an analytical framework built on four interdependent dimensions: spatial, temporal, dose, and compositional coherence that distinguishes microbiologically defensible interventions from speculative ones, applicable beyond honey to natural-product antimicrobials. Applied to honey, the framework identifies topical, localized application as the only translationally coherent clinical route. Reframed as ecological therapeutic biomaterials, honeys address interconnected AMR priorities: disrupting polymicrobial ESKAPE biofilms, preserving distant microbiotas, reducing systemic antibiotic use in wound care, potentiating antibiotics, and supporting stewardship. Planetary health benefits, pollinator conservation, meliponiculture, and equitable access emerge as corollaries, not primary justification.},
}
RevDate: 2026-11-10
CmpDate: 2026-11-10
Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm-Associated Diseases.
International journal of microbiology, 2026:4040189.
Incomplete bacterial eradication despite appropriate antimicrobial therapy contributes to the progression of some bacterial infections toward chronic or recurrent disease. Beyond genetically encoded antimicrobial resistance, bacterial persistence may be sustained by phenotypically tolerant subpopulations, including persister cells, together with biofilm-associated growth. These states arise within heterogeneous microenvironments shaped by antimicrobial exposure, immune pressure, nutrient and oxygen limitation, and tissue injury. Failure of inflammation to resolve effectively may further promote persistent inflammatory signaling, impaired phagocytic function, localized hypoxia, and extracellular matrix disruption, thereby creating conditions that favor bacterial survival and biofilm stability. This review critically examines the mesenchymal stem cell-derived secretome as a potential host-directed adjunct for persistent and biofilm-associated bacterial infections. Rather than reiterating its antimicrobial, immunomodulatory, and regenerative properties, we integrate direct antibiofilm and antimicrobial evidence with indirect host-mediated mechanisms involving NF-κB modulation, proresolving macrophage responses, efferocytosis, and tissue repair. These actions may converge on host-pathogen niches that sustain bacterial persistence. However, direct evidence that MSC-secretome reduces persister frequency, reverses bacterial dormancy, or eliminates persister populations remains limited. By distinguishing experimentally demonstrated effects from mechanistically inferred actions, this review proposes a host-pathogen ecological framework for evaluating MSC-secretome in bacterial persistence. Current evidence remains predominantly preclinical. Key priorities include improved product standardization and potency assessment, validation in physiologically relevant chronic infection models, and clearer definition of dosing, delivery, and combination strategies with conventional antimicrobials.
Additional Links: PMID-43005746
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43005746,
year = {2026},
author = {Arif, M and Putra, A and Trisnadi, S and Mulyani, SP},
title = {Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm-Associated Diseases.},
journal = {International journal of microbiology},
volume = {2026},
number = {},
pages = {4040189},
pmid = {43005746},
issn = {1687-918X},
abstract = {Incomplete bacterial eradication despite appropriate antimicrobial therapy contributes to the progression of some bacterial infections toward chronic or recurrent disease. Beyond genetically encoded antimicrobial resistance, bacterial persistence may be sustained by phenotypically tolerant subpopulations, including persister cells, together with biofilm-associated growth. These states arise within heterogeneous microenvironments shaped by antimicrobial exposure, immune pressure, nutrient and oxygen limitation, and tissue injury. Failure of inflammation to resolve effectively may further promote persistent inflammatory signaling, impaired phagocytic function, localized hypoxia, and extracellular matrix disruption, thereby creating conditions that favor bacterial survival and biofilm stability. This review critically examines the mesenchymal stem cell-derived secretome as a potential host-directed adjunct for persistent and biofilm-associated bacterial infections. Rather than reiterating its antimicrobial, immunomodulatory, and regenerative properties, we integrate direct antibiofilm and antimicrobial evidence with indirect host-mediated mechanisms involving NF-κB modulation, proresolving macrophage responses, efferocytosis, and tissue repair. These actions may converge on host-pathogen niches that sustain bacterial persistence. However, direct evidence that MSC-secretome reduces persister frequency, reverses bacterial dormancy, or eliminates persister populations remains limited. By distinguishing experimentally demonstrated effects from mechanistically inferred actions, this review proposes a host-pathogen ecological framework for evaluating MSC-secretome in bacterial persistence. Current evidence remains predominantly preclinical. Key priorities include improved product standardization and potency assessment, validation in physiologically relevant chronic infection models, and clearer definition of dosing, delivery, and combination strategies with conventional antimicrobials.},
}
RevDate: 2026-11-10
CmpDate: 2026-11-10
Hops β-Acids Extract: A Novel Toothpaste Ingredient for Superior Biofilm Disruption and More Effective Oral Hygiene.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):1-4.
Thorough removal of oral biofilm remains a challenge even with twice-daily hygiene, due largely to extracellular polymeric substance (EPS) matrix structures in biofilm. EPS provides structural cohesion to biofilm, impeding its removal through mechanical and/or chemical means. Recently, a novel approach to biofilm cleaning was introduced using hops beta (β)-acids (Activ Bio-Cleanser™) as a surfactant in toothpaste formulations. This introductory article highlights evidence presented in this special issue showing the surface-active properties of hops β-acids that allow it to modify the EPS matrix and enhance oral hygiene efficiency. Research presented in this special issue includes mechanistic, ex vivo, and in vivo findings demonstrating the ability of hops β-acids to disrupt biofilm through actions on EPS, enhance removal of adherent biofilm, and improve the accessibility of active ingredients (eg, stannous fluoride). This collective body of research shows the benefits of utilizing hops β-acids as a transformative toothpaste ingredient.
Additional Links: PMID-43007031
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007031,
year = {2026},
author = {St John, S and Reynolds, EC},
title = {Hops β-Acids Extract: A Novel Toothpaste Ingredient for Superior Biofilm Disruption and More Effective Oral Hygiene.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {1-4},
pmid = {43007031},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; *Toothpastes/pharmacology/chemistry ; Humans ; *Oral Hygiene ; *Plant Extracts/pharmacology/therapeutic use ; Surface-Active Agents/pharmacology ; },
abstract = {Thorough removal of oral biofilm remains a challenge even with twice-daily hygiene, due largely to extracellular polymeric substance (EPS) matrix structures in biofilm. EPS provides structural cohesion to biofilm, impeding its removal through mechanical and/or chemical means. Recently, a novel approach to biofilm cleaning was introduced using hops beta (β)-acids (Activ Bio-Cleanser™) as a surfactant in toothpaste formulations. This introductory article highlights evidence presented in this special issue showing the surface-active properties of hops β-acids that allow it to modify the EPS matrix and enhance oral hygiene efficiency. Research presented in this special issue includes mechanistic, ex vivo, and in vivo findings demonstrating the ability of hops β-acids to disrupt biofilm through actions on EPS, enhance removal of adherent biofilm, and improve the accessibility of active ingredients (eg, stannous fluoride). This collective body of research shows the benefits of utilizing hops β-acids as a transformative toothpaste ingredient.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
*Toothpastes/pharmacology/chemistry
Humans
*Oral Hygiene
*Plant Extracts/pharmacology/therapeutic use
Surface-Active Agents/pharmacology
RevDate: 2026-11-10
CmpDate: 2026-11-10
Enhanced Dental Biofilm Removal With Toothpastes Containing Hops β-Acids Extract: In Vivo Studies on Oral Hygiene.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):22-27.
OBJECTIVE: To quantify the dose-dependent cleansing effects of toothpastes formulated with a plant-derived surfactant (hops beta (β)-acids extract) within commercial sodium fluoride (NaF)/pyrophosphate toothpaste matrices on biofilm removal during standard toothbrushing, compared to an otherwise identical placebo control formulation without hops.
METHODS: Two independent, randomized, double-blind, crossover in vivo studies were carried out using digital image analysis (DIA) of biofilm coverage on facial tooth surfaces before and after a single supervised toothbrushing with an assigned toothpaste treatment. Participants from a prequalified team panel at the Procter & Gamble Oral Health Science Center were enrolled. Three toothpaste formulations were evaluated in both studies, all containing 0.243% NaF and pyrophosphate: (1) toothpaste with no hops (placebo control); (2) toothpaste with 0.15% hops β-acids; (3) toothpaste with 0.50% hops β-acids. In study 2, an additional NaF /pyrophosphate toothpaste formulation was included containing 0.50% hops hexahydro-beta acids (HBA), a chemically modified hops extract with reduced surfactant properties. Each toothpaste treatment was used in a single-brushing exercise three times during the study, for a total of nine visits per participant in study 1 and 12 visits per participant in study 2. The use of DIA of biofilm coverage via fluorescence labeling (eg, fluorescein) and long-wave ultraviolet imaging enabled segmentation of pixel classes to quantify biofilm on tooth versus gingival surfaces. Biofilm coverage percentage, spatial distribution (eg, near the gingival margin, interdental areas), and dose-response relationships were evaluated.
RESULTS: Twelve of 13 enrolled participants completed study 1 and 105 brushing sessions were analyzed. In study 2, all 15 enrolled participants completed the trial and 176 brushing sessions were analyzed. Dose-dependent, statistically significant reductions (P < 0.05) in adherent biofilm coverage were observed in both trials following toothbrushing with hops-containing toothpaste formulations, compared with brushing with matched control formulations without hops. Biofilm removal ranged from 80.4% to 85.2% for 0.15% and from 85.4% to 88.8% for 0.50% hops β-acid formulations. The formulation containing a chemically modified hops extract (HBA) demonstrated reduced cleaning efficacy compared with formulations containing native hops β-acids consistent with its reduced hydrophilic-lipophilic balance following hydrogenation. There were no adverse events in either trial, consistent with hops' gentleness on oral soft tissues.
CONCLUSIONS: Incorporation of hops β-acids extract (Activ Bio-Cleanser™) into toothpaste formulations enhances surfactant-driven, physicochemical cleaning behavior, resulting in improved removal of adherent biofilm during toothbrushing.
PRACTICAL IMPLICATIONS: Toothpaste formulated with hops β-acids extract provides greater cleaning via enhanced biofilm removal for patients because of optimized surfactant properties, facilitating more productive daily hygiene.
Additional Links: PMID-43007034
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007034,
year = {2026},
author = {Zsiska, M and Anastasia, MK and Baig, A and St John, S},
title = {Enhanced Dental Biofilm Removal With Toothpastes Containing Hops β-Acids Extract: In Vivo Studies on Oral Hygiene.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {22-27},
pmid = {43007034},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; Humans ; *Toothpastes/therapeutic use ; Double-Blind Method ; *Humulus ; *Plant Extracts/therapeutic use ; Cross-Over Studies ; Sodium Fluoride/therapeutic use ; Female ; Toothbrushing ; Male ; Adult ; Fluoride Treatment ; },
abstract = {OBJECTIVE: To quantify the dose-dependent cleansing effects of toothpastes formulated with a plant-derived surfactant (hops beta (β)-acids extract) within commercial sodium fluoride (NaF)/pyrophosphate toothpaste matrices on biofilm removal during standard toothbrushing, compared to an otherwise identical placebo control formulation without hops.
METHODS: Two independent, randomized, double-blind, crossover in vivo studies were carried out using digital image analysis (DIA) of biofilm coverage on facial tooth surfaces before and after a single supervised toothbrushing with an assigned toothpaste treatment. Participants from a prequalified team panel at the Procter & Gamble Oral Health Science Center were enrolled. Three toothpaste formulations were evaluated in both studies, all containing 0.243% NaF and pyrophosphate: (1) toothpaste with no hops (placebo control); (2) toothpaste with 0.15% hops β-acids; (3) toothpaste with 0.50% hops β-acids. In study 2, an additional NaF /pyrophosphate toothpaste formulation was included containing 0.50% hops hexahydro-beta acids (HBA), a chemically modified hops extract with reduced surfactant properties. Each toothpaste treatment was used in a single-brushing exercise three times during the study, for a total of nine visits per participant in study 1 and 12 visits per participant in study 2. The use of DIA of biofilm coverage via fluorescence labeling (eg, fluorescein) and long-wave ultraviolet imaging enabled segmentation of pixel classes to quantify biofilm on tooth versus gingival surfaces. Biofilm coverage percentage, spatial distribution (eg, near the gingival margin, interdental areas), and dose-response relationships were evaluated.
RESULTS: Twelve of 13 enrolled participants completed study 1 and 105 brushing sessions were analyzed. In study 2, all 15 enrolled participants completed the trial and 176 brushing sessions were analyzed. Dose-dependent, statistically significant reductions (P < 0.05) in adherent biofilm coverage were observed in both trials following toothbrushing with hops-containing toothpaste formulations, compared with brushing with matched control formulations without hops. Biofilm removal ranged from 80.4% to 85.2% for 0.15% and from 85.4% to 88.8% for 0.50% hops β-acid formulations. The formulation containing a chemically modified hops extract (HBA) demonstrated reduced cleaning efficacy compared with formulations containing native hops β-acids consistent with its reduced hydrophilic-lipophilic balance following hydrogenation. There were no adverse events in either trial, consistent with hops' gentleness on oral soft tissues.
CONCLUSIONS: Incorporation of hops β-acids extract (Activ Bio-Cleanser™) into toothpaste formulations enhances surfactant-driven, physicochemical cleaning behavior, resulting in improved removal of adherent biofilm during toothbrushing.
PRACTICAL IMPLICATIONS: Toothpaste formulated with hops β-acids extract provides greater cleaning via enhanced biofilm removal for patients because of optimized surfactant properties, facilitating more productive daily hygiene.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
Humans
*Toothpastes/therapeutic use
Double-Blind Method
*Humulus
*Plant Extracts/therapeutic use
Cross-Over Studies
Sodium Fluoride/therapeutic use
Female
Toothbrushing
Male
Adult
Fluoride Treatment
RevDate: 2026-11-10
CmpDate: 2026-11-10
Impact of Hops β-Acids Extract on eDNA in Oral Biofilm Extracellular Polymeric Substances Revealed by Molecular Probes, Microarray Polymer Profiling, and Scanning Electron Microscopy.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):28-34.
OBJECTIVE: To evaluate the effects of stannous fluoride (SnF2) toothpaste formulations, including one containing hops beta (β)-acids extract, on extracellular DNA (eDNA) within the extracellular polymeric substance (EPS) matrix of human saliva-derived in vitro oral biofilms.
METHODS: Disruption was evaluated using DNA-specific antibodies and high-throughput microarray polymer profiling, with disruption detected by reduction in antibody binding to microarrays (epitope depletion). The impact of different toothpaste formulations, including one with hops β-acids, was analyzed using scanning electron microscopy (SEM) imaging. In vitro-derived biofilms were cultured from pooled human saliva (from healthy volunteers) and printed onto nitrocellulose microarrays. Epitope depletion was used to assess the impact of five different SnF2 toothpaste compositions, including one containing hops β-acids, and a sodium monofluorophosphate toothpaste on the overall abundance and density of oral biofilm DNA within the EPS matrix of in vitro oral biofilms.
RESULTS: A toothpaste composition containing SnF2-gluconate/citrate-hops (0.454% SnF2) impacted both z-form DNA (z-DNA) and single-stranded DNA (ss-DNA) epitopes in oral biofilm EPS. Specifically, this composition elicited the greatest reduction in z-DNA present in oral biofilm EPS across all formulations tested (P < 0.05, aerobic and anaerobic biofilms). This treatment composition also visually reduced the abundance and density of the EPS matrix.
CONCLUSIONS: Addition of hops β-acids drives the selective depletion of z-DNA epitopes, consistent with a model in which hops-containing formulations modify the EPS matrix through physicochemical interactions that impact specific structural domains, thereby contributing to changes in biofilm integrity and organization, observed through SEM.
CLINICAL IMPLICATIONS: These findings provide a molecular-level rationale for formulation strategies that disrupt the EPS of adherent oral biofilms through surfactant-based modification and an experimental framework to determine which components of the EPS are most disrupted.
Additional Links: PMID-43007035
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007035,
year = {2026},
author = {Yau, HCL and Goldberg-Cavalleri, A and Muñoz-Bodnar, A and Rice, H and Lelėnaitė, I and Fletcher, CS and Lant, NJ and Jakubovics, NS and St John, S and Strand, R and Willats, WGT},
title = {Impact of Hops β-Acids Extract on eDNA in Oral Biofilm Extracellular Polymeric Substances Revealed by Molecular Probes, Microarray Polymer Profiling, and Scanning Electron Microscopy.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {28-34},
pmid = {43007035},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; Humans ; Microscopy, Electron, Scanning ; *Toothpastes/pharmacology/chemistry ; Tin Fluorides/pharmacology ; *Extracellular Polymeric Substance Matrix/drug effects ; Saliva/microbiology ; *Plant Extracts/pharmacology ; Extrachromosomal DNA ; Gluconates/pharmacology ; },
abstract = {OBJECTIVE: To evaluate the effects of stannous fluoride (SnF2) toothpaste formulations, including one containing hops beta (β)-acids extract, on extracellular DNA (eDNA) within the extracellular polymeric substance (EPS) matrix of human saliva-derived in vitro oral biofilms.
METHODS: Disruption was evaluated using DNA-specific antibodies and high-throughput microarray polymer profiling, with disruption detected by reduction in antibody binding to microarrays (epitope depletion). The impact of different toothpaste formulations, including one with hops β-acids, was analyzed using scanning electron microscopy (SEM) imaging. In vitro-derived biofilms were cultured from pooled human saliva (from healthy volunteers) and printed onto nitrocellulose microarrays. Epitope depletion was used to assess the impact of five different SnF2 toothpaste compositions, including one containing hops β-acids, and a sodium monofluorophosphate toothpaste on the overall abundance and density of oral biofilm DNA within the EPS matrix of in vitro oral biofilms.
RESULTS: A toothpaste composition containing SnF2-gluconate/citrate-hops (0.454% SnF2) impacted both z-form DNA (z-DNA) and single-stranded DNA (ss-DNA) epitopes in oral biofilm EPS. Specifically, this composition elicited the greatest reduction in z-DNA present in oral biofilm EPS across all formulations tested (P < 0.05, aerobic and anaerobic biofilms). This treatment composition also visually reduced the abundance and density of the EPS matrix.
CONCLUSIONS: Addition of hops β-acids drives the selective depletion of z-DNA epitopes, consistent with a model in which hops-containing formulations modify the EPS matrix through physicochemical interactions that impact specific structural domains, thereby contributing to changes in biofilm integrity and organization, observed through SEM.
CLINICAL IMPLICATIONS: These findings provide a molecular-level rationale for formulation strategies that disrupt the EPS of adherent oral biofilms through surfactant-based modification and an experimental framework to determine which components of the EPS are most disrupted.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
Humans
Microscopy, Electron, Scanning
*Toothpastes/pharmacology/chemistry
Tin Fluorides/pharmacology
*Extracellular Polymeric Substance Matrix/drug effects
Saliva/microbiology
*Plant Extracts/pharmacology
Extrachromosomal DNA
Gluconates/pharmacology
RevDate: 2026-11-10
CmpDate: 2026-11-10
Stannous Fluoride Deposition Into Plaque Biofilm: Effects of Formulation Chemistry and Hops β-Acids Extract Dispersion.
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 47(Suppl 3):35-43.
OBJECTIVE: To evaluate how surfactant-mediated biofilm disruption by hops beta (β)-acids extract influences stannous fluoride (SnF2) penetration and interaction with extracellular metabolites, including lipopolysaccharide (LPS).
METHODS: In two studies, oral biofilms were formed in vivo on artificial enamel surfaces mounted in dental appliances worn by volunteers and subsequently treated ex vivo under controlled conditions. Across the studies, biofilms were treated with supernatants of various commercial 0.454% SnF2 dentifrices containing: (1) pyrophosphate; (2) potassium nitrate (KNO3) and pyrophosphate; (3) tripolyphosphate; and (4) gluconate/citrate-stabilized 0.454% SnF2 (Crest) with and without hops β-acids extract (Activ Bio-Cleanser™). Both studies used phosphate-buffered saline as a negative control (NC). Confocal laser scanning microscopy with component-specific fluorescent probes was used to quantify Sn and LPS distribution relative to bacterial biomass, biofilm thickness, and extracellular polymeric substance (EPS) structure. Image analysis was used to quantify Sn and LPS signal within bacterial regions, normalized to bacterial volume or area; statistical comparisons were made across conditions.
RESULTS: SnF2 uptake and penetration varied significantly across formulations. In study 1, the rank order from greatest to least for Sn deposition and LPS neutralization was: gluconate/citrate > KNO3 + pyro > pyro > NC (P < 0.05 between groups). In study 2, the rank order from greatest to least was: gluconate/citrate + hops > gluconate/citrate > tripolyphosphate and KNO3 + pyro > NC (P < 0.05 between groups). Some stabilized SnF2 systems exhibited limited penetration, consistent with diffusion barriers imposed by dense EPS matrices or over-stabilization reducing bioavailability. Gluconate/ citrate-stabilized SnF2-only treated biofilms showed higher deposition per unit bacteria than other SnF2 technologies but uniformly exhibited the majority of uptake in surface regions. In the formulation containing both hops and SnF2, increased Sn penetration and reduced detectable biofilm-associated LPS was observed, consistent with enhanced access of SnF2 to extracellular plaque components following surfactant-enabled biofilm modification. In this case, Sn penetration achieved high relative deposition per unit bacteria in the treated regions throughout the biofilm.
CONCLUSIONS: Hops β-acids extract acts as a co-surfactant in toothpaste, capable of modifying EPS structure to improve accessibility and interaction of SnF2 with extracellular metabolites within oral biofilms. The observed changes in Sn penetration and biofilm-associated, extracellular LPS are consistent with enhanced cleaning with reduced concentration of known tissue irritants.
CLINICAL IMPLICATIONS: These findings provide a mechanistic rationale for formulation strategies that enhance SnF2 accessibility within adherent oral biofilms through surfactant-based modification of EPS supporting more efficient biofilm management during oral hygiene and providing a basis for selecting toothpastes based on their efficacy.
Additional Links: PMID-43007036
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43007036,
year = {2026},
author = {St John, S and Strand, R},
title = {Stannous Fluoride Deposition Into Plaque Biofilm: Effects of Formulation Chemistry and Hops β-Acids Extract Dispersion.},
journal = {Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)},
volume = {47},
number = {Suppl 3},
pages = {35-43},
pmid = {43007036},
issn = {2158-1797},
mesh = {*Biofilms/drug effects ; *Tin Fluorides/pharmacology/pharmacokinetics ; Humans ; Lipopolysaccharides/metabolism ; Polyphosphates/pharmacology ; *Dental Plaque/microbiology/drug therapy ; *Plant Extracts/pharmacology ; Potassium Compounds/pharmacology ; Gluconates/pharmacology ; Diphosphates/pharmacology ; Microscopy, Confocal ; Fluoride Treatment ; Surface-Active Agents/pharmacology ; Nitrates ; Phosphates ; },
abstract = {OBJECTIVE: To evaluate how surfactant-mediated biofilm disruption by hops beta (β)-acids extract influences stannous fluoride (SnF2) penetration and interaction with extracellular metabolites, including lipopolysaccharide (LPS).
METHODS: In two studies, oral biofilms were formed in vivo on artificial enamel surfaces mounted in dental appliances worn by volunteers and subsequently treated ex vivo under controlled conditions. Across the studies, biofilms were treated with supernatants of various commercial 0.454% SnF2 dentifrices containing: (1) pyrophosphate; (2) potassium nitrate (KNO3) and pyrophosphate; (3) tripolyphosphate; and (4) gluconate/citrate-stabilized 0.454% SnF2 (Crest) with and without hops β-acids extract (Activ Bio-Cleanser™). Both studies used phosphate-buffered saline as a negative control (NC). Confocal laser scanning microscopy with component-specific fluorescent probes was used to quantify Sn and LPS distribution relative to bacterial biomass, biofilm thickness, and extracellular polymeric substance (EPS) structure. Image analysis was used to quantify Sn and LPS signal within bacterial regions, normalized to bacterial volume or area; statistical comparisons were made across conditions.
RESULTS: SnF2 uptake and penetration varied significantly across formulations. In study 1, the rank order from greatest to least for Sn deposition and LPS neutralization was: gluconate/citrate > KNO3 + pyro > pyro > NC (P < 0.05 between groups). In study 2, the rank order from greatest to least was: gluconate/citrate + hops > gluconate/citrate > tripolyphosphate and KNO3 + pyro > NC (P < 0.05 between groups). Some stabilized SnF2 systems exhibited limited penetration, consistent with diffusion barriers imposed by dense EPS matrices or over-stabilization reducing bioavailability. Gluconate/ citrate-stabilized SnF2-only treated biofilms showed higher deposition per unit bacteria than other SnF2 technologies but uniformly exhibited the majority of uptake in surface regions. In the formulation containing both hops and SnF2, increased Sn penetration and reduced detectable biofilm-associated LPS was observed, consistent with enhanced access of SnF2 to extracellular plaque components following surfactant-enabled biofilm modification. In this case, Sn penetration achieved high relative deposition per unit bacteria in the treated regions throughout the biofilm.
CONCLUSIONS: Hops β-acids extract acts as a co-surfactant in toothpaste, capable of modifying EPS structure to improve accessibility and interaction of SnF2 with extracellular metabolites within oral biofilms. The observed changes in Sn penetration and biofilm-associated, extracellular LPS are consistent with enhanced cleaning with reduced concentration of known tissue irritants.
CLINICAL IMPLICATIONS: These findings provide a mechanistic rationale for formulation strategies that enhance SnF2 accessibility within adherent oral biofilms through surfactant-based modification of EPS supporting more efficient biofilm management during oral hygiene and providing a basis for selecting toothpastes based on their efficacy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/drug effects
*Tin Fluorides/pharmacology/pharmacokinetics
Humans
Lipopolysaccharides/metabolism
Polyphosphates/pharmacology
*Dental Plaque/microbiology/drug therapy
*Plant Extracts/pharmacology
Potassium Compounds/pharmacology
Gluconates/pharmacology
Diphosphates/pharmacology
Microscopy, Confocal
Fluoride Treatment
Surface-Active Agents/pharmacology
Nitrates
Phosphates
RevDate: 2026-11-07
Effects of cathodic polarization and coating defect size on SRB biofilm-associated corrosion of Q355 steel.
Bioelectrochemistry (Amsterdam, Netherlands), 174:109489 pii:S1567-5394(26)00275-6 [Epub ahead of print].
This study investigates the effect of cathodic polarization and coating defect size on sulfate-reducing bacteria (SRB)-associated corrosion of Q355 steel protected by an epoxy primer/polyurethane topcoat system. Artificial pinhole defects with diameters of 0.2, 0.5 and 1 mm were introduced on the coating, and the corrosion behavior was evaluated via corrosion morphology observation at defect sites, electrochemical measurements and characterization of microbial adhesion. In the absence of cathodic polarization, larger defects facilitated SRB biofilm formation and intensified localized corrosion. After 14 days of cathodic polarization application, the cathodic polarization at -0.95 VCSE provided the most effective protection for small defects, the bacterial adhesion was inhibited and protective calcareous deposits were formed. For specimens under cathodic protection potentials of -0.85 VCSE and - 0.95 VCSE, no cathodic disbondment was observed after 14 days of polarization. When the polarization period was extended to 60 days, cathodic disbondment propagated radially outward from the central artificial defect on the specimen surface. The cathodic potential of -0.95 VCSE led to more coating damage propagation than those under non-polarized and - 0.85 VCSE conditions, and 0.2 mm initial defects yielded higher area expansion ratios at equal polarization potentials.
Additional Links: PMID-42998411
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42998411,
year = {2026},
author = {Wang, Y and Guan, F and Zhai, X and Guo, D and Zhao, Z},
title = {Effects of cathodic polarization and coating defect size on SRB biofilm-associated corrosion of Q355 steel.},
journal = {Bioelectrochemistry (Amsterdam, Netherlands)},
volume = {174},
number = {},
pages = {109489},
doi = {10.1016/j.bioelechem.2026.109489},
pmid = {42998411},
issn = {1878-562X},
abstract = {This study investigates the effect of cathodic polarization and coating defect size on sulfate-reducing bacteria (SRB)-associated corrosion of Q355 steel protected by an epoxy primer/polyurethane topcoat system. Artificial pinhole defects with diameters of 0.2, 0.5 and 1 mm were introduced on the coating, and the corrosion behavior was evaluated via corrosion morphology observation at defect sites, electrochemical measurements and characterization of microbial adhesion. In the absence of cathodic polarization, larger defects facilitated SRB biofilm formation and intensified localized corrosion. After 14 days of cathodic polarization application, the cathodic polarization at -0.95 VCSE provided the most effective protection for small defects, the bacterial adhesion was inhibited and protective calcareous deposits were formed. For specimens under cathodic protection potentials of -0.85 VCSE and - 0.95 VCSE, no cathodic disbondment was observed after 14 days of polarization. When the polarization period was extended to 60 days, cathodic disbondment propagated radially outward from the central artificial defect on the specimen surface. The cathodic potential of -0.95 VCSE led to more coating damage propagation than those under non-polarized and - 0.85 VCSE conditions, and 0.2 mm initial defects yielded higher area expansion ratios at equal polarization potentials.},
}
RevDate: 2026-11-08
Biofilm phenotype-associated expression of icaA, icaD, sarA, and agrA in clinical Staphylococcus aureus isolates.
Microbial pathogenesis, 222:108917 pii:S0882-4010(26)00643-1 [Epub ahead of print].
The ability of Staphylococcus aureus to form biofilms is one of the major mechanisms for the persistence of these bacteria in clinical environments. However, the relationships between the level of biofilm formation, transcriptional control and methicillin resistance in S. aureus strains are not completely known. The aim of this study was to investigate the association between biofilm formation phenotype, expression of icaA, icaD, sarA, and agrA genes, and phenotypic methicillin-resistance status in clinical S. aureus strains. In total, 150 strains of S. aureus were tested for their ability to form biofilms in a microtiter plate assay, and the results demonstrated the presence of 16.7% non-producers, 28.0% weak, 32.0% moderate, and 23.3% strong biofilm producers. In turn, 24 strains, six for each biofilm phenotype, were used to evaluate the relative expression of the mentioned genes by means of quantitative real-time PCR. Normalization of the expression was performed using gyrB gene by the comparative Ct method. The relative expression of icaA, icaD, and sarA genes increased progressively depending on the level of biofilm production, while the expression of agrA decreased. Strong biofilm producers possessed the relative expression levels equal to 4.702, 5.582, 2.786, and 0.508 for icaA, icaD, sarA, and agrA genes, respectively. Biofilm phenotype categories were significantly associated with differential expression patterns of the studied genes, as indicated by the high partial eta-squared values (0.966, 0.948, 0.887, and 0.787 for icaA, icaD, sarA, and agrA, respectively), with statistically significant differences among biofilm phenotype groups (p < 0.001). No statistically detectable independent effect of phenotypic methicillin-resistance status on gene expression was observed in the 24-isolate qPCR subset, and no statistically significant interaction between biofilm phenotype and phenotypic methicillin-resistance status was detected.
Additional Links: PMID-42998811
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42998811,
year = {2026},
author = {Mohsin, AS and Ali, HM and Hussein, SI},
title = {Biofilm phenotype-associated expression of icaA, icaD, sarA, and agrA in clinical Staphylococcus aureus isolates.},
journal = {Microbial pathogenesis},
volume = {222},
number = {},
pages = {108917},
doi = {10.1016/j.micpath.2026.108917},
pmid = {42998811},
issn = {1096-1208},
abstract = {The ability of Staphylococcus aureus to form biofilms is one of the major mechanisms for the persistence of these bacteria in clinical environments. However, the relationships between the level of biofilm formation, transcriptional control and methicillin resistance in S. aureus strains are not completely known. The aim of this study was to investigate the association between biofilm formation phenotype, expression of icaA, icaD, sarA, and agrA genes, and phenotypic methicillin-resistance status in clinical S. aureus strains. In total, 150 strains of S. aureus were tested for their ability to form biofilms in a microtiter plate assay, and the results demonstrated the presence of 16.7% non-producers, 28.0% weak, 32.0% moderate, and 23.3% strong biofilm producers. In turn, 24 strains, six for each biofilm phenotype, were used to evaluate the relative expression of the mentioned genes by means of quantitative real-time PCR. Normalization of the expression was performed using gyrB gene by the comparative Ct method. The relative expression of icaA, icaD, and sarA genes increased progressively depending on the level of biofilm production, while the expression of agrA decreased. Strong biofilm producers possessed the relative expression levels equal to 4.702, 5.582, 2.786, and 0.508 for icaA, icaD, sarA, and agrA genes, respectively. Biofilm phenotype categories were significantly associated with differential expression patterns of the studied genes, as indicated by the high partial eta-squared values (0.966, 0.948, 0.887, and 0.787 for icaA, icaD, sarA, and agrA, respectively), with statistically significant differences among biofilm phenotype groups (p < 0.001). No statistically detectable independent effect of phenotypic methicillin-resistance status on gene expression was observed in the 24-isolate qPCR subset, and no statistically significant interaction between biofilm phenotype and phenotypic methicillin-resistance status was detected.},
}
RevDate: 2026-11-08
CmpDate: 2026-11-08
Estuarine Biofilm Communities Adapt to Changing Conditions While Retaining Crucial Pollutant-Combatting Functions.
Environmental microbiology, 28(11):.
Industrialization has increased the influx of toxicants into intertidal and estuarine ecosystems. Intertidal sediments are exposed to heavy metals, polycyclic aromatic hydrocarbons, pesticides, and other xenobiotics through effluents, shipping, spillages, battery disposal, and agricultural run-off. Pollutants accumulate in sediments, disrupting nutrient cycling and impairing primary productivity, thereby threatening coastal food webs. Sediment-bound biofilms or microphytobenthos are complex assemblages of microorganisms embedded in extracellular polymeric substances and play vital roles in biogeochemical cycling, sediment stabilization, and pollutant remediation. Their functional responses to contaminant exposure remain poorly understood, particularly in tropical estuaries. Biofilms from contaminated estuarine sediments were analysed using metagenome-assembled genomes (MAGs) and genome-scale metabolic models (GEMs) in a paired field-laboratory approach. Greater metabolic diversity of field biofilms indicated broader functional capacities to sustain pollutant exposure. Conserved genes linked to organic compound degradation and metal transport co-occurred across MAGs, suggesting integrated detoxification strategies. GEM-based simulations revealed metabolic cross-feeding underlying contaminant transformation. Culture conditions shaped microbial succession and ecological roles, yet core pollutant degradation and nutrient processing functions persisted, operated by dominant taxa. Microphytobenthic experimental studies rely on laboratory-cultured communities derived from field-collected samples. Contrasting community dynamics and altered metabolism due to 'bottle effect' are foundational for correctly interpreting laboratory-based experimental outcomes.
Additional Links: PMID-43000198
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43000198,
year = {2026},
author = {Mukherjee, M and Roy, AR and Seal, P and Islam, KH and Sarkar, A and Karmakar, S and Mukherjee, J and Das, R},
title = {Estuarine Biofilm Communities Adapt to Changing Conditions While Retaining Crucial Pollutant-Combatting Functions.},
journal = {Environmental microbiology},
volume = {28},
number = {11},
pages = {},
doi = {10.1111/1462-2920.70455},
pmid = {43000198},
issn = {1462-2920},
support = {SCP/2022/000739//Anusandhan National Research Foundation (ANRF)/ ; 09/096(0997)/2019-EMR-I//Council of Scientific and Industrial Research, India/ ; RFD/2022-23/GEN/ENV/314//Indian Council of Social Science Research/ ; Faculty Recharge Programme (FRP-74)//University Grants Commission/ ; 72 (Sanc.)-BT/P/Budget/RD-34/2017//Department of Biotechnology, Government of West Bengal/ ; },
mesh = {*Biofilms/growth & development ; *Geologic Sediments/microbiology/chemistry ; *Estuaries ; *Water Pollutants, Chemical/metabolism ; Biodegradation, Environmental ; *Bacteria/metabolism/genetics/classification ; Metagenome ; },
abstract = {Industrialization has increased the influx of toxicants into intertidal and estuarine ecosystems. Intertidal sediments are exposed to heavy metals, polycyclic aromatic hydrocarbons, pesticides, and other xenobiotics through effluents, shipping, spillages, battery disposal, and agricultural run-off. Pollutants accumulate in sediments, disrupting nutrient cycling and impairing primary productivity, thereby threatening coastal food webs. Sediment-bound biofilms or microphytobenthos are complex assemblages of microorganisms embedded in extracellular polymeric substances and play vital roles in biogeochemical cycling, sediment stabilization, and pollutant remediation. Their functional responses to contaminant exposure remain poorly understood, particularly in tropical estuaries. Biofilms from contaminated estuarine sediments were analysed using metagenome-assembled genomes (MAGs) and genome-scale metabolic models (GEMs) in a paired field-laboratory approach. Greater metabolic diversity of field biofilms indicated broader functional capacities to sustain pollutant exposure. Conserved genes linked to organic compound degradation and metal transport co-occurred across MAGs, suggesting integrated detoxification strategies. GEM-based simulations revealed metabolic cross-feeding underlying contaminant transformation. Culture conditions shaped microbial succession and ecological roles, yet core pollutant degradation and nutrient processing functions persisted, operated by dominant taxa. Microphytobenthic experimental studies rely on laboratory-cultured communities derived from field-collected samples. Contrasting community dynamics and altered metabolism due to 'bottle effect' are foundational for correctly interpreting laboratory-based experimental outcomes.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Geologic Sediments/microbiology/chemistry
*Estuaries
*Water Pollutants, Chemical/metabolism
Biodegradation, Environmental
*Bacteria/metabolism/genetics/classification
Metagenome
RevDate: 2026-11-09
CmpDate: 2026-11-09
Genome-wide screening reveals opposing roles for central metabolism in planktonic and biofilm survival of Salmonella under combined limonene and heat treatment.
Biofilm, 12:100406.
Salmonella enterica serovar Typhimurium is a major cause of foodborne illness and remains a persistent challenge for food safety due to its ability to survive in both planktonic and biofilm-associated states along the farm-to-fork chain. While conventional control strategies rely on chemical preservatives and thermal treatments, increasing consumer demand for clean-label foods has driven interest in natural antimicrobials such as essential oils, of which limonene is a major citrus-derived component. However, the cellular mechanisms underlying Salmonella's response to these strategies, and whether it differs between free and nanoemulsified formulations, or between planktonic and biofilm lifestyles, has not been defined. In this study, we applied an unbiased, transposon-directed insertion-site sequencing (TraDIS-Xpress) to systematically identify every gene and pathway contributing to the survival of S. Typhimurium when exposed to limonene in both free and nanoemulsion, across different inactivation temperatures and in both planktonic culture and established biofilms. We show that inactivation of genes involved in central metabolism and oxidative stress responses improves planktonic survival of heat treatment, but that this protective effect is lost under nanoemulsified limonene at 54 °C, a condition under which survival was not detected. Interestingly, these same genes and pathways were essential for the survival of established biofilms irrespective of heat or oil treatment, revealing that the genetic determinants of susceptibility invert between the two lifestyles. Together, these findings provide a genome-wide view of the genetic architecture underpinning Salmonella survival in response to limonene and heat and reveal that planktonic and biofilm cells have opposite vulnerabilities, meaning that effective decontamination strategies must be tailored to the physiological state in which Salmonella persists.
Additional Links: PMID-43001264
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43001264,
year = {2026},
author = {Holden, ER and Guillén, S and Yasir, M and Perez-Moral, N and Narbad, A and Palop, A and Webber, MA and Garcia-Gutierrez, E},
title = {Genome-wide screening reveals opposing roles for central metabolism in planktonic and biofilm survival of Salmonella under combined limonene and heat treatment.},
journal = {Biofilm},
volume = {12},
number = {},
pages = {100406},
pmid = {43001264},
issn = {2590-2075},
abstract = {Salmonella enterica serovar Typhimurium is a major cause of foodborne illness and remains a persistent challenge for food safety due to its ability to survive in both planktonic and biofilm-associated states along the farm-to-fork chain. While conventional control strategies rely on chemical preservatives and thermal treatments, increasing consumer demand for clean-label foods has driven interest in natural antimicrobials such as essential oils, of which limonene is a major citrus-derived component. However, the cellular mechanisms underlying Salmonella's response to these strategies, and whether it differs between free and nanoemulsified formulations, or between planktonic and biofilm lifestyles, has not been defined. In this study, we applied an unbiased, transposon-directed insertion-site sequencing (TraDIS-Xpress) to systematically identify every gene and pathway contributing to the survival of S. Typhimurium when exposed to limonene in both free and nanoemulsion, across different inactivation temperatures and in both planktonic culture and established biofilms. We show that inactivation of genes involved in central metabolism and oxidative stress responses improves planktonic survival of heat treatment, but that this protective effect is lost under nanoemulsified limonene at 54 °C, a condition under which survival was not detected. Interestingly, these same genes and pathways were essential for the survival of established biofilms irrespective of heat or oil treatment, revealing that the genetic determinants of susceptibility invert between the two lifestyles. Together, these findings provide a genome-wide view of the genetic architecture underpinning Salmonella survival in response to limonene and heat and reveal that planktonic and biofilm cells have opposite vulnerabilities, meaning that effective decontamination strategies must be tailored to the physiological state in which Salmonella persists.},
}
RevDate: 2026-11-09
Formononetin disrupts MRSA biofilm via potential SarA-associated regulatory modulation.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 205:120028 pii:S0753-3322(26)01064-4 [Epub ahead of print].
Biofilm formation is a crucial aspect of Methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis and contributes to its resistance against conventional antibiotics. This study reports the identification of a bioactive molecule, formononetin, from Glycyrrhiza glabra L., that is effective against MRSA. Formononetin significantly inhibited biofilm formation, disrupted sessile biofilm, and reduced the hemolytic activity of MRSA in a dose-dependent manner. Formononetin also increased the survival rate of MRSA-infected G. mellonella larvae by decreasing the bacterial load and increasing melanization. The combination of formononetin with antibiotics, like oxacillin, ampicillin, and streptomycin, showed a fractional inhibitory concentration index (FICI) ≤ 0.5, which indicates a synergistic effect. Molecular docking studies showed formononetin can bind to the global regulator, SarA, with an estimated binding score of -6.176 kcal/mol. Further, the aspartate residue (D20) in SarA was identified as a binding site for formononetin. Microscale thermophoresis and electrophoretic mobility shift assay of the SarAD20A mutant showed reduced affinity towards formononetin without affecting its DNA-binding activity compared to its wild-type counterpart. Further, proteomic profiling of MRSA upon treatment with formononetin showed significant modulation of SarA and SarA-related pathways, such as scdA and agrC. Our findings suggest that formononetin holds promise as a natural agent for combating MRSA biofilm.
Additional Links: PMID-43002829
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43002829,
year = {2026},
author = {Borah, A and Jena, JP and Vijay, M and Okram, A and M, G and P, N and Barbuddhe, SB and Hegde, NR and Rawool, DB and Srivastava, A},
title = {Formononetin disrupts MRSA biofilm via potential SarA-associated regulatory modulation.},
journal = {Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
volume = {205},
number = {},
pages = {120028},
doi = {10.1016/j.biopha.2026.120028},
pmid = {43002829},
issn = {1950-6007},
abstract = {Biofilm formation is a crucial aspect of Methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis and contributes to its resistance against conventional antibiotics. This study reports the identification of a bioactive molecule, formononetin, from Glycyrrhiza glabra L., that is effective against MRSA. Formononetin significantly inhibited biofilm formation, disrupted sessile biofilm, and reduced the hemolytic activity of MRSA in a dose-dependent manner. Formononetin also increased the survival rate of MRSA-infected G. mellonella larvae by decreasing the bacterial load and increasing melanization. The combination of formononetin with antibiotics, like oxacillin, ampicillin, and streptomycin, showed a fractional inhibitory concentration index (FICI) ≤ 0.5, which indicates a synergistic effect. Molecular docking studies showed formononetin can bind to the global regulator, SarA, with an estimated binding score of -6.176 kcal/mol. Further, the aspartate residue (D20) in SarA was identified as a binding site for formononetin. Microscale thermophoresis and electrophoretic mobility shift assay of the SarAD20A mutant showed reduced affinity towards formononetin without affecting its DNA-binding activity compared to its wild-type counterpart. Further, proteomic profiling of MRSA upon treatment with formononetin showed significant modulation of SarA and SarA-related pathways, such as scdA and agrC. Our findings suggest that formononetin holds promise as a natural agent for combating MRSA biofilm.},
}
RevDate: 2026-11-09
Overcoming hurdles in developing a reliable and reproducible biofilm model of Malassezia applied to M. furfur, M. pachydermatis, M. sympodialis and M. slooffiae.
Journal de mycologie medicale, 37(1):101669 pii:S1156-5233(26)00070-3 [Epub ahead of print].
Yeasts belonging to the Malassezia genus represent the predominant fungi of the human skin microbiota. Their involvement in various pathologies is notably associated with their ability to form biofilms. However, knowledge regarding these structures remains limited due to culture constraints related to lipid dependence. This study aimed to develop a reliable in vitro model for studying mono- and multispecies Malassezia biofilms, using M. furfur, M. pachydermatis, M. sympodialis, and M. slooffiae. To overcome the natural aggregation of cells, a sonication protocol was optimized to obtain homogeneous suspensions without affecting cell viability. A correlation between optical density at 600 nm and cell concentration enabled the rapid standardization of Malassezia inocula. The comparative study of planktonic growth kinetics revealed generation times ranging from 7 to 15 h depending on the species, with M. sympodialis exhibiting the fastest growth. No difference was observed for M. furfur and M. sympodialis grown in single or mixed culture in planktonic conditions. Biofilm development was monitored over 168 h by quantifying biomass and metabolic activity. M. furfur, M. pachydermatis, and M. sympodialis showed a significant increase in both parameters, typical of mature biofilms. In contrast, M. slooffiae exhibited an increase in metabolic activity without a significant increase in biomass, suggesting an unusual biofilm phenotype requiring further investigation. This study proposes a standardized biofilm model for the evaluation of mono- and multispecies biofilms suitable for the different species of Malassezia. This model represents a relevant tool for studying interspecies interactions and for the development of new antifungal strategies targeting Malassezia biofilms.
Additional Links: PMID-43002882
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43002882,
year = {2026},
author = {Porcheron, JE and Nalet, L and Crapart, S and Girardot, M and Imbert, C and Cateau, E},
title = {Overcoming hurdles in developing a reliable and reproducible biofilm model of Malassezia applied to M. furfur, M. pachydermatis, M. sympodialis and M. slooffiae.},
journal = {Journal de mycologie medicale},
volume = {37},
number = {1},
pages = {101669},
doi = {10.1016/j.mycmed.2026.101669},
pmid = {43002882},
issn = {1773-0449},
abstract = {Yeasts belonging to the Malassezia genus represent the predominant fungi of the human skin microbiota. Their involvement in various pathologies is notably associated with their ability to form biofilms. However, knowledge regarding these structures remains limited due to culture constraints related to lipid dependence. This study aimed to develop a reliable in vitro model for studying mono- and multispecies Malassezia biofilms, using M. furfur, M. pachydermatis, M. sympodialis, and M. slooffiae. To overcome the natural aggregation of cells, a sonication protocol was optimized to obtain homogeneous suspensions without affecting cell viability. A correlation between optical density at 600 nm and cell concentration enabled the rapid standardization of Malassezia inocula. The comparative study of planktonic growth kinetics revealed generation times ranging from 7 to 15 h depending on the species, with M. sympodialis exhibiting the fastest growth. No difference was observed for M. furfur and M. sympodialis grown in single or mixed culture in planktonic conditions. Biofilm development was monitored over 168 h by quantifying biomass and metabolic activity. M. furfur, M. pachydermatis, and M. sympodialis showed a significant increase in both parameters, typical of mature biofilms. In contrast, M. slooffiae exhibited an increase in metabolic activity without a significant increase in biomass, suggesting an unusual biofilm phenotype requiring further investigation. This study proposes a standardized biofilm model for the evaluation of mono- and multispecies biofilms suitable for the different species of Malassezia. This model represents a relevant tool for studying interspecies interactions and for the development of new antifungal strategies targeting Malassezia biofilms.},
}
RevDate: 2026-11-07
CmpDate: 2026-11-07
Quorum Sensing and Biofilm Regulation in ESKAPE Pathogens: Mechanisms, Therapeutic Targets, and Translational Challenges.
Current microbiology, 83(12):.
Antimicrobial resistance (AMR) is an emerging global health threat responsible for antibiotics being ineffective, leading to persistent infections, increased mortality, and healthcare costs. ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens have a higher priority worldwide for the development of therapeutic approaches other than traditional antibiotics. Quorum sensing (QS) links population-dependent gene expression with a mechanistic understanding of bacterial communication, virulence regulation, and biofilm-associated persistence. Major QS systems across ESKAPE pathogens are Agr and accessory gene regulator networks in Gram-positive bacteria; LuxS/AI-2 signaling; the LuxI/LuxR-family systems in Gram-negative bacteria; the Las, Rhl, and Pseudomonas quinolone signal (PQS) networks in P. aeruginosa; and the AbaI/AbaR system in A. baumannii. This review focuses on QS regulatory mechanisms in ESKAPE pathogens and discusses the novel approaches to target QS-associated virulence and biofilm formation. A review of the literature on QS signaling pathways, biofilm regulation, and anti-QS therapies was performed with special focus on combating strategies like plant-derived phytochemicals, synthetic QS inhibitors, enzymatic quorum quenching, probiotics, and combinations of QS-targeted agents with conventional antibiotics. QS systems are involved in virulence regulation, adhesion, biofilm maturation, and bacterial persistence. Plant-based compounds such as flavonoids, alkaloids, terpenoids, and polyphenols have been shown to have potential to interfere with QS-related processes. Synthetic inhibitors, quorum-quenching enzymes, probiotics, and antibiotic combination strategies are also promising approaches. By integrating QS regulation with virulence, biofilm biology, and antimicrobial response across ESKAPE pathogens, this review provides a comparative framework to guide future target prioritization, diagnostic development, and evaluation of adjunctive anti-virulence strategies. Mechanistic validation, standardized cross-pathogen comparisons, and long-term resistance-evolution studies are needed to establish the therapeutic readiness and clinical value of these approaches.
Additional Links: PMID-42998103
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42998103,
year = {2026},
author = {Saini, J and Gautam, S and Sharma, D and Khanduri, A and Venugopal, D},
title = {Quorum Sensing and Biofilm Regulation in ESKAPE Pathogens: Mechanisms, Therapeutic Targets, and Translational Challenges.},
journal = {Current microbiology},
volume = {83},
number = {12},
pages = {},
pmid = {42998103},
issn = {1432-0991},
mesh = {*Quorum Sensing/drug effects ; *Biofilms/growth & development/drug effects ; Anti-Bacterial Agents/pharmacology ; Humans ; Gene Expression Regulation, Bacterial ; Virulence ; Signal Transduction ; Bacterial Proteins/genetics/metabolism ; *Gram-Positive Bacteria/physiology/drug effects/genetics ; *Gram-Negative Bacteria/physiology/drug effects/genetics ; },
abstract = {Antimicrobial resistance (AMR) is an emerging global health threat responsible for antibiotics being ineffective, leading to persistent infections, increased mortality, and healthcare costs. ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens have a higher priority worldwide for the development of therapeutic approaches other than traditional antibiotics. Quorum sensing (QS) links population-dependent gene expression with a mechanistic understanding of bacterial communication, virulence regulation, and biofilm-associated persistence. Major QS systems across ESKAPE pathogens are Agr and accessory gene regulator networks in Gram-positive bacteria; LuxS/AI-2 signaling; the LuxI/LuxR-family systems in Gram-negative bacteria; the Las, Rhl, and Pseudomonas quinolone signal (PQS) networks in P. aeruginosa; and the AbaI/AbaR system in A. baumannii. This review focuses on QS regulatory mechanisms in ESKAPE pathogens and discusses the novel approaches to target QS-associated virulence and biofilm formation. A review of the literature on QS signaling pathways, biofilm regulation, and anti-QS therapies was performed with special focus on combating strategies like plant-derived phytochemicals, synthetic QS inhibitors, enzymatic quorum quenching, probiotics, and combinations of QS-targeted agents with conventional antibiotics. QS systems are involved in virulence regulation, adhesion, biofilm maturation, and bacterial persistence. Plant-based compounds such as flavonoids, alkaloids, terpenoids, and polyphenols have been shown to have potential to interfere with QS-related processes. Synthetic inhibitors, quorum-quenching enzymes, probiotics, and antibiotic combination strategies are also promising approaches. By integrating QS regulation with virulence, biofilm biology, and antimicrobial response across ESKAPE pathogens, this review provides a comparative framework to guide future target prioritization, diagnostic development, and evaluation of adjunctive anti-virulence strategies. Mechanistic validation, standardized cross-pathogen comparisons, and long-term resistance-evolution studies are needed to establish the therapeutic readiness and clinical value of these approaches.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Quorum Sensing/drug effects
*Biofilms/growth & development/drug effects
Anti-Bacterial Agents/pharmacology
Humans
Gene Expression Regulation, Bacterial
Virulence
Signal Transduction
Bacterial Proteins/genetics/metabolism
*Gram-Positive Bacteria/physiology/drug effects/genetics
*Gram-Negative Bacteria/physiology/drug effects/genetics
RevDate: 2026-11-06
CmpDate: 2026-11-06
Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq.
Journal of proteome research, 25(11):5873-5883.
Biofilms are estimated to account for a large proportion of persistent microbial infections and are associated with substantial mortality in hospitals. Pseudomonas aeruginosa biofilms exhibit higher resistance to antibiotics compared to their planktonic growth form, making them difficult to eradicate and contributing to the mounting global challenge posed by infectious diseases. To gain deeper insights into the metabolic response of biofilms to antibiotic pressure, we conducted a quantitative, untargeted metabolomics analysis using heteronuclear 2D NMR spectroscopy. Biofilms were grown in the presence of sub-inhibitory concentrations of tobramycin, and metabolic alterations were identified and quantified using the COLMARq analysis platform. Our analysis revealed significant metabolic shifts even at low doses of tobramycin with key metabolites such as UDP-glucose increasing and putrescine decreasing. Pathway enrichment analysis highlighted alterations in amino acid biosynthesis, energy metabolism, and stress response pathways. Notably, the accumulation of glutathione disulfide indicates enhanced oxidative stress, while the depletion of β-alanine, succinate, and GABA suggested metabolic shifts linked to biofilm adaptation. These findings provide new insights into the metabolic reprogramming of biofilms under antibiotic treatment and offer perspectives into biofilm behavior in the case of Pseudomonas aeruginosa when exposed to antibiotics from an early stage of infection.
Additional Links: PMID-42992865
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42992865,
year = {2026},
author = {Choo, M and Li, DW and Lee, K and Sindeldecker, D and Bruschweiler-Li, L and Brüschweiler, R},
title = {Metabolomic Changes in Biofilm of Pseudomonas aeruginosa Under Early-Stage Tobramycin Treatment Identified by 2D NMR-Based COLMARq.},
journal = {Journal of proteome research},
volume = {25},
number = {11},
pages = {5873-5883},
doi = {10.1021/acs.jproteome.6c00323},
pmid = {42992865},
issn = {1535-3907},
support = {R35GM139482//Foundation for the National Institutes of Health/ ; RS-2024-00407904//National Research Foundation of Korea/ ; },
mesh = {*Pseudomonas aeruginosa/drug effects/metabolism ; *Biofilms/drug effects/growth & development ; *Tobramycin/pharmacology ; *Anti-Bacterial Agents/pharmacology ; *Metabolomics/methods ; Oxidative Stress/drug effects ; Magnetic Resonance Spectroscopy ; *Metabolome/drug effects ; Putrescine/metabolism ; },
abstract = {Biofilms are estimated to account for a large proportion of persistent microbial infections and are associated with substantial mortality in hospitals. Pseudomonas aeruginosa biofilms exhibit higher resistance to antibiotics compared to their planktonic growth form, making them difficult to eradicate and contributing to the mounting global challenge posed by infectious diseases. To gain deeper insights into the metabolic response of biofilms to antibiotic pressure, we conducted a quantitative, untargeted metabolomics analysis using heteronuclear 2D NMR spectroscopy. Biofilms were grown in the presence of sub-inhibitory concentrations of tobramycin, and metabolic alterations were identified and quantified using the COLMARq analysis platform. Our analysis revealed significant metabolic shifts even at low doses of tobramycin with key metabolites such as UDP-glucose increasing and putrescine decreasing. Pathway enrichment analysis highlighted alterations in amino acid biosynthesis, energy metabolism, and stress response pathways. Notably, the accumulation of glutathione disulfide indicates enhanced oxidative stress, while the depletion of β-alanine, succinate, and GABA suggested metabolic shifts linked to biofilm adaptation. These findings provide new insights into the metabolic reprogramming of biofilms under antibiotic treatment and offer perspectives into biofilm behavior in the case of Pseudomonas aeruginosa when exposed to antibiotics from an early stage of infection.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Pseudomonas aeruginosa/drug effects/metabolism
*Biofilms/drug effects/growth & development
*Tobramycin/pharmacology
*Anti-Bacterial Agents/pharmacology
*Metabolomics/methods
Oxidative Stress/drug effects
Magnetic Resonance Spectroscopy
*Metabolome/drug effects
Putrescine/metabolism
RevDate: 2026-11-06
RelA-mediated stringent response orchestrates pleomorphism and stress resilience in Bacillus subtilis biofilm.
Microbiological research, 315:128812 pii:S0944-5013(26)00376-9 [Epub ahead of print].
Biofilm are spatially structured microbial communities where environmental gradients impose stress that drive bacterial adaptation. In this study, we show that the RelA-mediated stringent response orchestrates pleomorphism and stress resilience in Bacillus subtilis biofilm at acidic pH. Acidic conditions increased membrane fluidity and induced depolarization, which led to the upregulation of relA and the repression of cytoskeletal genes, thereby reducing cell size. Supplementation with Mg[2+], an essential cofactor for RelA, reduced cell size, suppressed dispersal pathways, and stimulated extracellular matrix production, ultimately enhancing biofilm integrity. In contrast, ΔrelA mutants failed to mount a stringent response and displayed aberrant morphology, reduced swarming motility and impaired pellicle formation. Moreover, this mutation led to a defect in adaptation to acid stress and was correlated with altered expression of the SigD regulon. These findings establish the RelA-mediated stringent response as the central switch coupling acidic pH sensing to morphological plasticity, membrane remodelling, and collective stress tolerance. By coordinating pleomorphic transitions with biofilm stabilization, RelA enables bacterial populations to withstand hostile microenvironments while maintaining structural cohesion. This study shows that the stringent response is an important factor in bacterial survival and identifies RelA as a key regulator of biofilm pleomorphism and stress tolerance, which could be targeted to interfere with biofilm persistence in clinical, industrial and ecological contexts.
Additional Links: PMID-42994042
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42994042,
year = {2026},
author = {Dey, S and Das, S},
title = {RelA-mediated stringent response orchestrates pleomorphism and stress resilience in Bacillus subtilis biofilm.},
journal = {Microbiological research},
volume = {315},
number = {},
pages = {128812},
doi = {10.1016/j.micres.2026.128812},
pmid = {42994042},
issn = {1618-0623},
abstract = {Biofilm are spatially structured microbial communities where environmental gradients impose stress that drive bacterial adaptation. In this study, we show that the RelA-mediated stringent response orchestrates pleomorphism and stress resilience in Bacillus subtilis biofilm at acidic pH. Acidic conditions increased membrane fluidity and induced depolarization, which led to the upregulation of relA and the repression of cytoskeletal genes, thereby reducing cell size. Supplementation with Mg[2+], an essential cofactor for RelA, reduced cell size, suppressed dispersal pathways, and stimulated extracellular matrix production, ultimately enhancing biofilm integrity. In contrast, ΔrelA mutants failed to mount a stringent response and displayed aberrant morphology, reduced swarming motility and impaired pellicle formation. Moreover, this mutation led to a defect in adaptation to acid stress and was correlated with altered expression of the SigD regulon. These findings establish the RelA-mediated stringent response as the central switch coupling acidic pH sensing to morphological plasticity, membrane remodelling, and collective stress tolerance. By coordinating pleomorphic transitions with biofilm stabilization, RelA enables bacterial populations to withstand hostile microenvironments while maintaining structural cohesion. This study shows that the stringent response is an important factor in bacterial survival and identifies RelA as a key regulator of biofilm pleomorphism and stress tolerance, which could be targeted to interfere with biofilm persistence in clinical, industrial and ecological contexts.},
}
RevDate: 2026-11-06
Polymer-specific stimulation of sulfide and methane production by microplastics in sewer biofilm.
Environmental research pii:S0013-9351(26)02459-X [Epub ahead of print].
Microplastics (MPs) in wastewater elicit unintended impacts on bio-processes. However, little information is available regarding the response of sewer biofilm to MPs. This work clarifies how three structurally distinct MPs (i.e., polyethylene terephthalate (PET), polyvinyl chloride (PVC), and polyamide 6 (PA6)) at 500 μg/L within the reported wastewater range influence sulfide and methane production in sewer biofilm during long-term exposure and after cessation of external MP addition. Results showed all MPs increased the sulfidogenic activity relative to the control, with PVC exhibiting the greatest increase (33.3 ± 1.8%), followed by PA6 (23.7 ± 6.2%) and PET (16.0 ± 2.4%). PET uniquely increased methane production (21.3 ± 3.9%, p < 0.01), while PVC and PA6 showed no significant effect. Critically, these enhanced activities persisted after terminating external MP addition, indicating that the functional effects of long-term MP exposure can extend into the post-dosing phase. Genetically determined EPS restructuring enabled sewer biofilm defense against MPs, with enhanced secretion and hydrophobic component binding forming protective barriers against both MPs and associated chemical stress. The pronounced sulfidogenic response under PVC exposure coincided with increased humic-substance content and electron transport system activity, suggesting that alterations in the extracellular redox environment contributed to sulfate reduction. PET-specific methanogenesis was closely associated with elevated F420 activity and greater acetate-associated metabolic potential. Additionally, microbial community restructuring revealed a substrate-focused adaptation characterized by increased representation of hydrolytic/acidogenic populations and enhanced upstream substrate-processing potential. Collectively, these results indicate that MPs alter sewer sulfur and carbon transformations through polymer-dependent changes across extracellular, microbial, and metabolic levels. This study underscores the pervasive presence of MPs in wastewater as a concealed threat that aggravates corrosion and greenhouse gas emission in sewer systems.
Additional Links: PMID-42994779
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42994779,
year = {2026},
author = {Guo, H and Li, Z and Li, Y and Mu, L and Dai, S and Hou, J and He, Y and Wang, Y and Zhu, T and Tong, Y and Ni, BJ and Liu, Y},
title = {Polymer-specific stimulation of sulfide and methane production by microplastics in sewer biofilm.},
journal = {Environmental research},
volume = {},
number = {},
pages = {126124},
doi = {10.1016/j.envres.2026.126124},
pmid = {42994779},
issn = {1096-0953},
abstract = {Microplastics (MPs) in wastewater elicit unintended impacts on bio-processes. However, little information is available regarding the response of sewer biofilm to MPs. This work clarifies how three structurally distinct MPs (i.e., polyethylene terephthalate (PET), polyvinyl chloride (PVC), and polyamide 6 (PA6)) at 500 μg/L within the reported wastewater range influence sulfide and methane production in sewer biofilm during long-term exposure and after cessation of external MP addition. Results showed all MPs increased the sulfidogenic activity relative to the control, with PVC exhibiting the greatest increase (33.3 ± 1.8%), followed by PA6 (23.7 ± 6.2%) and PET (16.0 ± 2.4%). PET uniquely increased methane production (21.3 ± 3.9%, p < 0.01), while PVC and PA6 showed no significant effect. Critically, these enhanced activities persisted after terminating external MP addition, indicating that the functional effects of long-term MP exposure can extend into the post-dosing phase. Genetically determined EPS restructuring enabled sewer biofilm defense against MPs, with enhanced secretion and hydrophobic component binding forming protective barriers against both MPs and associated chemical stress. The pronounced sulfidogenic response under PVC exposure coincided with increased humic-substance content and electron transport system activity, suggesting that alterations in the extracellular redox environment contributed to sulfate reduction. PET-specific methanogenesis was closely associated with elevated F420 activity and greater acetate-associated metabolic potential. Additionally, microbial community restructuring revealed a substrate-focused adaptation characterized by increased representation of hydrolytic/acidogenic populations and enhanced upstream substrate-processing potential. Collectively, these results indicate that MPs alter sewer sulfur and carbon transformations through polymer-dependent changes across extracellular, microbial, and metabolic levels. This study underscores the pervasive presence of MPs in wastewater as a concealed threat that aggravates corrosion and greenhouse gas emission in sewer systems.},
}
RevDate: 2026-11-07
CmpDate: 2026-11-07
Clear aligner interface properties, oral microbial ecology, and strategies for biofilm control and caries-risk mitigation: a scoping review.
Frontiers in cellular and infection microbiology, 16:1951083.
BACKGROUND: Clear aligners create an aligner-tooth interface that may retain saliva, microorganisms, and dietary substrates. Evidence linking interface properties, oral microecological responses, and preventive interventions remains fragmented.
OBJECTIVE: To map and synthesize evidence on clear aligner interface properties and microbial adhesion, oral microbial ecology during clear aligner wear, and strategies for biofilm control and caries-risk mitigation.
METHODS: Following Joanna Briggs Institute methodology and PRISMA-ScR guidance, PubMed, Embase, and Web of Science Core Collection were searched from inception to August 31, 2026, without language restrictions. Backward and forward citation searching supplemented database searches. Original clinical, in vitro, and ex vivo studies involving active clear aligner treatment, associated materials or interfaces, or clear-aligner-specific interventions were eligible when they reported microbial, biofilm, microbiome, metabolomic, caries-related, or mineral outcomes. Two reviewers independently screened records; two authors charted and verified data. Findings were synthesized descriptively within three evidence domains.
RESULTS: Of 988 records, 132 reports were included. Because reports could contribute to more than one domain, 62 informed interface properties and microbial adhesion, 47 oral microbial ecology during wear, and 76 biofilm control and caries-risk mitigation. No single polymer, manufacturing method, or surface parameter consistently predicted microbial adhesion or biofilm formation. Outcomes reflected interactions among material characteristics, local topography, salivary conditioning, aging and exposure, microbial species, and experimental models. Clinical microbial responses were compartment- and time-dependent. Salivary and tooth-associated communities often remained relatively stable at the community level, whereas the inner aligner surface sometimes exhibited localized taxonomic, functional, metabolic, and pH-related changes. Investigated interventions included cleaning, antimicrobial and antifouling interface modifications, anticaries and remineralizing approaches, probiotics, and environment-responsive systems. Although many strategies reduced microbial burden, biofilm-related outcomes, acidogenicity, or mineral loss under tested conditions, evidence was predominantly short-term and preclinical. Assessments of durability, material performance, and safety were heterogeneous.
CONCLUSIONS: Clear aligner-microbiota interactions appear context-dependent rather than uniformly favorable or unfavorable. Evidence neither establishes causal relationships between interface or microecological changes and clinical disease nor identifies a universally superior intervention. More standardized, clinically representative evidence may clarify their clinical relevance and inform preventive management during clear aligner treatment.
Additional Links: PMID-42997201
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42997201,
year = {2026},
author = {Li, Z and Yang, Y and Liu, B and Sun, J and Tang, X and Yang, Y},
title = {Clear aligner interface properties, oral microbial ecology, and strategies for biofilm control and caries-risk mitigation: a scoping review.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {1951083},
doi = {10.3389/fcimb.2026.1951083},
pmid = {42997201},
issn = {2235-2988},
mesh = {*Biofilms/growth & development ; Humans ; *Dental Caries/prevention & control/microbiology ; *Microbiota ; *Mouth/microbiology ; Saliva/microbiology ; Bacterial Adhesion ; },
abstract = {BACKGROUND: Clear aligners create an aligner-tooth interface that may retain saliva, microorganisms, and dietary substrates. Evidence linking interface properties, oral microecological responses, and preventive interventions remains fragmented.
OBJECTIVE: To map and synthesize evidence on clear aligner interface properties and microbial adhesion, oral microbial ecology during clear aligner wear, and strategies for biofilm control and caries-risk mitigation.
METHODS: Following Joanna Briggs Institute methodology and PRISMA-ScR guidance, PubMed, Embase, and Web of Science Core Collection were searched from inception to August 31, 2026, without language restrictions. Backward and forward citation searching supplemented database searches. Original clinical, in vitro, and ex vivo studies involving active clear aligner treatment, associated materials or interfaces, or clear-aligner-specific interventions were eligible when they reported microbial, biofilm, microbiome, metabolomic, caries-related, or mineral outcomes. Two reviewers independently screened records; two authors charted and verified data. Findings were synthesized descriptively within three evidence domains.
RESULTS: Of 988 records, 132 reports were included. Because reports could contribute to more than one domain, 62 informed interface properties and microbial adhesion, 47 oral microbial ecology during wear, and 76 biofilm control and caries-risk mitigation. No single polymer, manufacturing method, or surface parameter consistently predicted microbial adhesion or biofilm formation. Outcomes reflected interactions among material characteristics, local topography, salivary conditioning, aging and exposure, microbial species, and experimental models. Clinical microbial responses were compartment- and time-dependent. Salivary and tooth-associated communities often remained relatively stable at the community level, whereas the inner aligner surface sometimes exhibited localized taxonomic, functional, metabolic, and pH-related changes. Investigated interventions included cleaning, antimicrobial and antifouling interface modifications, anticaries and remineralizing approaches, probiotics, and environment-responsive systems. Although many strategies reduced microbial burden, biofilm-related outcomes, acidogenicity, or mineral loss under tested conditions, evidence was predominantly short-term and preclinical. Assessments of durability, material performance, and safety were heterogeneous.
CONCLUSIONS: Clear aligner-microbiota interactions appear context-dependent rather than uniformly favorable or unfavorable. Evidence neither establishes causal relationships between interface or microecological changes and clinical disease nor identifies a universally superior intervention. More standardized, clinically representative evidence may clarify their clinical relevance and inform preventive management during clear aligner treatment.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
Humans
*Dental Caries/prevention & control/microbiology
*Microbiota
*Mouth/microbiology
Saliva/microbiology
Bacterial Adhesion
RevDate: 2026-11-05
Statement of Retraction: Analysis of abnormal intestinal flora on risk of intestinal cancer and effect of heparin on formation of bacterial biofilm.
Bioengineered, 17(1):2745507.
Additional Links: PMID-42987299
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42987299,
year = {2026},
author = {},
title = {Statement of Retraction: Analysis of abnormal intestinal flora on risk of intestinal cancer and effect of heparin on formation of bacterial biofilm.},
journal = {Bioengineered},
volume = {17},
number = {1},
pages = {2745507},
doi = {10.1080/21655979.2026.2745507},
pmid = {42987299},
issn = {2165-5987},
}
RevDate: 2026-11-05
Statement of Retraction: Regulatory network controls microbial biofilm development, with Candida albicans as a representative: from adhesion to dispersal.
Bioengineered, 17(1):2745754.
Additional Links: PMID-42987402
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42987402,
year = {2026},
author = {},
title = {Statement of Retraction: Regulatory network controls microbial biofilm development, with Candida albicans as a representative: from adhesion to dispersal.},
journal = {Bioengineered},
volume = {17},
number = {1},
pages = {2745754},
doi = {10.1080/21655979.2026.2745754},
pmid = {42987402},
issn = {2165-5987},
}
RevDate: 2026-11-05
Microbial biofilm-radionuclide interfaces in contaminated soils and waters: Extracellular polymeric substances, redox transformations and remobilisation risks.
Journal of environmental radioactivity, 301:108221 pii:S0265-931X(26)00336-X [Epub ahead of print].
Microbial biofilms are increasingly recognised as chemically active interfaces that determine whether radionuclides remain dissolved, accumulate in sediments or enter secondary transport pathways. Their extracellular polymeric substances (EPS) supply diverse binding ligands, create steep microenvironmental gradients and retain redox-active cofactors, thereby coupling sorption to metabolic and mineral-mediated transformations. Yet these same properties complicate claims of durable immobilisation: adsorbed radionuclides may desorb, biomass-associated reduced species may be less persistent than crystalline minerals, and detachment can convert a local sink into a mobile carrier. This review critically examines the interaction of microbial biofilms with uranium, technetium, neptunium, plutonium, caesium, strontium and selected redox-sensitive co-contaminants in contaminated soils, groundwater and surface-water sediments. Particular attention is given to molecular EPS composition, coordination chemistry, extracellular electron transfer, U(IV) product identity, Fe-Mn-S coupling, phosphate mineralisation and redox reversal. Recent evidence from contaminated-aquifer biofilms, field bioaugmentation, flow-through reactors and molecular spectroscopy is assessed by distinguishing instantaneous removal, retained inventory, mineralogical persistence and cumulative contaminant export. A mechanistic risk framework is proposed in which long-term performance depends on the evolving relationship among biofilm physiology, aqueous ligands, oxidant fluxes, hydraulic connectivity and particle mobilisation. The central implication is that biofilm-enhanced sequestration should be judged by radionuclide mass balance and post-disturbance stability rather than by short-term decreases in dissolved concentration alone.
Additional Links: PMID-42987540
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42987540,
year = {2026},
author = {Meivelu Moovendhan, },
title = {Microbial biofilm-radionuclide interfaces in contaminated soils and waters: Extracellular polymeric substances, redox transformations and remobilisation risks.},
journal = {Journal of environmental radioactivity},
volume = {301},
number = {},
pages = {108221},
doi = {10.1016/j.jenvrad.2026.108221},
pmid = {42987540},
issn = {1879-1700},
abstract = {Microbial biofilms are increasingly recognised as chemically active interfaces that determine whether radionuclides remain dissolved, accumulate in sediments or enter secondary transport pathways. Their extracellular polymeric substances (EPS) supply diverse binding ligands, create steep microenvironmental gradients and retain redox-active cofactors, thereby coupling sorption to metabolic and mineral-mediated transformations. Yet these same properties complicate claims of durable immobilisation: adsorbed radionuclides may desorb, biomass-associated reduced species may be less persistent than crystalline minerals, and detachment can convert a local sink into a mobile carrier. This review critically examines the interaction of microbial biofilms with uranium, technetium, neptunium, plutonium, caesium, strontium and selected redox-sensitive co-contaminants in contaminated soils, groundwater and surface-water sediments. Particular attention is given to molecular EPS composition, coordination chemistry, extracellular electron transfer, U(IV) product identity, Fe-Mn-S coupling, phosphate mineralisation and redox reversal. Recent evidence from contaminated-aquifer biofilms, field bioaugmentation, flow-through reactors and molecular spectroscopy is assessed by distinguishing instantaneous removal, retained inventory, mineralogical persistence and cumulative contaminant export. A mechanistic risk framework is proposed in which long-term performance depends on the evolving relationship among biofilm physiology, aqueous ligands, oxidant fluxes, hydraulic connectivity and particle mobilisation. The central implication is that biofilm-enhanced sequestration should be judged by radionuclide mass balance and post-disturbance stability rather than by short-term decreases in dissolved concentration alone.},
}
RevDate: 2026-11-06
CmpDate: 2026-11-06
Biofilm Engineering for Efficient Substrate-Enzyme Interactions to Enhance Enzymatic PET Degradation.
Microbial biotechnology, 19(11):.
Despite extensive protein engineering efforts to significantly increase the catalytic efficiency of plastic-degrading enzymes, inefficient plastic-enzyme interactions during the interfacial biocatalytic process continue to impede their widespread applications. Here, we engineered the complete csgBACEFG curli operon through multicopy chromosomal integration to generate a csgBACEFG-optimized (CSGO) biofilm with enhanced curli assembly and plastic-surface adhesion. Unlike previou curli-based enzyme immobilization studies using individual CsgA curli components or pre-existing curli scaffolds, our strategy uses the complete curli assembly machinery to construct a dense, surface-associated catalytic biofilm. FAST-PETase was then embedded in a 2-day PET-surface CSGO biofilm through the SpyTag/SpyCatcher system, producing 2.5-fold more hydrolysis products from PET film depolymerization than soluble FAST-PETase with the same initial enzyme mass. The carrier-free biofilm-supported FAST-PETase also retained more than 50% of its first-cycle product formation after five 24-h PET nanoplastic (NanoPET) degradation cycles. These findings support biofilm-mediated enhancement of PET depolymerization and provide a proof-of-concept strategy that may inform future biofilm-assisted plastic treatment.
Additional Links: PMID-42989819
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42989819,
year = {2026},
author = {Zhou, X and Zhou, X and Feng, L and Wei, R and Schwaneberg, U and Blank, LM and Xu, A and Dong, W and Jiang, M},
title = {Biofilm Engineering for Efficient Substrate-Enzyme Interactions to Enhance Enzymatic PET Degradation.},
journal = {Microbial biotechnology},
volume = {19},
number = {11},
pages = {},
doi = {10.1111/1751-7915.70458},
pmid = {42989819},
issn = {1751-7915},
support = {2023YFC3905002//National Key R & D Program of China/ ; 32670035//National Natural Science Foundation of China/ ; U23A20126//National Natural Science Foundation of China/ ; 101307220//HORIZON EUROPE European Innovation Council (EIC)/ ; //Werner Siemens Foundation in the frame of the WSS Research Center/ ; //Jiangsu Postgraduate Research and Practice Innovation Program/ ; },
mesh = {*Biofilms/growth & development ; *Polyethylene Terephthalates/metabolism ; Enzymes, Immobilized/metabolism/genetics ; Protein Engineering ; Bacterial Proteins/metabolism/genetics ; Operon ; },
abstract = {Despite extensive protein engineering efforts to significantly increase the catalytic efficiency of plastic-degrading enzymes, inefficient plastic-enzyme interactions during the interfacial biocatalytic process continue to impede their widespread applications. Here, we engineered the complete csgBACEFG curli operon through multicopy chromosomal integration to generate a csgBACEFG-optimized (CSGO) biofilm with enhanced curli assembly and plastic-surface adhesion. Unlike previou curli-based enzyme immobilization studies using individual CsgA curli components or pre-existing curli scaffolds, our strategy uses the complete curli assembly machinery to construct a dense, surface-associated catalytic biofilm. FAST-PETase was then embedded in a 2-day PET-surface CSGO biofilm through the SpyTag/SpyCatcher system, producing 2.5-fold more hydrolysis products from PET film depolymerization than soluble FAST-PETase with the same initial enzyme mass. The carrier-free biofilm-supported FAST-PETase also retained more than 50% of its first-cycle product formation after five 24-h PET nanoplastic (NanoPET) degradation cycles. These findings support biofilm-mediated enhancement of PET depolymerization and provide a proof-of-concept strategy that may inform future biofilm-assisted plastic treatment.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Biofilms/growth & development
*Polyethylene Terephthalates/metabolism
Enzymes, Immobilized/metabolism/genetics
Protein Engineering
Bacterial Proteins/metabolism/genetics
Operon
RevDate: 2026-11-06
CmpDate: 2026-11-06
Contact-dependent interactions between Cutibacterium acnes and Staphylococcus lugdunensis promote biofilm matrix remodeling.
Research square pii:rs.3.rs-11542571.
Prosthetic joint infections (PJIs) pose a substantial burden to patients and healthcare systems. These infections are often persistent and frequently require revision procedures, increasing the risk of surgical failure and mortality. A major virulence determinant underlying their persistence is biofilm formation, which protects bacteria from antibiotic treatment and host immune defenses. Understanding the mechanisms that promote biofilm formation is therefore critical for improving PJI management. Staphylococcus spp. and Cutibacterium acnes are common skin commensals that are frequently co-isolated from chronic prosthetic device infections. We hypothesized that these organisms interact synergistically to enhance the persistence of polymicrobial infections. We found that C. acnes increases dual-species biofilm formation with Staphylococcus lugdunensis and Staphylococcus hominis relative to monocultures. This phenotype was specific to these species combinations and was widespread among the strains tested. To investigate the underlying mechanism, we focused on the interaction between C. acnes and S. lugdunensis . Enhanced biofilm formation required both species to be metabolically active and in direct physical contact. Notably, co-culture shifted S. lugdunensis biofilms from their typical proteinaceous matrix to a polysaccharide intercellular adhesin (PIA)-rich matrix. Consistent with this transition, co-culture with C. acnes significantly increased expression of icaA , a gene involved in PIA biosynthesis, while having no effect on expression of atlL and mgtE , genes associated with the proteinaceous matrix of S. lugdunensis . Together, these findings reveal a novel contact-dependent interspecies interaction in which C. acnes promotes a switch to PIA-mediated biofilm formation in S. lugdunensis , a mechanism that may enhance persistence on medical devices and contribute to chronic polymicrobial infections.
Additional Links: PMID-42990535
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42990535,
year = {2026},
author = {Ng, BD and Reviello, JS and Snider, RL and Faria, MFM and Lopes, JFS and Ferreira, EO and Lobo, LA and Ferreira, RBR},
title = {Contact-dependent interactions between Cutibacterium acnes and Staphylococcus lugdunensis promote biofilm matrix remodeling.},
journal = {Research square},
volume = {},
number = {},
pages = {},
doi = {10.21203/rs.3.rs-11542571/v1},
pmid = {42990535},
issn = {2693-5015},
abstract = {Prosthetic joint infections (PJIs) pose a substantial burden to patients and healthcare systems. These infections are often persistent and frequently require revision procedures, increasing the risk of surgical failure and mortality. A major virulence determinant underlying their persistence is biofilm formation, which protects bacteria from antibiotic treatment and host immune defenses. Understanding the mechanisms that promote biofilm formation is therefore critical for improving PJI management. Staphylococcus spp. and Cutibacterium acnes are common skin commensals that are frequently co-isolated from chronic prosthetic device infections. We hypothesized that these organisms interact synergistically to enhance the persistence of polymicrobial infections. We found that C. acnes increases dual-species biofilm formation with Staphylococcus lugdunensis and Staphylococcus hominis relative to monocultures. This phenotype was specific to these species combinations and was widespread among the strains tested. To investigate the underlying mechanism, we focused on the interaction between C. acnes and S. lugdunensis . Enhanced biofilm formation required both species to be metabolically active and in direct physical contact. Notably, co-culture shifted S. lugdunensis biofilms from their typical proteinaceous matrix to a polysaccharide intercellular adhesin (PIA)-rich matrix. Consistent with this transition, co-culture with C. acnes significantly increased expression of icaA , a gene involved in PIA biosynthesis, while having no effect on expression of atlL and mgtE , genes associated with the proteinaceous matrix of S. lugdunensis . Together, these findings reveal a novel contact-dependent interspecies interaction in which C. acnes promotes a switch to PIA-mediated biofilm formation in S. lugdunensis , a mechanism that may enhance persistence on medical devices and contribute to chronic polymicrobial infections.},
}
RevDate: 2026-11-06
CmpDate: 2026-11-06
From biofilm tolerance to antimicrobial resistance: molecular adaptation strategies and emerging therapeutic vulnerabilities in resistant pathogens.
Frontiers in microbiology, 17:1988464.
Bacterial biofilms are highly structured microbial communities which allow organisms to persist under different environmental challenges such as limitation of nutrients, oxidative stress, host immune defense, and antimicrobial agents. While antimicrobial resistance (AMR) has been well recognized as a key factor contributing to treatment failure, more and more evidence reported that biofilm-associated persistence is initially caused by antimicrobial tolerance rather than genetically encoded resistance. Tolerance is a change in physiology that enables the bacterial population to persist through a temporary exposure to an antimicrobial agent, while resistance is a stable heritable alteration that confers a decreased susceptibility to an antimicrobial agent. In biofilms, the bacteria are distributed in a heterogeneous manner in different ecological niches with different metabolic activities, oxygen gradients, stress responses and nutrient accessibility. This heterogeneity gives rise to specialized subpopulations, including dormant persisters that serve as reservoirs for further evolutionary adaptation. Biofilm development results in a selective environment that allows the pressure of antimicrobial agents to induce molecular adaptation through remodelling of extracellular polymeric substance (EPS), metabolic reprogramming, oxidative stress management, quorum sensing, cyclic di-guanosine monophosphate (c-di-GMP) signaling, efflux activation, horizontal gene transfer and diversification via mutations. Such processes form a continuum of tolerance-resistance, with short-term survival processes potentially leading to the development and fixation of resistant phenotypes. Traditional antimicrobial strategies, mainly relying on planktonic susceptibility testing, fail in the resilience of biofilms, necessitating biofilm-specific therapeutic strategies. Here, we review an integrated framework that describes the way in which bacterial biofilms move from antimicrobial tolerance to resistance evolution. We focus on strategies to intercept biofilm adaptation before stable resistance is achieved, using a combination of evolutionary microbiology, molecular regulation, single-cell biology and therapeutic innovation.
Additional Links: PMID-42991282
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42991282,
year = {2026},
author = {Guchhait, KC and Dey, S and Pradhan, SR and Panda, AK and Ghosh, C},
title = {From biofilm tolerance to antimicrobial resistance: molecular adaptation strategies and emerging therapeutic vulnerabilities in resistant pathogens.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1988464},
pmid = {42991282},
issn = {1664-302X},
abstract = {Bacterial biofilms are highly structured microbial communities which allow organisms to persist under different environmental challenges such as limitation of nutrients, oxidative stress, host immune defense, and antimicrobial agents. While antimicrobial resistance (AMR) has been well recognized as a key factor contributing to treatment failure, more and more evidence reported that biofilm-associated persistence is initially caused by antimicrobial tolerance rather than genetically encoded resistance. Tolerance is a change in physiology that enables the bacterial population to persist through a temporary exposure to an antimicrobial agent, while resistance is a stable heritable alteration that confers a decreased susceptibility to an antimicrobial agent. In biofilms, the bacteria are distributed in a heterogeneous manner in different ecological niches with different metabolic activities, oxygen gradients, stress responses and nutrient accessibility. This heterogeneity gives rise to specialized subpopulations, including dormant persisters that serve as reservoirs for further evolutionary adaptation. Biofilm development results in a selective environment that allows the pressure of antimicrobial agents to induce molecular adaptation through remodelling of extracellular polymeric substance (EPS), metabolic reprogramming, oxidative stress management, quorum sensing, cyclic di-guanosine monophosphate (c-di-GMP) signaling, efflux activation, horizontal gene transfer and diversification via mutations. Such processes form a continuum of tolerance-resistance, with short-term survival processes potentially leading to the development and fixation of resistant phenotypes. Traditional antimicrobial strategies, mainly relying on planktonic susceptibility testing, fail in the resilience of biofilms, necessitating biofilm-specific therapeutic strategies. Here, we review an integrated framework that describes the way in which bacterial biofilms move from antimicrobial tolerance to resistance evolution. We focus on strategies to intercept biofilm adaptation before stable resistance is achieved, using a combination of evolutionary microbiology, molecular regulation, single-cell biology and therapeutic innovation.},
}
RevDate: 2026-11-06
CmpDate: 2026-11-06
Genomic insight into Enterococcus faecium biofilm formation isolated from catheter associated urinary tract infection.
Iranian journal of microbiology, 18(5):752-764.
BACKGROUND AND OBJECTIVES: Enterococcus faecium is a major nosocomial pathogen frequently associated with catheter-related infections and biofilm-mediated antimicrobial resistance. This study aimed to investigate the genomic determinants and structural characteristics underlying biofilm formation in a clinical E. faecium isolate recovered from a catheter-associated urinary tract infection (CAUTI).
MATERIALS AND METHODS: A clinical isolate, E. faecium MFKCC-BF.UR33, was subjected to whole-genome sequencing and comprehensive genome annotation to identify biofilm-associated and antimicrobial resistance genes. Phylogenetic analysis was performed to determine its relatedness to reference clinical strains. Structural modeling of selected biofilm-associated proteins was conducted using AlphaFold2 to assess their three-dimensional conformations and potential as therapeutic targets.
RESULTS: Whole-genome sequencing revealed a 3.32 Mb genome with a G+C content of 37.35%, comprising 2,321 predicted coding sequences and no detectable plasmids. Genome annotation identified several biofilm-associated genes, including sgrA, acm, fss3, scm, and efbA, as well as antimicrobial resistance genes (antA/B, tetM, tetL, efmA, and liaFSR). Phylogenetic analysis placed the isolate within the E. faecium clade, closely related to other clinical reference strains. Structural modeling demonstrated high-confidence 3D structures for Fss3 and EfbA proteins.
CONCLUSION: The integration of genomic and structural analyses provides insights into the genetic and structural basis of biofilm formation in E. faecium and establishes a foundation for future functional and structure-based investigations.
Additional Links: PMID-42992164
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42992164,
year = {2026},
author = {Rahayu, A and Aminy, SA and Umaroh, DA and Gusnaniar, N and Atikana, A and Lisdiyanti, P and Perraud, E and Imbert, C and Nuryastuti, T},
title = {Genomic insight into Enterococcus faecium biofilm formation isolated from catheter associated urinary tract infection.},
journal = {Iranian journal of microbiology},
volume = {18},
number = {5},
pages = {752-764},
pmid = {42992164},
issn = {2008-3289},
abstract = {BACKGROUND AND OBJECTIVES: Enterococcus faecium is a major nosocomial pathogen frequently associated with catheter-related infections and biofilm-mediated antimicrobial resistance. This study aimed to investigate the genomic determinants and structural characteristics underlying biofilm formation in a clinical E. faecium isolate recovered from a catheter-associated urinary tract infection (CAUTI).
MATERIALS AND METHODS: A clinical isolate, E. faecium MFKCC-BF.UR33, was subjected to whole-genome sequencing and comprehensive genome annotation to identify biofilm-associated and antimicrobial resistance genes. Phylogenetic analysis was performed to determine its relatedness to reference clinical strains. Structural modeling of selected biofilm-associated proteins was conducted using AlphaFold2 to assess their three-dimensional conformations and potential as therapeutic targets.
RESULTS: Whole-genome sequencing revealed a 3.32 Mb genome with a G+C content of 37.35%, comprising 2,321 predicted coding sequences and no detectable plasmids. Genome annotation identified several biofilm-associated genes, including sgrA, acm, fss3, scm, and efbA, as well as antimicrobial resistance genes (antA/B, tetM, tetL, efmA, and liaFSR). Phylogenetic analysis placed the isolate within the E. faecium clade, closely related to other clinical reference strains. Structural modeling demonstrated high-confidence 3D structures for Fss3 and EfbA proteins.
CONCLUSION: The integration of genomic and structural analyses provides insights into the genetic and structural basis of biofilm formation in E. faecium and establishes a foundation for future functional and structure-based investigations.},
}
RevDate: 2026-11-06
CmpDate: 2026-11-06
[Investigation of Biofilm Formation and als1, hwp1 and sap1 Genes in Candida Species Isolated from Urine Samples of Intensive Care Patients Using PCR].
Mikrobiyoloji bulteni, 60(4):494-506.
Candida species are among the important opportunistic agents associated with urinary tract infections and candiduria in intensive care units. Biofilm formation is clinically significant in terms of persistence and antifungal treatment failure in catheter-related infections. This study aimed to investigate the biofilm-forming ability of Candida species isolated from urine cultures of patients followed in intensive care units and the als1, hwp1 and sap1 genes which have been reported to be associated with biofilm, using polymerase chain reaction (PCR). A total of 70 Candida isolates obtained from pediatric and adult urine cultures were included in the study. Biofilm formation was evaluated using the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction method. PCR was performed to detect positivity for the als1, hwp1 and sap1 genes. Biofilm formation was detected in a total of 63 isolates (90.0%). Biofilm formation was more frequent in the adult group (97.1%) than in the pediatric group (82.8%), but the difference was not statistically significant (p= 0.106). Positivity rates for als1, hwp1 and sap1 genes were determined to be 69.6%, 52.2% and 69.6% in Candida albicans isolates and 8.5%, 6.4% and 6.4% in non-albicans Candida species isolates respectively and the difference between the groups was statistically significant (p< 0.001). In C.albicans isolates, the most frequently detected gene profile in biofilm-producing isolates was the als1-hwp1-sap1 triple positivity and this gene combination was more frequently detected in isolates forming moderate to strong biofilms. In our study, als1, hwp1 and sap1 genes were detected significantly more frequently in C.albicans isolates compared to non-albicans Candida isolates. This is consistent with the role of these genes in C.albicans biology. Due to the limitations of boilbased DNA extraction and primers, negative PCR results, particularly for non-albicans Candida species, should not be interpreted as gene absence. While our pediatric unit data contribute to local epidemiology, more advanced extraction methods and larger sample sizes are needed for definitive results.
Additional Links: PMID-42992494
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42992494,
year = {2026},
author = {Ateş, E and Birinci, A and Tanriverdi Çayci, Y and Gür Vural, D and Bilgin, K and Çinar, C},
title = {[Investigation of Biofilm Formation and als1, hwp1 and sap1 Genes in Candida Species Isolated from Urine Samples of Intensive Care Patients Using PCR].},
journal = {Mikrobiyoloji bulteni},
volume = {60},
number = {4},
pages = {494-506},
doi = {10.5578/mb.202604155},
pmid = {42992494},
issn = {0374-9096},
mesh = {Humans ; *Biofilms/growth & development ; *Candida/genetics/physiology/isolation & purification/classification ; Polymerase Chain Reaction ; *Candidiasis/microbiology ; Child ; Adult ; *Fungal Proteins/genetics ; *Urinary Tract Infections/microbiology ; Intensive Care Units ; *Membrane Glycoproteins/genetics ; *Urine/microbiology ; Child, Preschool ; },
abstract = {Candida species are among the important opportunistic agents associated with urinary tract infections and candiduria in intensive care units. Biofilm formation is clinically significant in terms of persistence and antifungal treatment failure in catheter-related infections. This study aimed to investigate the biofilm-forming ability of Candida species isolated from urine cultures of patients followed in intensive care units and the als1, hwp1 and sap1 genes which have been reported to be associated with biofilm, using polymerase chain reaction (PCR). A total of 70 Candida isolates obtained from pediatric and adult urine cultures were included in the study. Biofilm formation was evaluated using the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction method. PCR was performed to detect positivity for the als1, hwp1 and sap1 genes. Biofilm formation was detected in a total of 63 isolates (90.0%). Biofilm formation was more frequent in the adult group (97.1%) than in the pediatric group (82.8%), but the difference was not statistically significant (p= 0.106). Positivity rates for als1, hwp1 and sap1 genes were determined to be 69.6%, 52.2% and 69.6% in Candida albicans isolates and 8.5%, 6.4% and 6.4% in non-albicans Candida species isolates respectively and the difference between the groups was statistically significant (p< 0.001). In C.albicans isolates, the most frequently detected gene profile in biofilm-producing isolates was the als1-hwp1-sap1 triple positivity and this gene combination was more frequently detected in isolates forming moderate to strong biofilms. In our study, als1, hwp1 and sap1 genes were detected significantly more frequently in C.albicans isolates compared to non-albicans Candida isolates. This is consistent with the role of these genes in C.albicans biology. Due to the limitations of boilbased DNA extraction and primers, negative PCR results, particularly for non-albicans Candida species, should not be interpreted as gene absence. While our pediatric unit data contribute to local epidemiology, more advanced extraction methods and larger sample sizes are needed for definitive results.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Biofilms/growth & development
*Candida/genetics/physiology/isolation & purification/classification
Polymerase Chain Reaction
*Candidiasis/microbiology
Child
Adult
*Fungal Proteins/genetics
*Urinary Tract Infections/microbiology
Intensive Care Units
*Membrane Glycoproteins/genetics
*Urine/microbiology
Child, Preschool
RevDate: 2026-11-04
CmpDate: 2026-11-04
Direct regulation of a tRNA modification enzyme by ppGpp links stress signaling to translational control and biofilm development.
Science advances, 12(45):eaek6976.
Transfer RNA (tRNA) modifications influence decoding efficiency and translational fidelity, yet how they are integrated into bacterial signaling networks remains poorly understood. Here, we identify a direct connection between stress signaling and codon-specific translational regulation. We show that the alarmone guanosine tetraphosphate (ppGpp) directly inhibits MnmE (TrmE), a conserved tRNA-modification GTPase required for methylaminomethyl (mnm) modification of wobble uridine. High-resolution ribosome profiling in Bacillus subtilis revealed that loss of MnmE selectively increases ribosome pausing at AAG codons and reprograms translation of a subset of genes, including small open reading frames. Among these is a previously unrecognized AAG-containing leader peptide that controls expression of the biofilm repressor AbrB. Consistent with this mechanism, mnmE mutants exhibit constitutive extracellular matrix production and bypass the biofilm defect of a relA mutant. Together, these findings establish a pathway linking ppGpp signaling, tRNA modification, codon-specific translation, and multicellular development.
Additional Links: PMID-42981386
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42981386,
year = {2026},
author = {Trinquier, AE and Slama, F and Liu, J and Pham, L and Stolt, L and Wang, JD},
title = {Direct regulation of a tRNA modification enzyme by ppGpp links stress signaling to translational control and biofilm development.},
journal = {Science advances},
volume = {12},
number = {45},
pages = {eaek6976},
pmid = {42981386},
issn = {2375-2548},
mesh = {*RNA, Transfer/metabolism/genetics ; *Biofilms/growth & development ; *Bacillus subtilis/genetics/physiology/metabolism ; *Guanosine Tetraphosphate/metabolism ; *Signal Transduction ; *Protein Biosynthesis ; *Stress, Physiological ; Ribosome Profiling ; Bacterial Proteins/metabolism/genetics ; Gene Expression Regulation, Bacterial ; Codon ; Ribosomes/metabolism ; Mutation ; },
abstract = {Transfer RNA (tRNA) modifications influence decoding efficiency and translational fidelity, yet how they are integrated into bacterial signaling networks remains poorly understood. Here, we identify a direct connection between stress signaling and codon-specific translational regulation. We show that the alarmone guanosine tetraphosphate (ppGpp) directly inhibits MnmE (TrmE), a conserved tRNA-modification GTPase required for methylaminomethyl (mnm) modification of wobble uridine. High-resolution ribosome profiling in Bacillus subtilis revealed that loss of MnmE selectively increases ribosome pausing at AAG codons and reprograms translation of a subset of genes, including small open reading frames. Among these is a previously unrecognized AAG-containing leader peptide that controls expression of the biofilm repressor AbrB. Consistent with this mechanism, mnmE mutants exhibit constitutive extracellular matrix production and bypass the biofilm defect of a relA mutant. Together, these findings establish a pathway linking ppGpp signaling, tRNA modification, codon-specific translation, and multicellular development.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*RNA, Transfer/metabolism/genetics
*Biofilms/growth & development
*Bacillus subtilis/genetics/physiology/metabolism
*Guanosine Tetraphosphate/metabolism
*Signal Transduction
*Protein Biosynthesis
*Stress, Physiological
Ribosome Profiling
Bacterial Proteins/metabolism/genetics
Gene Expression Regulation, Bacterial
Codon
Ribosomes/metabolism
Mutation
▼ ▼ LOAD NEXT 100 CITATIONS
RJR Experience and Expertise
Researcher
Robbins holds BS, MS, and PhD degrees in the life sciences. He served as a tenured faculty member in the Zoology and Biological Science departments at Michigan State University. He is currently exploring the intersection between genomics, microbial ecology, and biodiversity — an area that promises to transform our understanding of the biosphere.
Educator
Robbins has extensive experience in college-level education: At MSU he taught introductory biology, genetics, and population genetics. At JHU, he was an instructor for a special course on biological database design. At FHCRC, he team-taught a graduate-level course on the history of genetics. At Bellevue College he taught medical informatics.
Administrator
Robbins has been involved in science administration at both the federal and the institutional levels. At NSF he was a program officer for database activities in the life sciences, at DOE he was a program officer for information infrastructure in the human genome project. At the Fred Hutchinson Cancer Research Center, he served as a vice president for fifteen years.
Technologist
Robbins has been involved with information technology since writing his first Fortran program as a college student. At NSF he was the first program officer for database activities in the life sciences. At JHU he held an appointment in the CS department and served as director of the informatics core for the Genome Data Base. At the FHCRC he was VP for Information Technology.
Publisher
While still at Michigan State, Robbins started his first publishing venture, founding a small company that addressed the short-run publishing needs of instructors in very large undergraduate classes. For more than 20 years, Robbins has been operating The Electronic Scholarly Publishing Project, a web site dedicated to the digital publishing of critical works in science, especially classical genetics.
Speaker
Robbins is well-known for his speaking abilities and is often called upon to provide keynote or plenary addresses at international meetings. For example, in July, 2012, he gave a well-received keynote address at the Global Biodiversity Informatics Congress, sponsored by GBIF and held in Copenhagen. The slides from that talk can be seen HERE.
Facilitator
Robbins is a skilled meeting facilitator. He prefers a participatory approach, with part of the meeting involving dynamic breakout groups, created by the participants in real time: (1) individuals propose breakout groups; (2) everyone signs up for one (or more) groups; (3) the groups with the most interested parties then meet, with reports from each group presented and discussed in a subsequent plenary session.
Designer
Robbins has been engaged with photography and design since the 1960s, when he worked for a professional photography laboratory. He now prefers digital photography and tools for their precision and reproducibility. He designed his first web site more than 20 years ago and he personally designed and implemented this web site. He engages in graphic design as a hobby.
RJR Picks from Around the Web (updated 11 MAY 2018 )
Old Science
Weird Science
Treating Disease with Fecal Transplantation
Fossils of miniature humans (hobbits) discovered in Indonesia
Paleontology
Dinosaur tail, complete with feathers, found preserved in amber.
Astronomy
Mysterious fast radio burst (FRB) detected in the distant universe.
Big Data & Informatics
Big Data: Buzzword or Big Deal?
Hacking the genome: Identifying anonymized human subjects using publicly available data.